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Abstract
This  thesis  describes  the  synthesis,  characterisation  and  application  of  artificial
metalloenzymes  as  catalysts.  The  focus  was  on  two  mutants  of  SCP-2L  (SCP-2L
A100C and SCP-2L V83C) both of which possess a hydrophobic tunnel in which apolar
substrates can accumulate.
The crystal structure of SCP-2L A100C was determined and discussed with a special
emphasis on its hydrophobic tunnel.
The  SCP-2L  mutants  were  covalently  modified  at  their  unique  cysteine  with  two
different  N-ligands  (phenanthroline  or  dipicolylamine  based) or  three  different
phosphine ligands (all based on triphenylphosphine) in order to increase their binding
capabilities towards metals. The metal binding capabilities of these artificial proteins
towards different transition metals was determined. Phenanthroline modified SCP-2L
was found to be a promising scaffold for Pd(II)-, Cu(II)-, Ni(II)- and Co(II)-enzymes
while dipicolylamine-modified SCP-2L was found to be a promising scaffold for Pd(II)-
enzymes.  The rhodium binding capacity of two additional phosphine modified protein
scaffolds was also investigated. Promising scaffolds for Rh(I)- and Ir(I)-enzymes were
identified.
Rh-enzymes  of  the phosphine  modified  proteins  were tested  in  the  aqueous-organic
biphasic  hydroformylation  of  linear  long  chain  1-alkenes  and  compared  to  the
Rh/TPPTS reference system.  Some Rh-enzymes  were found to be several  orders  of
magnitude more active than the model system while yielding comparable selectivities.
The reason for this  remarkable  reactivity  increase could not  be fully  elucidated  but
several potential modes of action could be excluded. 
Cu-,  Co-,  and Ni-enzymes  of  N-ligand modified  SCP-2L A100C were tested in  the
asymmetric  Diels-Alder  reaction  between  cyclopentadiene  and  trans-azachalcone.  A
promising  29% ee  for  the  exo-product  was  found  for  the  phenanthroline  modified
protein in the presence of nickel.
Further improvement of these catalyst systems by chemical means (e.g. optimisation of
ligand structure) and bio-molecular tools (e.g. optimisation of protein environment) can
lead to even more active and (enantio)selective catalysts in the future.
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1 (Maleimido)propionic acid hydrazide
acac Acetylacetonato
BSA Bovine serum albumin
CD Circular dichroism
COD 1,5-cyclooctadiene
CP Cyclopenta-1,3-diene
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ESI+ Electrospray ionisation, positive mode
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fig. Figure
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GC Gas chromatography
h Hour(s)
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HOMO Highest occupied molecular orbital
HPLC High pressure liquid chromatography
VII
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IPTG Isopropyl β-D-1-thiogalactopyranoside
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KPi Potassium phosphate (buffer) 
LC-MS Liquid chromatography-mass spectrometry
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LUMO Lowest unoccupied molecular orbital
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MALDI Matrix assisted laser desorbtion/ionisation
MeCN Acetonitrile
MES 2-(N-morpholino)ethanesulfonic acid
min. Minute(s)
MS Mass spectrum
MFE Multifunctional enzyme
MWCO Molecular weight cut off
NMR Nuclear magnetic resonance
OAc Acetoxy group 
O/N Over night
PB Production broth
PBS Phosphored buffered saline
Phen 5-Maleiamido-1,10-phenanthroline
Picol N,N-Dipicolyl-N’-maleoyl-3-aminopropanamide
ppb Parts per billion
ppm Parts per million
P(meta) meta-Diphenylphosphino benzaldehyde
P(ortho) ortho-Diphenylphosphino benzaldehyde
P(para) para-Diphenylphosphino benzaldehyde
PYP Photoactive yellow protein
VIII
RNA Ribonucleic acid
rpm Revolutions per minute
RT Room temperature
SCP Sterol carrier protein
SCP-2L Sterol carrier protein 2-like domain of the human mult functional 
enzyme
SCP-2L A100C SCP-2L in which amino acid alanine (A) at position 100 was 
replaced by cysteine (C)
SCP-2L V83C SCP-2L in which amino acid valine (V) at position 83 was 
replaced by cysteine (C)
SDS Sodium dodecyl sulfate
syn gas Synthesis gas, a 1:1 mixture of H2 and CO 
TCEP Tris(2-carboxyethyl)phosphine
TEV Tobacco etch virus
TFA Trifluoro acetic acid
THF Tetrahydrofuran
TON Turnover number(s)
TPP Triphenylphosphine
TPPTS Sodium triphenylphosphine trisulfonate
Tris Tris(hydroxymethyl)aminoethane
TS Transition state(s)
UV-VIS Ultraviolet-visible
Artificial (metallo)enzyme abbreviation scheme:
The artificial (metallo)enzymes used within this thesis are abbreviated following the 
scheme
1) Protein Scaffold used
2) Mutations (if present)
3) Abbreviation of modification A (if present)
4) Abbreviation of modification B (if present)
IX
5) Metal (if present)
Part 1) and 2) are separated by a space, all other parts are separated by "-".
 
Examples:
1) "SCP-2L A100C-1-P(para)-Rh" is the abbreviation for:
SCP-2L in which amino acid alanine (A) at position 100 was replaced by cysteine (C)
which  is  modified  (at  the  cysteine)  with  (maleimido)proppionic  acid  hydrazide
(abbreviated  as  ”1”).  A  second  modification  (at  the  hydrazide)  with  para-
diphenylphosphino-benzaldehyde  (abbreviated  as  “P(para)”)is  present.  Rh  is
coordinating to it.
2) "SCP 2L V83C-Phen-Cu" is the abbreviation for:
SCP-2L in which amino acid  valine (V) at position 83 was replaced by cysteine (C)
which is modified (at the cysteine) with 5-Maleimido-1,10-phenanthroline (abbreviated
as “Phen”). Cu is coordinating to it.
X
Chapter 1:  Alternative  approaches  for the  aqueous-organic
biphasic hydroformylation of higher alkenes 
1.1 Abstract
Many different approaches to enhance the low activity of the Rh/TPPTS-system used in
the  aqueous-organic  biphasic  hydroformylation  of  higher  alkenes  exist.  In  addition
many alternative approaches trying to tackle the low activity while maintaining a high
selectivity have been developed as well. All these systems are discussed in this chapter.
Additionally, an outlook on this thesis is given.
This chapter was published before. Due to corrections it is slightly changed. The sub
chapters “outlook on this thesis”, “Overview on the different aqueous-organic biphasic
hydroformylation concepts”, as well as the “abstract” were not part of this publication.
L. Obrecht, P. C. J. Kamer, W. Laan, Catal. Sci. Technol., 2013, 3, 541
http://pubs.rsc.org/en/content/articlelanding/2013/cy/c2cy20538f#!divAbstract
Reproduced by permission of The Royal Society of Chemistry
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1.2 Introduction
Hydroformylation (also known as oxo synthesis or oxo process) is one of the largest
industrial applications of homogeneous catalysis, with a current world-wide production
of  approximately 9  million  tons  per  year.[1] The  process  entails  the  transition-metal
catalysed  reaction  of  alkenes  with  carbon  monoxide  and  hydrogen  gas  affording
aldehydes. The aldehydes are easily hydrogenated to alcohols, which can be converted
to  important  products  such as  detergents  and plasticizers.  Both branched and linear
aldehydes can be formed, but their more prevalent use in downstream processes makes
linear aldehydes the more desirable products.[2] 
Catalyst separation is crucial for industrial processes.  Catalyst recovery allows for the
implementation of catalyst recycling strategies, thus reducing the overall process costs.
Also contamination of the product with the catalyst or metal species can pose problems
for downstream processes or applications. This issue has been very effectively tackled
for the hydroformylation of propene and butene by the development of the aqueous
biphasic  Ruhrchemie/Rhône-Poulenc  (RCH/RP)  process,  commercially  used  since
1984.[3] Water is a cheap, environmentally friendly and safe solvent, which renders it
very attractive for green and sustainable production processes. The RCH/RP process
uses the highly water-soluble ligand triphenylphosphine-3,3',3''-trisulfonate (TPPTS) to
immobilize a rhodium catalyst in the aqueous phase, while the substrate and products
form a second phase. The catalyst can be completely and quickly recovered by phase-
separation.  The  process  produces  almost  exclusively  aldehydes  with  over  96%
selectivity  for  the  linear  products  under  relatively  mild  conditions  -  “mild”  in
comparision to other hydroformylation setups. This technology is currently in operation
at five plants worldwide, furnishing an annual production of 800000 tons of aldehydes.
[4] The operational simplicity,  robustness and the excellent economics  of the process
(loss of rhodium by leaching into the organic phase lies in the ppb range) make the
RCH/RP  a  benchmark  process  in  the  field of  aqueous  biphasic  transition-metal
catalysis.
The solubilities of propene and C4 alkenes in the aqueous phase are sufficient to allow
chemical  reactions  to  occur  at  an acceptable rate  without  phase transfer  limitations.
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However, for longer alkenes, the reaction rate is too low to be economically viable. For
example, hydroformylation of 1-octene under standard conditions (125 °C, 30 bar, [Rh]
= 300 ppm) proceeds with a rate constant of 5.3×10−4 min−1 .[2] 
For the hydroformylation of higher alkenes (>C5), homogeneous  processes are used.
For  alkenes  up  to  C8  commercial  processes  using  phosphine-modified  rhodium
catalysts are known. For longer alkenes the distillation conditions required to separate
the high-boiling products may lead to catalyst decomposition and concomitant loss of
metal.  Therefore  cheaper  cobalt  catalysts  are  used,  ensuring  the  processes  are  still
economically viable. However, cobalt catalysts are less active than rhodium-catalysts,
requiring higher reaction temperatures and pressures.[5]
For these  reasons the  development  of  a  process  for  the  hydroformylation  of  higher
alkenes using rhodium catalysts under biphasic conditions, which allows for catalyst
recycling by phase separation,  is highly desirable. Using the unmodified Rh–TPPTS
system, only minor improvements can be achieved by varying the reaction conditions
such as the syngas pressure or the ligand–metal ratio.[6] Many approaches have been
developed  to  tackle  the  issue  of  low  space-time  yield  in  biphasic  aqueous–organic
reaction systems involving poorly water-soluble substrates. In this perspective, we will
discuss  various  alternative  approaches  which  have  been developed to overcome the
mass-transfer limitations in the biphasic hydroformylation of higher 1-alkenes. Unless
stated otherwise, the catalyst system applied in the studies discussed below is based on
the Rh–TPPTS system.
Additives
Various additives are available to improve the solubility or the transport of hydrophobic
substrates into the aqueous phase. To be suitable, an additive should (i) be inert with
respect to the catalyst, substrate and reaction products; (ii) not increase the solubility of
the catalyst in the product phase; (iii) exert a minimal influence on phase separation and
(iv) show minimal leaching into the product phase.
Co-solvents
One of the first strategies employed to improve mass transfer in biphasic catalysis is the
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use of co-solvents. Co-solvents increase the lipophilicity of the aqueous phase, thereby
increasing the solubility of alkenes in the catalyst phase. For example, the solubility of
1-octene has been estimated to be 104 times higher in 50% ethanol than in pure water.[7]
Indeed,  the  use  of  ethanol,  acetone,  acetonitrile  or  methanol  as  co-solvent  in  the
hydroformylation  of  1-octene  leads  to  a  significant  increase  of  the  reaction  rate.[7–9]
However, the addition of co-solvents results in a decrease in the linear selectivity,  i.e.
from 98% to 92% upon addition of 20% methanol to the alkene phase.[6] Transfer of the
co-solvent from the aqueous to the organic phase due to the formation of nonanal has
been reported.[7] This might affect the partition coefficient of the catalyst between  the
two phases. Also, ethanol was found to react with the product nonanal to yield acetals. A
buffer solution of sodium carbonate and bicarbonate in the aqueous phase (pH=10) was
found to be effective in suppressing acetal formation.[7]
The erosion of the linear  selectivity,  the fact  that  they react  with the product,  their
leaching into the product phase as well as the potential leaching of catalyst make co-
solvents an unattractive additive for commercial applications.
Surfactants
Above the critical micelle concentration surfactants form micelles, which can solubilize
hydrophobic  compounds  within their  hydrophobic  cores.  The  formation  of  micelles
increases the interfacial area in biphasic systems, thus increasing the phase transfer. The
first  reports  of  rate-enhancements  in  biphasic  hydroformylation  by using  surfactants
came from Johnson Matthey.[10] Despite their ability to encapsulate substrates, neutral
and  anionic  surfactants  show  no  activating  effect  on  reaction  rates.[6,11] In  contrast,
cationic  surfactants  greatly  enhance  reaction  rates.  For  example,  no  aldehydes  are
formed during the hydroformylation of 1-dodecene in the presence of sodium dodecyl
sulfate  (SDS),  while the use of cetyltrimethylammonium bromide (CTAB  1,  Fig.  1)
afforded 61% conversion.[11] High reaction rates can be obtained using CTAB: turnover
frequency (TOF) values up to 900 h-1 have been reported.[12]
The difference in the ability of anionic and cationic surfactants to enhance the reaction
rate has been ascribed to electrostatic interaction between the surface of the micelle and
the  catalyst.  Electrostatic  repulsion  between the  negatively charged catalyst  and the
4
surface of micelles formed by anionic surfactants prevents reaction of the catalyst with
the  substrate.  In  the  case  of  cationic  surfactants,  however,  electrostatic  attraction
between the negatively charged sulfonate group of the TPPTS ligand and the cationic
headgroup of the surfactant leads to sequestering of the catalyst on the micelle surface,
providing  a  high  local  concentration  of  catalyst  in  the  vicinity  of  a  high  local
concentration of substrate and thus causing an increase in reaction rate.  Indeed,  31P-
NMR data  suggest  a  strong interaction  between the  catalyst  and CTAB micelles.[13]
Light-scattering experiments confirmed that the rate increase of the hydroformylation of
1-dodecene in the presence of CTAB is due to solubilisation of the substrate inside the
micelle and the binding of [HRh(CO)[TPPTS3] to the micelle surface, leading to a 90
fold increase of the rhodium concentration in the micelle interface compared to the bulk
water phase.[14] 
The  reported  effects  of  surfactants  on  the  linear  selectivity  are  inconsistent.  For
instance,  for  the  use  of  CTAB,  both  an  increase[11] and  a  decrease[6]  in  the  linear
selectivity have been reported. Interestingly, Chen et al. observed a synergistic effect of
Na-TPPTS  and  Na-TPPDS  (disodium  triphenylphosphine-  3,3'-disulfonate)  on  the
regioselectivity of 1-dodecene hydroformylation in the presence of CTAB, increasing
the ratio of linear to branched products (l/b) from 6.5 to 22.3 for TPPTS/ TTPDS = 2 :
1.[15] 
Motivated  by  the  high  reaction  rates  obtained  with  CTAB,  several  other  types  of
cationic surfactants have been explored. Li,  Chen and co-workers found that gemini
surfactants  2 (Fig.  1)  containing  alkyl  bridges  afford  slightly  higher  rates  and
selectivities than CTAB in the hydroformylation of 1-dodecene.[16] Notably, shorter alkyl
bridges  lead  to  increased  selectivities.  The  surfactants  with  shorter  bridges  were
suggested to form more compact micelles, favouring the formation of the less crowded
linear aldehyde. Also gemini-surfactants  3 and  piperazine-based  4, as well as trimeric
triazine-based surfactant 6 (Fig. 1) were explored, with 4 performing the best, affording
a TOF of 1845 h-1 in the hydroformylation of 1-decene.[17] 
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Fig. 1 Cationic surfactants applied in aqueous biphasic hydroformylation.
Nonetheless, the highest rate enhancements to date have been achieved by using double
long-chain surfactants (DLCS, 5). Using 5 (Fig. 1), Fu et al. achieved a TOF of 7472 h-1
for the biphasic hydroformylation of 1-dodecene, with an aldehyde selectivity of 94%;
values  which  are  comparable  to  those  of  the  equivalent  homogeneous  reaction. [18]
Threshold values for the length of both chains were determined: high reaction rates are
obtained when n ≥ 8 if m = 22 and n ≥ 12 if m = 16 (see Fig. 1).[18]
Although the addition of surfactants provides high reaction rates and the leaching of
metal into the product phase is generally low, it often makes reaction mixtures prone to
emulsification,  particularly  at  high  stirring  rates  and  conversions,  rendering  phase
separation difficult.[19] 
Desset  et  al.  found that the weak surfactant 1-octyl-3-methylimidazolium bromide  7
([Octmim]Br, Fig. 1; X = Br‒, R = C8H17) provides high reaction rates while at the same
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time allows rapid and complete phase separation and good catalyst retention, albeit with
a slight decrease in the linear  selectivity.  While  imidazolium and triethylammonium
salts  with  longer  alkyl  ‘‘tails’’ (R>C8)  also  provide  large  rate  enhancements,  these
amphiphiles  lead  to  stable  emulsions.[20,21] It  appears  that  [Octmim]Br  and  related
molecules  are  promising  surfactants  for  increasing  the  rate  of  aqueous  biphasic
hydroformylation  without  compromising  the  inherent  strength  characteristic  of  the
RCH/RP process.
Polyethylene glycol
Polyethylene  glycol  (PEG)  of  medium  molecular  mass  (400–1000)  is  an  effective
additive for increasing the reaction rate.[6] It significantly enhances the reaction rate,
although it leads to a slight decrease in the l/b ratio. Leaching of the PEG and rhodium
into the organic phase is very low, and phase separation is fast and straightforward.
Inverse phase transfer catalysts
Another approach to facilitate the migration of hydrophobic molecules from an organic
to an aqueous phase is the use of inverse phase transfer catalysts. The two most widely
studied  classes  of  compounds  are  cyclodextrins[22,23] and  calixarenes,[24] which  are
widely applied in aqueous biphasic catalysis. Cyclodextrins  8 (CD, Fig. 2) are cyclic
oligosaccharides, and the three main types (α, β or γ) are composed of 6, 7 or 8  α-D-
glucopyranoside  units  respectively.  CDs  are  shaped  like  conical  cylinders  with  a
hydrophobic  inner  surface  and  a  hydrophilic  outer  surface;  the  wider  rim  contains
secondary hydroxyl-groups while primary hydroxyl groups occupy the narrower rim (R1
= R2 = R3 = OH). 
α- and γ-CD show no effect while β-CD only provides a moderate 2-fold increase in the
reaction  rate.[25,26] However,  the  effectiveness  of  CDs  can  be  greatly  improved  by
chemical modification of the hydroxyl-groups with hydrophobic or hydrophilic groups
such as methyl, acetyl or 2-hydroxypropyl. 
Randomly methylated  β-CD (RAME-β-CD; on average 12.6 methyl groups added on
positions  2,  3  and 6)  is  particularly effective.[25,26] This  was initially ascribed to  the
solubility of  the  modified  CD in both the  aqueous and organic  phase.  Indeed,  CDs
7
which are little soluble in either water or the organic phase have little influence on the
reaction  rate.  Complementary  experiments  have  demonstrated  that  modified  CDs
concentrate  at  the  liquid–liquid  interface,  where  substrate  recognition  leads  to  the
formation of inclusion complexes which facilitate the reaction between the substrate and
the water-soluble organometallic catalyst.[27,28] Interestingly, positive synergistic effects
of  binary mixtures  of  RAME-α-,β-,  and  γ-CDs have  been observed,  suggesting  the
formation of 2 : 1 ternary complexes.[29] 
Unfortunately,  the use of RAME-β-CD leads to  a significant  reduction of the linear
selectivity. This decrease in selectivity stems from the formation of inclusion complexes
between  TPPTS  and  the  CD.  The  formation  of  such  complexes  facilitates  ligand
dissociation,  leading to  catalyst  species  which afford lower linear  selectivity.[30,31] To
prevent this, various combinations of CD and ligands have been explored. 
Due to their smaller cavity size, chemically modified  α-CDs do not interact with the
catalyst, and RAME-α-CD enhances the reaction rate while not affecting the l/b ratio.[32]
Also  α-  and  β-CDs  bearing  alkyl  chains  on  the  secondary  face  and  sulfoalkyl-  or
poly(ethyleneoxide) chains on the primary face afford higher rates and regioselectivity
than randomly methylated β-CD.[33–36]
Noteworthy is the use of the sulphonated xantphos ligand (9, Fig. 2) in combination
with  RAME-α and  β-CDs.  Although  the  CDs  bind  a  ligand  phenyl  ring,  ligand
dissociation  does  not  occur  and  improved  chemo-  and  regioselectivities  in  the
hydroformylation of 1-octene and 1-decene are obtained.[37] The ligand 1,3,5-triaza-7-
phosphaadamantane 10 (PTA) and its N-benzylated derivative 11 (Fig. 2) were recently
found not  to  interact  with RAME-β-CD during the biphasic  hydroformylation of 1-
decene. Although this system affords poor linear selectivity, PTA may provide a suitable
framework for  ligand optimization.[38] In  general,  upon addition  of  CDs to  biphasic
hydroformylation reactions the phase-separation is still excellent, and leaching of the
catalyst  is  minimal.  Also catalyst  recycling  can  be  done without  significant  loss  of
activity.  Even  an  increase  in  activity  upon  recycling  has  been  reported;  this  was
attributed  to  a  gradual  supramolecular  organization  of  the  rhodium  complex,  its
solvation sphere and cyclodextrin in the interphase.[39] 
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Fig. 2 Inverse phase transfer catalysts applied in aqueous biphasic hydroformylation.
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Supramolecular  organization has  also been suggested  to  explain the  performance of
recently  introduced  β-CD  functionalized  polymers  in  biphasic  hydroformylation.[40]
Acrylamide polymers 12 with up to 50% degrees of β-CD substitution were synthesized
(Fig. 2). Whereas highly substituted polymers were found to be nearly as effective as
RAME-β-CD  as  mass-transfer  promoters  in  the  hydroformylation  of  1-decene,  the
ineffectiveness of less substituted polymers was interpreted to stem from unfavourable
organisation  of  the  main-chains  of  the  polymers  at  the  phase-boundary,  leading  to
shielding  of  the  substrate  from  the  CDs.  With  1-hexadecene  as  substrate,  highly
substituted  polymers  were  much  more  effective  than  RAME-β-CD.  Whereas  the
substrate is too long to be efficiently transferred by a single  β-CD cavity, cooperative
multivalent  substrate  recognition  by  close-in-space  polymer-bound  CDs  leads  to
efficient recognition and higher reaction rates. 
Calixarenes are cyclic oligomers of substituted benzene units, synthesised from phenols
and  aldehydes.  While  calixarenes  have  been  applied  as  phase-transfer  agents  in  a
number of biphasic catalysis reactions, to the best of our knowledge their use as additive
in  biphasic  hydroformylation  of  linear  alkenes  has  not  been  reported.  Due  to  the
performance of phosphine-modified Calixarenes as ligands (described further on) they
are probably a suitable additive as well.
The group of Vogt recently applied polystyrene-based latices as phase transfer agents in
the  biphasic  hydroformylation  of  1-octene.[41] The  latices  17,  obtained  from  the
polymerization of PEGylated styrene 13, divinylbenzene 14, styrene 15 and styrylsalts
16 (Fig.  2;  R  =  H,  SO3Na  or  CH2NMe3BF4),  consist  of  a  lipophilic  core  and  a
hydrophilic  shell.  It  was  found that  the  rate-enhancement  critically  depends  on  the
nature  of  the  styrylsalt:  the  highest  rate  (TOF  of  150  h-1)  was  achieved  using
ammonium-modified styrene, while latices containing unmodified or sulfonated styrene
had little effect. In analogy to the situation with cationic surfactants, this was explained
by the association of the anionic catalyst  with the cationic ammonium-group on the
outer shell.
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Activated carbon
Recently Monflier introduced activated carbon (e.g. Nuchar® WV-B) as a novel mass-
transfer additive for aqueous biphasic catalysis.[42] Considerable rate-enhancements are
achieved  in  biphasic  hydroformylation  using  either  cobalt/trisulfonated
tris(biphenyl)phosphine (BiphTS) or the Rh–TPPTS system, with little effect on the l/b
ratio. Also the aqueous phase catalyst and activated carbon can be recovered easily and
recycled multiple times without significant loss of activity.[43,44] It was proposed that the
activated carbon facilitates the mixing of the aqueous and organic phases, leading to a
more effective interfacial area concomitant with confinement of the reactants and the
catalyst.[42]
Ligand variation
TPPDS, TPPMS, TPP
Substituting  TPPTS  by  the  less  water-soluble  triphenylphosphine-  3,3'disulfonate
(TTPDS)  or  triphenylphosphine-3-  sulfonate  (TPPMS)  as  ligand  leads  to  a  slight
increase in reaction rate, but also leads to significant leaching of the ligand into the
organic phase.[6,45]
Chaudhari et al. proposed the use of promoter ligands which are exclusively soluble in
the  organic  phase.  This  was  suggested  to  lead  to  the  formation  of  mixed  ligand
complexes  which  would  concentrate  at  the  phase  boundary,  affording  interfacial
catalysis. Although inclusion of triphenylphosphine (TPP) in the hydroformylation of 1-
octene with HRh(CO)(TPPTS)3 leads to a 10–50 fold increase in the reaction rate, [46] it
has been argued that TPP simply increases the solubility of the catalytic species in the
organic phase, which may affect downstream processing.[6] 
Amphiphilic ligands
Another approach that has been explored is the use of ligands which combine surface-
activity with water solubility. Analogous to surfactants, the aggregation of amphiphilic
ligands  may lead  to  the  formation  of  micelles,  which  are  capable  of  encapsulating
substrates  in  their  hydrophobic  core.  This  increases  the  substrate  solubility  in  the
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aqueous phase and also brings the substrate and the catalyst in close proximity, thus
increasing the reaction rate. Fell and Papadogianakis were the first to use a specifically
designed  amphiphilic  ligand  in  biphasic  hydroformylation.[47] Application  of  the
zwitterionic trisulfoalkylated tris(2-pyridyl)-phosphine (18, Fig. 3) for the conversion of
1-tetradecene resulted in TOFs up to 340 h-1. The best yields were obtained with the
ligand where  n  = 5; longer chains afforded lower yields while stable emulsions were
formed with n = 9, 11. The catalysts with n = 0–7 could be quantitatively recovered by a
simple  phase separation.  Various  other  amphiphilic  monodentate  ligands  superior  to
TPPTS in biphasic hydroformylation have been reported. Most of these ligands bear the
hydrophilic group (either sulfonate or phosphate) and the phosphorous atom on the two
ends of the alkyl chain, including phosphonatephosphines developed by Bischoff and
the Hanson group’s sulfonated tris(ω-phenylalkyl)phosphines.[8,48–51] The sodium salt of
sulfonated  n-C12H25O C6H4P(C6H4-p(CH3O)2 (DMOPPS, 19, Fig. 3) affords significant
rate  enhancements in  the biphasic  hydroformylation of long chain alkenes,  not  only
providing  TOFs  up  to  673  h-1 for  1-dodecene  but  even  a  TOF  of  100  h-1 for  1-
hexadecene, with l/b ratios around 2.4.[52] 
Surface  active  ligands  based  on  diphosphine  frameworks  such  as  2,2'-
bis(diphenylphosphino)-1,1'-biphenyl  (BISBI)  and  2,2'-bis(diphenylphosphino)-1,1'-
binaphthyl  (BINAP)  have  also  been  developed.[53] Sulfonated  xantphos-derivatives
containing long apolar chains (20, Fig. 3) spontaneously form large and thermally stable
vesicles in water.[54] These vesicles were proven to increase the solubility of 1-octene in
aqueous  solution,  and  the  activity  of  the  vesicle-forming  ligands  in  the  biphasic
hydroformylation was found to be 12–14 times higher than that of xantphos. It was
shown that the aggregates stay intact during recycling,  the rhodium is quantitatively
retained in the aqueous phase and the TOF and linear selectivity remained the same in
four consecutive runs. 
Monflier and co-workers found that the performance of the surface-active ligands (21,
22,  Fig. 3) in the biphasic hydroformylation of 1-decene could be improved, by the
addition of stoichiometric amounts of ionic b-cyclodextrins, leading to a 4-fold increase
in reaction rate and an excellent phase separation. In contrast, the addition of neutral β-
cyclodextrins led to a decrease in performance, which was shown to be due to 
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Fig. 3 Amphiphilic ligands used in the aqueous biphasic hydroformylation.
13
destruction of the micelles formed by the ligand.[55] This shows that for amphiphilic
ligands, addition of CD with the right structure may provide an elegant way to further
improve their performance in biphasic catalysis. 
Ligands containing cyclodextrins or calixarenes
In addition to their use as additives in biphasic catalysis, cyclodextrins and calixarenes
have also been incorporated as phase-transfer  agents  in ligand structures to  develop
dual-function catalysts.
Reetz reported the evaluation of a series of diphosphine-ligands modified with β-CD in
the rhodium catalyzed biphasic hydroformylation of 1-octene (23,  Fig. 4). Very high
activities were achieved with  l/b ratios of 3.2.  Disappointingly,  the activity dropped
50%  upon  reuse.[56] Also  methylated  α-cyclodextrins  capped  with  a
diphosphine/rhodium moiety were active catalysts in the biphasic hydroformylation of
1-octene, but significant leaching of the catalyst to the organic phase occurred over the
course of the reaction.[57]
Using rhodium complexes of water-soluble calix[4]arene based ligands modified with
two phosphines (24, Fig. 4) on the upper rim provided considerable rate-enhancements
but  slightly  reduced  l/b ratios  in  the  biphasic  hydroformylation  of  1-octene.
Remarkably, the system showed almost complete retention of activity and selectivity
over two recycling runs.[58] 
The  use of  hemispherical  1,3-calix[4]arene-diphosphites  25 (Fig.  4)  as  ligands  in
combination  with  upper  rim sulfonated  calix[4]arenes  as  surfactants  in  the  biphasic
hydroformylation  of  1-octene  and  1-hexene  was  recently  reported  by Matt  and  co-
workers. In the absence of surfactant, catalysis takes place in the organic phase. In the
presence of surfactant, the activity increased, and TOFs of 1160 h-1 and 750 h-1 were
obtained for 1-octene and 1-hexene, respectively, with high l/b ratios (up to 61.8 for 1-
octene using a 10-fold excess of ligand). However, stable emulsions were recovered
after  each  reaction  including  surfactant.  Although  no  recycling  experiments  were
reported, this will probably hamper efficient catalyst recovery.[59]
14
Fig. 4 Ligands containing cyclodextrins or calixarenes.
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Polymer supported ligands
Water soluble polymers as support
In this approach the catalytically active metal is complexed to a water soluble polymer
modified with donor groups. In most cases the coordinating groups are phosphorous
based:  mono-[60–66] or  bidentate[67] phosphines,  phosphine  oxides,[68] phosphinites,[66]
phosphonites[66] or bidentate P–N[69] ligands. There are also examples where bidentate
N–N-ligands,[69] carbenes,[70] acetylacetonate[71] or  glycolate[72] groups  act  as  donor
ligands for a rhodium metal, although these ligands afford less active hydroformylation
catalysts. 
These polymer bound catalysts are believed to act as phase transfer agents[64] and are
successfully used in the aqueous biphasic hydroformylation of water insoluble alkenes.
In general rhodium leaching to the organic phase is low and the catalyst can easily be
reused. TOFs obtained are low (<100 h-1) for these systems, while the  l/b ratio varies
from moderate to excellent (1.3–8.5) depending on the conditions, the polymer and the
donor atoms used.[61,63–67,71]
There are two research groups who obtained remarkably high TOF (>500 h-1) in the
hydroformylation  of  long  chain  1-alkenes  when  using  water  soluble  polymers  as
support. 
The group of Ritter used a polyethylene glycolate complex which was synthesised from
rhodium  trichloride  and  polyethylene  glycol.  The  rhodium  polyethylene  glycolate
complex was not definitively characterised. They assumed that the reaction takes place
at the aqueous/organic interphase as the TOF is almost unaffected by the alkene chain
length  –  and  therefore  by  their  water  solubility;  though  they  did  not  neglect  the
possibility  of  the  catalyst  being  transferred  into  the  organic  phase.[72] For  the
hydroformylation of 1-dodecene the rhodium content in the organic phase after five
catalytic cycles was measured as 1.9 ppm. The high TOF cannot be attributed to leached
rhodium as upon addition of 4 equivalents of TPPTS to the reaction mixture the amount
of leached rhodium drops below the detection limit of 0.1 ppm while the TOF even
increased. Unfortunately their system is rather unselective, yielding a l/b ratio of ≈0.9. 
Weberskirch  and  his  group  postulated  that  their  tailor  made  amphiphilic  block
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copolymers form micelles encapsulating the olefin and the catalytic centre (see Fig. 5).
[60,70,73,74] 
All their catalysts were evaluated using 1-octene as substrate, resulting in TOFs as high
as 3700 h-1 and a moderate selectivity (l/b≈3) in most cases. When rhodium leaching
and catalyst recycling were investigated for one of their systems, the former was found
to be low (0.4 ppm). Reusing this catalyst four times resulted in an increasing TOF in
the first three cycles (from 1100 to 2185 h-1), after which it remained constant in the
next cycle. This effect was not clarified. On the other hand the l/b ratio of the aldehydes
formed dropped from 2.57 to 1.33 during the first three cycles, indicating an increase in
free  rhodium,  and  remained  constant  in  the  last  run.[70] Phase  separation  after  the
reaction  is  highly  dependent  on  the  polymer  used.  For  some  polymers  a  simple
decantation can be applied while for others the separation was poor. 
As a conclustion, the use of most water soluble polymers is unattractive due to low
TOF. The use of polyethylene glycol as support gives high TOFs but low selectivities.
The use of tailor made amphiphilic block copolymers is probably the most interesting
approach as the TOFs are high, the l/b ratio can be tuned, rhodium leaching is small and
recycling is possible.
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Fig. 5 Example of an amphiphilic block copolymer forming micelles.
Proteins as support
A promising approach was invented by the group of Marchetti. Instead of using rather
poorly defined man-made polymers, they used proteins as support. Although the protein
structure  itself  is  well-defined,  the  protein–rhodium  complexes  synthesised  are
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undefined  as  the  proteins  contain  numerous  donor  atoms  (for  example  amines  and
carboxylates). 
They investigated  the  proteins  human serum albumin,[75] as  well  as  papain  and egg
albumin[76] in  combination with Rh(I)  in  the  hydroformylation  of  1-octene  using an
excess  of  rhodium  (up  to  120  eq.).  The  latter  complexes  are  not  stable  under
hydroformylation conditions but precipitate and release rhodium to the organic phase,
while  the  rhodium–human  serum  albumin  complex  can  be  reused  several  times.
Unfortunately rhodium leaching was quite significant in the range of 8 ppm.[75]
Supported aqueous phase catalysis
One  approach  to  increase  the  surface  area  of  the  interphase  between  aqueous  and
organic phase and therefore the reaction rate  is  Supported Aqueous Phase Catalysis
(SAPC), which was developed in 1989.[77] 
In SAPC a thin aqueous layer containing a water soluble catalyst complex is adsorbed
onto hydrophilic solids. The solid should have a large surface area and should be inert to
thermal and mechanical stress and to all chemicals present in the reaction mixture. For
hydroformylation  most  supports  are  based  on  silica,  but  other  supports  like  cation
exchange resin,[78,79] glass[80] and apatitic tricalcium phosphates[81] have been investigated
as well. In most cases, the catalyst is based on rhodium but some examples for cobalt-
[79,80,82] and  platinum-based  catalysts[82] exist.  The  reaction  itself  takes  place  at  the
interphase of the organic phase and the water layer absorbed to the particles (see Fig. 6),
therefore the reaction rate is almost unaffected by the water solubility of the substrate.
At the end of the reaction the organic phase containing the products can be separated
from the support and its catalyst-containing water layer by filtration and the latter can be
reused. SAPC not only depends on the nature of the metal-complex, it is also highly
dependent on the inherent properties of the support such as particle size and surface
area.  Additionally the hydration of  the support  is  important.[83] The influence of  the
hydration on the hydroformylation of long chain 1-alkenes was shown very clearly by
Kalck  et al.  They varied the water content near the optimal hydration degree of their
system in  steps  of  0.1%.  Changing  their  optimal  hydration  by  0.2% in  either  way
reduces the conversion by about 13%, while the selectivity remained unchanged.[84] 
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Fig. 6 SAPC concept.
In SAPC, the activity is low (TOF<100 h-1) in most cases for both rhodium[82,85] and
cobalt  based[79,80] catalysts.  The group of Hanson showed that  in  SAPC the reaction
takes place at the phase-boundary: conversion of 1-octene, 1-decene and 1-dodecene
occurred with similar TOFs of ≈45 h-1 affording the corresponding aldehydes with a l/b
ratio of ≈2.3.[82] Ligand tuning is a powerful tool to influence the selectivity in SAPC.
Using a xantphos-derivative as ligand results in a linear to branched selectivity of >30[86]
which is almost as high as in biphasic catalysis.[87] Using TPPTS as ligand under almost
the  same  conditions  gives  a  much  lower  selectivity  (l/b =  3).[85] There  are  some
examples with high TOFs (>100 h-1),[82,85,86,88,89] two of which use TPPTS as ligand and
silica as support, the high TOFs are most likely due to optimised conditions.[82,85] 
In one of the other successful approaches a mixture of polyethyleneglycol and water
instead of pure water is adsorbed onto the particle.[88] Both the TOF (≈1000 h-1) as well
as the selectivity (l/b ≈ 16) are remarkably high in this case but it should be mentioned
that the TOF was measured by the initial  gas uptake of the reaction.  This approach
should give the same values but is prone to errors and TOF calculated this way tend to
be higher than conventionally measured TOFs. No products were formed when reusing
the organic phase, indicating that no rhodium had leached.
Another  approach  was  published  by  Zhu  and  co-workers.[86] Their  system  is  a
combination of SAPC and heterogeneous catalysis as there are rhodium particles on the
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support in addition to the adsorbed water-soluble catalyst (Fig. 7). Both TOF (>300 h -1)
and selectivity (l/b ≈ 6) are good and rhodium leaching is low (<0.1 ppm). The catalyst
could be reused three times without significant erosion of performance. 
Yuan  et al.  reported high TOF (up to >500 h-1) and good selectivities (up to  l/b ≈ 6)
when using fumed silica as support.[89]
Fig. 7 Combining SAPC with heterogeneous catalysis.
Smart systems 
In  smart  systems  the  aqueous  biphasic  system  can  be  triggered  to  turn  into  a
monophasic  system during  the  reaction.  Upon completion  of  the  reaction  it  can  be
turned back into a biphasic system to allow for the separation of catalyst and products.
There are small variations of this concept (Fig. 8) and a variety of different triggers
exist. 
Smart  systems for  biphasic  hydroformylation  were  already reported  in  1973.  Using
cobalt,  rhodium  or  iridium  complexes  with  basic  aminophosphine  ligands  such  as
P(CH2CH2CH2NEt2)3,  the  catalyst  could  be  extracted  either  by  aqueous  solution  of
carbon dioxide under pressure or by using ‘‘standard’’ acids/ bases like sulphuric acid
and  sodium hydroxide.  Reusing  the  catalyst  afforded  very  similar  conversions  and
selectivities.[90,91]
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Fig. 8 Principle of smart systems.
The group  of van Leeuwen and Kamer reported several rhodium complexes with pH
dependent solubility.[92–94] In neutral solutions these complexes are soluble in the organic
layer while upon acidification they become water soluble. Acidic extraction into the
water layer and/or backwash upon neutralisation into a new organic layer proved to be
effective for two ligands (26, 27, Fig. 9) of a series of mono- and bidentate ligands. In
the case of these ligands 97–98% of rhodium could be transferred to a new organic
layer.  When  the  xantphos  based  ligand  26 was  tested  in  the  rhodium  catalysed
hydroformylation of 1-hexene, 1-octene and 1-dodecene a remarkably high selectivity
(l/b =  48–52)  and  good  TOF  (≈200  h-1)  were  obtained.  They  investigated  the
hydroformylation of 1-octene at a higher temperature (100  °C instead of 80 °C) and
obtained a slightly lower selectivity (l/b ≈ 45) and slightly more isomerisation but a
much higher activity (≈900 h-1). The results are expected to be similar for different 1-
alkenes. Unfortunately, for both ligands the activity in a new catalytic run dropped to
≈86%.[93,94] It was shown that this drop in activity was due to catalyst decomposition
during  the  acidic  extraction.[94] In  addition  to  the  significant  rhodium leaching  and
catalyst decomposition, salt is formed in the acid–base reaction as undesired byproduct. 
22
Fig. 9 pH dependent smart ligands.
The group of Cole-Hamilton used the pH change caused by bubbling carbon dioxide
through the solution to obtain a water soluble ligand,  e.g.  29. Upon bubbling nitrogen
through  the  solution  carbon  dioxide  is  released  and  the  ligand  becomes  soluble  in
organic solvents again (Scheme 1).[95,96] 
Scheme 1 A smart system using gases to change catalyst solubility.
The system has a remarkably high initial TOF (>10 000 h-1 measured by the initial gas
uptake) and the linear to branched selectivity is highly dependent on the type of ligand
used: when using ligand 28 the l/b ratio is ≈3. When using a xantphos based bidentate
ligand (30, Fig. 10) the l/b ratio is ≈20 for the hydroformylation of 1-octene. Rhodium
leaching of 1.9 ppm was measured for 28. Although the level of rhodium leaching when
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using  30 was not determined it was visually deemed to be very high. When  28 was
reused the activity dropped to 92%. Upon reusing it for three times an activity of 91%
was  observed.  The  l/b ratio  remains  almost  unchanged  during  these  recycle
experiments.  In  contrast  to  the  approach of  van Leeuwen,  the  use of  gases  to  tune
catalyst solubility does not suffer from the build-up of byproducts and the catalyst does
not have to withstand harsh recycling conditions. 
Fig. 10 Xantphos based smart ligand.
Although not strictly aqueous–organic biphasic reactions, some alternative approaches
are also worth mentioning. In the Union Carbide process for the hydroformylation of
higher alkenes, the reaction is carried out as a homogenous process using the TPPMS
ligand  in  N-methylpyrrolidone  (NMP)  as  solvent.  The  addition  of  water  after  the
reaction brings about a phase separation, resulting in complete transfer of the catalyst to
the aqueous phase,  which is  then recovered.[97] In  another  approach a  homogeneous
mixture of THF and water (7 : 3 (v : v)) was used as homogeneous reaction medium
yielding a good TOF (≈400 h-1) and moderate selectivity (l/b = 2.4).[98] At the end of the
reaction carbon dioxide pressure is applied to induce phase separation. Different ligands
were tested and it was shown that the aqueous layer containing the catalyst could be
reused when using TPPMS as  ligand for  three  times  without  changing the  activity.
Furthermore the rhodium content in the organic layer was below the detection limit of 1
ppm. 
Using  temperature  as  trigger  to  change  the  solubility  was  investigated  by  various
groups. 
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The group of Monflier[99] used a thermo controlled cyclodextrin based system to obtain
really high TOF (6000–7000 h-1). At low temperatures an amphiphilic phosphine ligand
is totally or partly located within the hydrophobic cavity of a modified cyclodextrin.
Upon increasing the temperature the proportion of  ligand within the cyclodextrin  is
reduced,  consequently  raising  the  ligand  concentration  at  the  aqueous/organic
interphase. When the temperature is reduced this process is reversed, which gives rise to
an easy phase separation. They investigated this concept for various 1-alkenes and the
TOFs obtained were independent of the alkene chain length. Unfortunately the linear
selectivity was rather poor (l/b = 1.7–2.0). They investigated the possibility to recycle
the aqueous layer and found it  could be recycled at  least  twice with little effect on
conversion or selectivity. Unfortunately no data on the amount of rhodium or ligand
leaching were published. 
A further class of thermo regulated ligands used for the hydroformylation of long chain
1-alkenes was intensively investigated by the group of Jin.[100–106] The ligands are based
on triphenylphosphines modified with a polyethylene chain 31–33 (Fig. 11) and have an
inverse temperature dependent  solubility in  water.  Good to excellent  activities  were
found for the biphasic hydroformylation of various 1-alkenes (300–4000 h-1 ), while the
l/b ratio  tends  to  be  poor  (l/b =  0.4–2.1).  It  was  shown that  the  l/b ratio  is  highly
temperature dependent: increasing the temperature from 80 to 120 °C caused the ratio to
drop from 2.06 to 0.64. Though the selectivity is unsatisfying, the reusability of this
type of ligands is very good as they could reuse one of their catalysts twenty times
without significantly affecting its activity.[106] 
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Fig. 11 Temperature-dependent smart ligands.
Overview on the different aqueous-organic biphasic hydroformylation concepts
It should be obvious that it is basically impossible to compare the methods presented in
a single table.  Anyway,  one approach of every method introduced in this chapter is
summarised  in  the  following table  to  give a  quick overview on activity,  selectivity,
leaching and reusability. The method with the highest TOF is listed and methods with
TOF <500 were not taken into account.
Table 1 Summary of different aqueous-organic biphasic hydroformylation approaches
a: An activity loss of 10 % over eight consecutive runs was observed. b:  An activity loss of 10 % over four
consecutive runs was observed. c: activity increase upon reuse, further reuse results in an activity drop. d:
not determined. e:  An activity loss of 10 % over three consecutive runs was observed. *: determined using
the initial gas uptake reaction.  f: Data taken from[18] g: Data taken from[52] h: Data taken from[60,70,73,74] I:
Data taken from[88] j:  Data taken from[95]
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entry Approach substrate l/b Rh leaching reusability
Additives 1-dodecene 7472 15.7 0.5 ppm
Ligand varation 1-dodecene 673 2.4 0.01-0.1 ppm
Polymer supported 1-octene 3700 3 0.4 ppm
SAPC 1-octene 1000* 16
“smart” system 1-octene >10000 * 20 1.9 ppm
TOF [h-1]
1f Yesa
2g Yesb
3h Yesc
4i n.d.d n.d.d
5j Yese
Outlook
Transferring  the  effectiveness  and elegance  of  the  RCH/RP process  to  the  biphasic
hydroformylation of higher alkenes has been a long-standing goal in transition-metal
catalysis  research.  Despite  intensive  and  creative  research  leading  to  a  variety  of
approaches to overcome the mass-transfer limitations, most of these have drawbacks
inhibiting  their  practical  application,  like  reduced  linear  selectivity  or  poor  catalyst
recovery/recyclability. Nonetheless, some promising approaches like those based on the
use  of  certain  additives  or  smart  ligands  have  been  established,  which  provide
considerable rate enhancements while preserving some of the inherent strength of the
original process. To date, none of the concepts outlined above has been applied to the
industrial hydroformylation of higher olefins. There is still a need for an approach that
meets all of the strict requirements of a technical two-phase process, such as complete
catalyst  retention,  high activity and stability,  high aldehyde selectivity,  simple phase
separation,  and  low  ligand  costs  in  order  to  be  economically  competitive  with  the
currently used processes.
1.3 Outlook on this thesis
Nature uses enzymes which are the most efficient and selective catalysts known. If their
properties  could  be  combined  with  the  reactivity  of  transition  metals  it  would  be
possible to form highly active and selective hybrid catalysts. Because of their chirality
the resulting catalysts could be used for asymmetric reactions as well.
Regarding  the  design  of  hybrid  catalysts  the  following  two  requirements  were
considered to be essential:
• In order to avoid catalysis by free (leached) metal the transition metal has to be
firmly bound to the enzyme. 
• In order to take full advantage of the tertiary structure of the enzyme the location
of the transition metal  should be in  close proximity to the active site of the
enzyme (e.g. a tunnel). 
Covalent modification of enzymes allows the introduction of a metal binding site in
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close proximity to the active site  of a  protein.  This  concept  which is  schematically
depicted in fig. 12 was used in this thesis.
Fig.  12  Schematic  representation  of  an  ideal  artificial  metalloenzyme  obtained  by
covalent modification.
The figure shows a protein with an active site (a hydrophobic tunnel) which is capable
to bind the desired apolar substrate (as an example 1-octene is depicted).  At a well
defined site of the protein a ligand with a high affinity to a transition metal is covalently
attached. If the binding capacity of the ligand is higher than other randomly distributed
binding sites of the enzymes (e.g. amino acids) a  transition metal is coordinated to this
ligand.  The modification is  near  the active  site,  so the  introduced metal  is  in  close
proximity to the substrate. Due to high substrate concentrations within the tunnel next to
the  transition  metal  rate  enhancements  should  be  observed.  In  addition  the  protein
environment should induce (enantio)selectivity.
In the design, synthesis and application of artificial metalloenzymes the basic concept
outlined  in  fig.  12  is  pursued  throughout  the  whole  thesis.  The  main  focus  of  the
research is on the two mutants SCP-2L A100C and SCP-2L V83C which were found to
be suitable protein scaffolds.[107]
In the long run using artificially modified proteins has a lot of potential as it might use
the high activities and selectivities of enzymes for reactions not catalysed by enzymes.
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There are already many different reactions catalysed by artificial metalloenzymes – the
ones  relevant  for  this  thesis  will  be  discussed  in  the  corresponding  chapters.
Additionally, a short general introduction about artificial metalloenzymes is given in
chapter  3.  The  interested  reader  is  refered  to  the  many  reviews[108–111] on  artificial
metalloenzymes for additional information. 
Chapter 2:
The  crystal  structure  of  the  SCP-2L A100C mutant  was  obtained  and  discussed.  A
special emphasis on its hydrophobic tunnel is taken and it is shown that the mutation
has a small effect on this tunnel. 
Additionally,  the binding capability of the two SCP-2L mutants and their  covalently
modified counterparts  towards different  metal  salts  is  investigated.  Two different  N-
ligands (phenanthroline or dipicolylamine based) and three different phosphine ligands
(all based on triphenylphosphine)  were used for this study. Additionally, the rhodium
binding capabilities of two protein scaffolds which were tested as a reference in the
latter investigated hydroformylation reaction were determined as well.
Chapter 3:
This chapter focusses on the application of Rh-enzymes in the aqueous-organic biphasic
hydroformylation  of  long  chain  1-alkenes.  Six  different  SCP-2L  based  phosphine
modified  Rh-enzymes  were  tested.  In  order  to  evaluate  the  high  activities  and
selectivities observed the mode of action was further investigated.
Chapter 4:
This  chapter  describes  the  application  of  N-ligand  modified  SCP-2L A100C in  the
asymmetric  Diels-Alder  reaction.  Cu(II)-,  Ni(II)-  and  Co(II)-enzymes  which  were
determined  as  promising  artificial  metalloenzymes  in  chapter  2  are  tested.  In  these
reactions the chiral environment of the protein is utilized to induce enantioselectivity in
catalytic reactions. 
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Chapter 5:
Finally, the fifth chapter will give a summary, discussion and final conclusion on the
approach and methodology applied in this thesis.
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Chapter 2: Crystal structures and metal complexes
2.1 Abstract
In this chapter the crystal structure of SCP-2L A100C, which is a mutant of the sterol
carrier protein-2 like domain of the human peroxisomal multifunctional enzyme type 2
is  described  and  compared  to  its  wild  type.  The  mutant  SCP-2L V83C  is  briefly
discussed as well.  A special  emphasis  is  placed on the hydrophobic tunnel  of  these
proteins.
The two SCP-2L mutants, lysozyme and a mutant of the photo-active yellow protein
(PYP R52G) were modified with P-ligands based on triphenylphosphine. Additionally
both  SCP-2L  mutants  were  modified  with  N-ligands  based  on  either  1,10-
phenanthroline or di-(2-picolyl)amine. The synthesised artificial enzymes as well as the
unmodified proteins were treated with selected transition metals (twelve different metals
were tested) and analysed by ESI-MS. The metal loading of most of these artificial
metalloenzymes was also determined by ICP-MS. 
Some of the phosphine modified proteins were identified as promising scaffolds for
Ir(I)- and Rh(I)-enzymes as the artificial metalloenzymes could be detected by ESI-MS
and a high metal loading was determined by ICP-MS. 
The N-ligand modified proteins of SCP-2L A100C were also analysed by ICP-MS. The
ICP-MS and  ESI-MS data  suggests  that  di-(2-picolyl)amine)  modified  SCP-2L is  a
promising scaffold for Pd(II)-enzymes and 1,10-phenanthroline modified SCP-2L is a
promising scaffold for Pd(II)-, Cu(II)- Ni(II) and Co(II)-enzymes.
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2.2 Introduction
SCP-2L
Multi functional enzyme type 2 (MFE-2) is one class of proteins in mammals, which
catalyses  β-oxidation of fatty acids. MFE-2 consists of three domains. The C-terminal
domain  shows  similarities  to  sterol  carrier  protein  type  2  (SCP-2)  and  is  therefore
referred to as sterol carrier protein 2-like (SCP-2L). SCP-2 proteins are known to have
high binding affinity for  a  variety of  different  substrates  like cholesterol  (and other
steroids), various phospholipids,[1] or long chain fatty acids.[2] 
SCP-2L was described as almost spherical with both a large and a small hydrophobic
tunnel and several large apolar cavities.[3] The crystal structure of SCP-2L is depicted in
figure 1.
Fig.  1  Crystal  structure  of  SCP-2L  with  ligand  Triton  X-100  within  the  (large)
hydrophobic tunnel (pdb-code: RCSB013373). Triton X-100 is shown as ball and stick
model  with  carbon  in  green,  oxygen  in  red;  hydrogens  are  omitted.  Left:  Cartoon
representation of the protein, protein in blue except for the amino acid V83 and A100
which  are  coloured  magenta.  Right:  Surface  view  with  20%  transparency.  Protein
coloured in blue except for V83 which is coloured magenta.
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The most relevant part of the protein is the hydrophobic tunnel in which a molecule of
Triton  X-100  is  located.  Additionally  the  two  amino  acids  V83  and  A100  are
highlighted. These amino acids are of importance because of their location at either end
of the large hydrophobic tunnel (see fig. 1). They can be replaced with cysteine, which
is not found elsewhere in the protein. Therefore research had been focussed on the two
mutants SCP-2L A100C and SCP-2L V83C. Both mutants can  be expressed in high
yield,  its  purification  is  straightforward  and  both  have  a  remarkable  temperature
stability.[4] These  are  important  features  of  a  potential  artificial  metalloenzyme.  By
covalent  modification  of  the  unique  introduced  cysteine  several  artificial  enzymes
bearing nitrogen ligands[5] (see scheme 1) were successfully synthesised.
Scheme 1 Protein modification with the N-ligands used in this thesis.
In this procedure the thiol group of the cysteine is site specifically modified with a N-
ligand bearing maleimide.  The introduced  N-ligands are based on either the bidentate
1,10-phenanthroline  structure  (Phen)  or  the  tridentate  di-(2-picolyl)amine-based
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structure (Picol). The synthesis of these ligands as well as the modification of the two
SCP-2L mutants is straightforward but only copper-enzymes have been investigated so
far.[4] This places the introduced N-ligand in close proximity to either end (dependent on
the  mutant  used)  of  the  large  hydrophobic  tunnel  present  within  the  SCP-2L  via a
covalent  linkage   (see  scheme  1).  A method  for  the  site  specific  introduction  of
phosphine moieties has already been described in the literature[6] and used within this
work (see scheme 2)
Scheme 2 Protein modification with phosphine ligands and the phosphines used in this
thesis.
This  procedure comprises  a  series of  sequential  reactions.  In  the first  step the thiol
group of the cysteine is reacted with a short commercially available hydrazide bearing
maleimide linker (abbreviated as "1"). In the second step the phosphine is introduced by
reacting  the  hydrazide  with  an  aldehyde  bearing  phosphine.  Three  different  mono-
phosphines (ortho, meta and para-derivative) which are all based on triphenylphosphine
were used in this thesis (see scheme 2).
The subsequent treatment of the modified SCP-2L with an appropriate metal resulted in
artificial metalloenzymes which were tested as catalysts in the Diels-Alder-,[5] and the
hydroformylation reaction[4] with promising results. The introduced metal was assumed
to be in close proximity to the hydrophobic tunnel. This was used as rationalisation for
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the  rate  accelerations  observed  when  apolar  substrates  were  used,  as  they  would
accumulate  within  the  tunnel,  in  close  proximity  to  the  introduced  metal. [4] CD-
spectroscopy, 1H NMR and binding studies did indicate that the tertiary structure of the
protein was not influenced by neither the mutations nor the chemical modifications of
the protein scaffold[4] but crystal structures as a definitive proof were not obtained so far.
Metalloenzymes
It is estimated that about 30% of all characterised proteins are associated with at least
one metal.[7] A wide array of qualitative and quantitative characterisation methods for
these  are  known  and  used.[8–10] The  characterisation  of  artificial  metalloenzymes  is
usually based on ultraviolet-visible[11–15] (UV-VIS) spectroscopy, circular dichroism[14–
17,5,18,19] (CD)  spectroscopy,  mass  spectroscopy,[6,11,13,14,16,18,20–23] usually  electrospray
ionisation (ESI), sometimes matrix assisted laser desorption/ionisation (MALDI)) and
inductively coupled plasma[16,20,22,24] (ICP)-techniques. If applicable other techniques like
fluorescence  measurements[5,12,23],  electron  paramagnetic  resonance[13,25] (EPR)  and
nuclear magnetic resonance[6,23] (NMR) are used as well. 
Artificial metalloenzymes in this thesis
Various phosphine- and N-ligand-modified proteins were used within this thesis. SCP-
2L based ones are most relevant, therefore it was aimed to obtain the crystal structures
of the modified proteins, to gain insight on the protein environment surrounding the
introduced ligand. This would make it possible to fine-tune the active site by biological
or chemical means in respect to its substrate- or metal coordination. In order to obtain
artificial metalloenzymes suitable for catalysis it is of utmost importance to determine
the binding capabilities of the modified proteins towards transition metals before testing
them in catalytic reactions. An artificial enzyme with a small binding capability towards
a metal is an undesired catalyst, as a comparably high concentration of unligated metal
would  be  present  in  solution.  This  unligated  metal  could  outperform  the  catalytic
activity of the artificial metalloenzyme itself, which would make it impossible to draw
any  conclusions  on  the  performance  of  the  artificial  metalloenzyme.  In  theory  the
concentration of unligated metal could also be reduced by using a high artificial enzyme
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to metal ratio, but due to the time consuming synthesis of artificial enzymes this is less
desirable. In this chapter these issues are addressed.
2.3 Results and discussions
Crystal structure of SCP-2L A100C
Most of the artificial metalloenzymes investigated in this thesis are based on SCP-2L
A100C and SCP-2L V83C, therefore it was of high importance to obtain the crystal
structures of the two mutants. Additionally, attempts on the crystallisation of sulphur
protected phosphine-bearing modifications were performed, which were unsuccessful
(see experimental section). The crystallisation attempts on the mutants SCP-2L A100C
and SCP-2L V83C were successful but only the refined crystal  structure of SCP-2L
A100C could be obtained so far.
Various aspects of the crystal structure of SCP-2L A100C in comparision to its wild-
type are depicted in figure 2 and figure 3. 
40
Fig. 2 Crystal Structure of SCP-2L and SCP-2L A100C with ligand Triton X-100. The
ligand Triton X-100 within the large hydrophobic tunnel is shown as a ball and stick
model with carbon in green, oxygen in red; hydrogens are omitted. Protein represented
as cartoon and coloured in blue except for the single amino acid cysteine which is
coloured green. Cysteine is shown as ball and stick model with the thiol as yellow. b-
strands and a-helices are indicated with Roman numbers (I-IV) and Roman capitals (A-
E) respectively.
Top: Crystal structure of SCP-2L
Bottom: Crystal structure of SCP-2L A100C
41
Figure 2 shows both SCP-2L (at the top) and the mutant SCP-2L A100C (at the bottom)
as cartoon with labelled a-helices and b-strands as a “front” view and turned by 180°.
The molecule Triton X-100 which is located within the tunnel is shown as ball and stick
model. The introduced cysteine is located on b-strand “V” and coloured green. In case
of the mutant SCP-2L A100C the amino acid cysteine is additionally shown as ball and
stick with the sulphur coloured in yellow. 
In figure 3 the surface potential of SCP-2L and SCP-2L A100C is depicted:
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Fig. 3 Electrostatic surface potential of SCP-2L A100C and the wild-type protein SCP-
2L with ligand Triton X-100. The ligand Triton X-100 within the large hydrophobic tunnel
is shown as a ball and stick model with carbon in green, oxygen in red; hydrogens are
omitted.  Red corresponds to  a  negative,  white  to a neutral  and blue to a positive
surface potential. Either entrance of the large tunnel is shown.
Top: Electrostatic surface potential of SCP-2L
Bottom: Electrostatic surface potential of SCP-2L A100C
In  Figure  3  the  electrostatic  surface  potential  of  SCP-2L (top)  and  SCP-2L A100C
(bottom) is depicted (calculated using APBS, see experimental section). The left side of
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figure 3 is focussing on the electrostatic surface poteintial next to the side where the
mutation took place. The tunnel entrance and the ethoxychain of the Triton X-100 is
visible (Triton X-100 is represented as a ball and stick model). The electrostatic surface
potential  of the protein next to the tunnel is mostly neutral  (represented by a white
colour).  Most  of  the  surface  visible  in  this  figure  has  a  positive  surface  potential
(represented  by a  blue  colour).  The  right  half  of  the  figure  shows  the  electrostatic
surface potential of the protein focussing on the other end of the tunnel. The surface
potential around this end of the tunnel is -similar to most of the protein surface shown in
this figure - mostly neutral. Although this side of the protein contains more areas with a
negative surface potential these areas are quite scattered making the hydrophobic tunnel
by far the major hydrophobic area of the mutant.
The crystal structure for the SCP-2L A100C mutant and its surface potential is very
similar to the previously published crystal structure of its wild type.[3] 
As the large tunnel was considered important for any artificial metalloenzyme based on
this scaffold, it was further investigated by analysing the contact environment of Triton
X-100. The schematic contact environment between Triton X-100 and the amino acids
of SCP-2L A100C is shown in fig. 4.
Fig.  4  Schematic  contact  environment  between  Triton  X-100  and  SCP-2L A100C.
Amino acids are abbreviated using their 1-letter code, their residue number is given. All
atoms of Triton X-100 are numbered.
The contact environment has many similarities compared to the contact environment
between SCP-2L and Triton X-100. In order to perform a profound comparison between
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the tunnel of the mutant and the wild type protein the distances between each atom of
the Triton X-100 to each atom of both the wild type protein and the mutant (when either
of it has a distance ≤4.0 Å) was compared (see Table 8 in the experimental section for
all details). The results are quite similar for the wild type SCP-2L and its mutant SCP-
2L A100C, but some minor differences were observed:
• The amino acid L114 is in close proximity to C7 of the Triton X-100 in the
native protein. In case of the mutant SCP-2L A100C, L110 is in close proximity
to C7 instead of L114. This shows the flexibility of the protein structure.
• The amino acids  next  to  C11 are  much further  away in case  of  the mutant.
Therefore the tunnel of SCP-2L A100C has a larger diameter at this place.
• The ethoxychain (especially C17, then from C20 to C25) is much closer to the
protein in case of the wild-type than in the case of the SCP-2L A100C mutant.
Therefore the tunnel of SCP-2L A100C has a larger diameter at these regions as
well.
The single A100C is close to the end of the tunnel where the ethoxychain of the Triton
X-100 is  located.  The cysteine  side-chain  is  slightly  larger  than  the  alanine  and an
expansion of the tunnel diameter in this region can be observed.
Metal complexes of N-Ligand modified proteins
Artificial  metalloenzymes  covalently  modified  with  N-Ligands  were  synthesised
according to the previously described site-specific modification (see scheme 1).[5] The
previously  introduced  mutants  SCP-2L  A100C  and  SCP-2L  V83C  were  used  as
scaffolds. Subsequently, 2 eq. of the metal salts were added to the  N-ligand modified
proteins to obtain different artificial metalloenzymes. These were characterised by ESI-
MS and ICP-MS. The acetate salts of the following metals were used: Pd(II), Zn(II),
Mn(II), Fe(II), Cu(II), Ni(II) and Co(II).
ESI-MS data of Picol-modified proteins
The ESI-MS data regarding the  Picol- modified proteins as well as the corresponding
control  reactions  where the unmodified proteins SCP-2L A100C and SCP-2L V83C
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were used showed no metal-modified protein adducts except in the case of Pd(II). When
palladium(II)-acetate  was  used  adducts  between modified  protein  and the  metal  ion
were detected for both Picol-modified protein scaffolds. In the reaction between SCP-
2L V83C-Picol and Pd(II) the new peaks could be characterised as species with one,
two or  three Pd(II)  coordinating to  the scaffold (see fig.  1 in  the appendix).  In  the
reaction  between  SCP-2L  A100C-Picol and  Pd(II)  the  new  species  were  mostly
unassigned,  but  three  peaks  corresponding  to  species  with  one,  two or  three  Pd(II)
coordinating to the scaffold could be assigned as well (see fig. 2 in the appendix). 
After treating the SCP-2L A100C-Picol-Pd mixture with EDTA and removal of EDTA-
complexed metal  by filtration  (see  experimental  section  for  more  details)  the major
species  detected  by  ESI-MS  is  the  1:1  (Protein  :  Pd)-complex  (see  fig.  3  in  the
appendix). This indicates that one of the binding sites is much stronger than the other
ones. 
When unmodified protein SCP-2L A100C or SCP-2L V83C were treated with Pd(II) the
resulting ESI-MS did not show any distinguishable mass peaks due to a low signal to
noise ratio. Therefore it cannot be concluded whether the unmodified mutants posess
any Pd(II)  binding sites.  From this  data  it  is  yet  unclear  whether  the strong Pd(II)-
binding observed is due to the introduced ligand or to the protein scaffold itself.
ESI-MS data of Phen-modified proteins
The ESI-MS data regarding the  Phen-modified proteins as well as the corresponding
control reactions where unmodified protein was used are listed in table 1.
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Table 1 ESI-MS analysis of artificial metalloenzymes based on unmodified- and Phen-
modified proteina
a: Reaction and analysis  conditions:  To 0.1 µmol  protein in  buffer 2-3 eq. of  metal  salt  were added,
reaction time 1 day. After buffer exchange a fifth was analysed by LC-MS. When SCP-2L A100C-Phen was
used and the metal  complex (or an unknown complex in case of  Mn(II))  was detected the remaining
solution was treated with EDTA and buffer exchanged. The EDTA treatment was repeated three times and
the supernatant analysed by LC-MS. See experimental section for all details. +: A mass corresponding to
the  expected  mass  of  the  artificial  metalloenzymes  was  detected,  -:  No  masses  higher  than  the
(un)modified protein were detected (excluding sodium adducts). B:  Low signal to noise ratio  C: A mass
corresponding to two metals coordinating were detected. After treatment with EDTA the noise to signal
ratio is too low D: Peaks with masses corresponding to complexes with two and three metals coordinating
were detected  E: A species with a mass of 60-63 Da higher than the modified protein is detected. After
treatment with EDTA only the modified protein can be detected by ESI-MS F: After treatment with EDTA
only the modified protein can be detected by ESI-MS.  G: The peak with the mass corresponding to the
metal enzyme is broad and only slightly higher than the background signal, therefore it might be noise. 
When  Phen-modified  proteins  were  treated  with  Palladium(II)-acetate  (entry  1)  the
results are similar to the ones obtained when Picol-modified proteins were used. In the
reaction between SCP-2L A100C-Phen and Pd(II) species corresponding to one and two
Pd(II) coordinating were assigned (see fig. 4 in the appendix). In the reaction between
SCP-2L V8C-Phen and Pd(II) the protein scaffold as well as species with one, two and
three Pd(II)  coordinating to  the scaffold were detected (see fig.  6  in  the appendix).
When unmodified protein SCP-2L A100C or SCP-2L V83C were treated with Pd(II) the
resulting ESI-MS did not show any distinguishable mass peaks due to a low signal to
noise ratio (as mentioned before). After treating the SCP-2L A100C-Phen-Pd mixture
with EDTA and removal of unbound metal by filtration (see experimental section for
more details) the major species detected by ESI-MS is the mono-Pd-complex (see fig. 5
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entry metal salt Protein scaffoldSCP-2L A100C SCP-2L V83C
1
2 - - - -
3 - - -
4 - - - -
5 - - +
6 - - +
7 - - -
SCP-2L A100C-Phen SCP-2L V83C-Phen
Pd(OAc)
2 -
b -b +c +d
Zn(OAc)
2
Mn(OAc)
2 -
e
Fe(OAc)
2
Cu(OAc)
2 +f
Ni(OAc)
2 +
f
Co(OAc)
2 +g
in the appendix).
When Zn(II)- (entry 2) or Fe(II)-acetate (entry 4) were used as metal precursors the
masses corresponding to the artificial metalloenzymes could not be detected for the two
control reactions and the Phen modified proteins. 
When Mn(II)-acetate was used as metal precursor (entry 3) no masses corresponding to
the artificial metalloenzymes could be detected for neither the unmodified proteins nor
the SCP-2L V83C-Phen scaffold.  After treating SCP-2L A100C-Phen with Mn(II)  a
peak with a mass of ≈61 Da higher than the modified protein was detected (see fig. 7 in
the appendix). Due to the broadness of the peaks it might correspond to the Mn(II)-
enzyme (M(Mn) = 55 Da). After EDTA treatment this species could not be detected
anymore, strengthening this hypothesis (see fig. 7 in the appendix).
When Cu(II)-  (entry 5)  or  Ni(II)-acetate  (entry 6)  were  used as  metal  precursor  no
masses corresponding to the artificial metalloenzymes could be detected in the control
reactions where unmodified protein was used. Both Phen- modified scaffolds did show
the expected mass corresponding to the respective artificial metalloenzymes (see fig. 8-
11 in the appendix). After treatment of both the Ni(II)- and Cu(II)-enzymes based on the
SCP-2L A100C-Phen scaffold with EDTA and subsequent analysis by ESI-MS only the
mass corresponding to the metal-free SCP-2L A100C-Phen could be detected (see fig.
10 for SCP-2L A100C-Phen-Ni(II) and fig. 11 for SCP-2L A100C-Phen-Cu(II); both in
the appendix).
When Co(II)-acetate was used as metal precursor (entry 7) no masses corresponding to
the artificial metalloenzymes could be detected for neither the unmodified proteins nor
the SCP-2L A100C-Phen scaffold. The mass corresponding to SCP-2L V83C-Phen-Co
could be detected (see fig. 12 in the appendix).
Summary  on  the  ESI-MS  data  of  N-ligand  modified  and  unmodified  artificial
metalloenzymes
Addition of Pd(II) to unmodified mutants of SCP-2L resulted in low signal to noise
ratios. Addition of Pd(II) to modified SCP-2L mutants bearing  Phen or  Picol-ligands
resulted in up to three Pd(II)-ions coordinating to the modified proteins. This indicates
high affinity of Pd(II) and probably unspecific coordination to exposed amino acids.
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The 1:1 complexes of Pd(II) and SCP-2L A100C modified with either  Phen or  Picol
could be detected by ESI-MS after EDTA treatment, indicating that one Pd(II) atom per
modified protein is coordinating much stronger than the other ones.
In contrast to  Phen-based artificial metalloenzymes,  Picol-based ones (except for the
Pd(II)  discussed  above)  could  not  be  detected  by ESI-MS.  This  indicates  a  higher
stability of the Phen-based artificial metalloenzymes in general. This finding is contrary
to the expectation, as the equilibrium constants of the 1:1 complexes between Cu(II),
Ni(II),  Co(II)  or  Zn(II)  and  di-(2-picolyl)amine  are  much  much  higher  than  the
equilibrium constants for the corresponding 1:1 complexes with 1,10-phenanthroline as
ligand.  The equilibrium constants  of the 1:1 complex between Fe(II)  or  Mn(II)  and
1,10-phenanthroline are higher than the corresponding constants of di-(2-picolyl)amine
under the same conditions.[26–28] The equilibrium constants between Fe(II) or Mn(II) to
the ligands are significantly smaller than the equilibrium constants of Ni(II),  Cu(II),
Co(II) or Zn(II) (the literature known complexation constants are listed in table 9 in the
experimental section of this chapter). Even when the influence of the slightly acidic pH
used in the protein complexation reactions is taken into account the phenomena cannot
be explained. 
The  complexation  constants  of  the  Phen-modified  proteins  are  higher  than  the
corresponding Picol-modified proteins, which is basically the opposite of the literature
known  data  of  the  "free"  ligands.  This  might  be  explained  by the  coordination  of
multiple  Phen-modified  proteins  to  a  single  metal  which  seems  unlikely  as  the
introduced ligand is supposed to be buried within a pockt. It might also be possible that
metal  complexes  of  Phen-modified  protein  are  subject  to  a  higher  stabilisation
(compared to the Picol-modified proteins) due to amino acids coordinating to the metal.
While Picol is a tridentate ligand in solution it might be possible that Picol bound to the
protein can only act as a bidentate ligand due to steric hindrance caused by the bulky
protein.
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ICP-MS of SCP-2L A100C scaffolds
After metal treatment of the protein scaffolds SCP-2L A100C, SCP-2L A100C-Phen
and SCP-2L A100C-Picol the coordinating metal was removed by EDTA and the EDTA
and metal  containing  fractions  combined,  concentrated  and analysed  by ICP-MS to
calculate the initial metal loading (see experimental section for details). The resulting
data are listed in table 2. 
Table 2 ICP-MS and metal loading of different artificial metalloenzymes.a
a: Reaction and analysis conditions: To 0.1 µmol protein in buffer 2 eq. of metal salt were added (in case
of SCP-2L A100C 3 eq. were used), reaction time 1 day. After buffer exchange a fifth was analysed by LC-
MS. The remaining solution was treated with EDTA and the buffer was exchanged. The EDTA treatment
was repeated three times and the flow through collected, concentrated and its metal content determined
by  ICP-MS.  See  experimental  section  for  all  details.  b:  n(metal)  /  n(Protein),  corrected  for  the  1/5th
removed for ESI-MS analysis; 50% corresponds to 0.5 mol metal per 1 mol (un)modified protein, 100%
corresponds to 1 mol metal per 1 mol (un)modified protein and so on.  c: Rather high concentration of
metal  in  the  blank  is  probably  the  reason for  the  negative  value  d:  Probably  due to  multiple  metals
coordinating to the scaffold. e: In a control reaction where SCP-2L V83C was reacted with Cu(OAc)2 under
the same conditions 950 ppb Cu (corrected for the blank) were determined by ICP-MS which corresponds
to 18.7% metal. 
It should be noted that SCP-2L A100C is not a perfect reference as its thiol is likely to
coordinate metals, The wild type SCP-2L without the thiol would have been a better
comparison. Comparing the metal loading of SCP-2L A100C-Phen and SCP-2L A100C-
Picol  still  gives  insight  into  the  different  binding  capabilities  of  the  two  artificial
enzymes. 
SCP-2L A100C-Picol has a significantly higher metal loading (and therefore a higher
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entry metal salt Protein scaffoldSCP-2L A100C
ppb ppb ppb
1 1500 9 7900 93 3900 23
2 1000 10 1000 10
3 800 9 1200 13 500 5
4 3600 41 12000 70
5 1200 6 4900 23
6 600 6 700 8 1000 11
7 200 3 300 3 2500 27
SCP-2L A100C-Picol SCP-2L A100C-Phen
% metal loadingb % metal loadingb % metal loadingb 
Pd(OAc)
2
Zn(OAc)
2 -600
c -6c
Mn(OAc)
2
Fe(OAc)
2 15600
d 175d
Cu(OAc)
2 21000
e 66e
Ni(OAc)
2
Co(OAc)
2
equilibrium constant) to Pd(II) (entry 1) and a slightly higher to Mn(II) (entry 3) than
SCP-2L A100C-Phen and the unmodified mutant. 
The metal loading for SCP-2L A100C-Phen and Fe(II) (entry 4), Cu(II) (entry 5), Ni(II)
(entry 6) and Co(II) (entry 7) is significantly higher than the metal loading for SCP-2L
A100C-Picol and the corresponding metal. 
The metal  loading between both modified proteins and Zn(II)  (entry 2) is  basically
identical. 
The metal loading of the modified proteins is in general higher than for the unmodified
protein. The only exceptions are Fe(II) (entry 4) and Cu(II) (entry 5). The high metal
loading  of  the  unmodified  protein  in  these  cases  might  be  due  to  the  previously
mentioned free thiol.
The differences in metal loading indicate the coordination of metals to the introduced
ligand. Only in case of Fe(II), Cu(II) and Mn(II) no such conclusion can be drawn.
The metal loadings listed in the table were also used to calculate equilibrium constants
between the  N-ligand modified protein and each metal. Due to several simplifications
the calculated equilibrium constants are most likely inaccurate (see experimental section
for details).
Conclusion on the ESI-MS- and ICP-MS-analysis of N-ligand modified proteins
The  Pd-enzyme  derived  from the  Picol-modified  SCP-2L A100C show  high  metal
loading and could be detected by ESI-MS. This is a strong indication for a promising
artificial metalloenzyme. The Phen-modified SCP-2L A100C mutants were found to be
promising scaffolds for Pd(II), Cu(II) and Ni(II)-enzymes as they could be detected by
ESI-MS indicating a strong binding and possessed a high metal loading according to
ICP-MS as well.  Phen-modified SCP-2L V83C showed the same promising ESI-MS
results for these metals, the corresponding metal loadings were not determined but can
be expected to be similar. The results for the Co-enzyme of the Phen modified SCP-2L
mutants tested is ambivalent. While SCP-2L V83C-Phen-Co was detected by ESI-MS,
SCP-2L A100C-Phen-Co could not be detected by ESI-MS but this Co-enzyme showed
a high metal loading by ICP-MS.
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Metal complexes of proteins modified with P-ligands
Synthesis and characterisation of phosphine containing proteins
In addition to the  N-ligand modified proteins, phosphine-modified proteins were used
for metal complexation reactions as well. Four cysteine containing enzymes were used
as scaffold: SCP-2L A100C, SCP-2L V83C, a mutant of the photoactive yellow protein
(PYP R52G)  and  lysozyme.  The  latter  two  proteins  were  meant  to  act  as  control
reactions as they do not posess a hydrophobic tunnel.
In case of the SCP-2L based proteins, as well as of PYP R52G, the thiol group of the
cysteine  present  in  each  protein  was  modified  according  to  the  literature  known
procedure introduced earlier (see scheme 2).[6] 
Lysozyme contains eight cysteines, all of which are present as disulfides. In order to
modify lysozyme the disulfides were reduced prior to the modification described above.
For this  reduction two different  reducing agents  were tested (TCEP and DTT).  The
linker modification after reduction with TCEP was more efficient as the reduction using
DTT resulted in the degradation of lysozyme (see experimental section). The product
obtained was a mixture of lysozyme species containing up to four linker moieties (the
product  mixture  is  refered to  as  lysozyme-(1)x),  where  "1" represents  the  hydrazide
linker (see fig. 18 in the appendix for the ESI-MS). The modified lysozyme was used as
the  feedstock  for  the  subsequent  modification  reactions  with  the  three  different
phosphines. The reaction between lysozyme-(1)x  and P(para) as well as  P(meta) were
incomplete after long reaction times (about one week) and vast excess of phosphine (up
to 25 eq.) (see fig. 19 and fig. 20 in the appendix for the ESI-MS). In both cases only
the phosphine oxides were detected by ESI-MS indicating that these lysozyme based
artificial enzymes are much more oxygen sensitive than the SCP-2L and PYP based
ones. The modification with P(ortho) was virtually unsuccessful yielding only marginal
quantities of phosphine modified lysozyme (according to ESI-MS, only the oxides were
detected). The lysozyme-based partly phosphine modified artificial enzymes were used
for metal complexation reactions with Rh(I) as well.
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Metal complexes of P-ligand modified proteins
The synthesised artificial proteins bearing a phosphine were treated with different metal
salts to obtain the corresponding artificial metalloenzymes. Table 3 gives an overview of
all phosphine based artificial metalloenzymes synthesised and analysed in this study.
Table 3 List of artificial metalloenzymes bearing a phosphine synthesised in this thesis.a
a: Slightly different reaction conditions for (almost) every metal complexation reaction. See experimental
section for details. b: protein scaffold synthesised according to a published procedure:[4] c: protein scaffold
synthesised according to a published procedure:[6] d: Synthesised according to the procedure outlined in
the  experimental  section  e:  Synthesised  by  Dr.  W.  Laan  according  to  a  published  procedure:[29] "+":
Synthesis was performed "-" No attempt on synthesising the artificial metalloenzymes performed.
All resulting artificial metalloenzymes were analysed by ESI-MS and ICP-MS, except
for PYP R52G-1-P(para)-Rh which was only characterised by ESI-MS.
Characterisation of phosphine based artificial metalloenzymes
ESI-MS of Rh-enzymes
The ESI-MS of the complex between SCP-2L A100C-1-P(para) (entry 1) and Rh(acac)
(CO)2 as well as the complex of SCP-2L V83C-1-P(para) (entry 4) and Rh(acac)(CO)2
were published previously[4] and could be reproduced (see figures  21 and 22 in  the
appendix). The ESI-MS shows three peaks. The first peak corresponds to the phosphine
modified protein. The second peak has a mass which is 16 Da higher than the first peak
and corresponds to the oxidised phosphine modified protein (oxidation most likely due
to the ESI-MS conditions which are not oxygen free). The third peak has a mass which
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entry protein scaffold
metal precursor
Mn(II) Fe(II) Co(II) Ni(II) Cu(II) Zn(II) Ru(III) Rh(I) Pd(II) Re(I) Ir(I) Pt(II)
1 + + + + + + + + + + + +
2 - - - - - - - + - - - -
3 - - - - - - - + - - - -
4 + + + + + + + + + + + +
5 - - - - - - - + - - - -
6 - - - - - - - + - - - -
7 - - - - - - - + - - - -
8 - - - - - - - + - - - -
9 - - - - - - - + - - - -
10 - - - - - - - + - - - -
SCP-2L A100C-1-P(para)b
SCP-2L A100C-1-P(meta)b
SCP-2L A100C-1-P(ortho)b
SCP-2L V83C-1-P(para)c
SCP-2L V83C-1-P(meta)c
SCP-2L V83C-1-P(ortho)c
Lysozyme-(1)
x
-P(para)d
Lysozyme-(1)
x
-P(meta)d
Lysozyme-(1)
x
-P(ortho)d
PYP R52G-1-P(para)e
is 131 Da higher than the first peak. This difference was attributed to the presence of the
fragment "Rh(CO)" (M (RhCO) = 131 Da). Two additional Rh(I) precursors were tested
on SCP-2L A100C-1-P(para).  When [Rh(MeCN)2COD]BF4 was  used as  precursor  a
new peak with a mass of 99 Da higher than the phosphine modified scaffold is observed
(see fig. 13 in the appendix). Due to the broadness of the peaks and the resulting mass-
inaccuracy this was attributed to a Rh-adduct (M (Rh) = 103 Da). When RhH(PPh3)3CO
was used as precursor no additional peaks beside the modified protein and its oxide
could be detected. This indicates the importance of the metal precursor used in order to
detect species by ESI-MS. The reaction between SCP-2L A100C-1-P(meta) (entry 2)
and  Rh(acac)(CO)2 resulted  in  a  MS  with  a  high  noise  to  signal  ratio  making  it
impossible to allocate peaks. The ESI-MS of the reaction between SCP-2L A100C-1-
P(ortho) (entry 3) and Rh(acac)(CO)2 contains the peaks corresponding to the phosphine
and its oxide but no higher mass adducts. When SCP-2L V83C-1-P(meta) (entry 5) was
treated  with  Rh(acac)(CO)2  the  Rh-enzyme  was  detected  by  LC-MS.  Peaks
corresponding  to  the  modified  enzyme,  its  oxide  as  well  as  a  peak  with  a  mass
difference caused by a Rh(CO)-fragment were detected (see fig. 14 in the appendix). It
should be noted that the signal to noise ratio was quite low. The ESI-MS obtained for
the reaction between SCP-2L V83C-1-P(ortho)  (entry 6)  and  Rh(acac)(CO)2  showed
three main peaks (see fig. 15 in the appendix).  The first  two correspond to SCP-2L
V83C-1-P(ortho) and its oxide. The third peak has a mass of "SCP-2L V83C-1-P(ortho)
+ 100". Due to the broadness of the peaks this was attributed to a Rh-adduct (M (Rh) =
103 Da). The issues with the phosphine modification of linker modified lysozyme was
mentioned before. When the lysozyme based phosphines as well as lysozyme-(1)x  were
treated with Rh(acac)(CO)2 no rhodium adducts could be detected by ESI-MS analysis
for any of these proteins (entries 7-9). The ESI-MS obtained when PYP R52G-1-P(para)
was treated with Rh(acac)(CO)2 results in a rather complicated spectrum (see fig. 16 in
the appendix). Five peaks were identified: The first peak corresponds to the phosphine
modified protein PYP R52G-1-P(para) (M = 16325 Da). The second and third peaks
correspond to the mono and double oxidised species. The fourth peak (M = 16456 Da)
corresponds  to  the  desired  product  PYP  R52G-1-P(para)-Rh(CO).  The  fifth  peak
corresponds to an oxidised species of the Rh-enzyme. The next group of three peaks
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with masses of 16727 Da, 16745 Da and 16763 Da respectively cannot be accounted for
but it seems plausible to assume that the latter two of this group are the oxidised and
double oxidised species of the first.
ICP-MS of Rh-enzymes
After extensive washing of each Rh-enzyme using molecular weight cut-off technique
to  retain  both  the  modified  enzyme  and  the  Rh-enzyme  the  rhodium  content  was
determined by ICP-MS (see experimental section for details). The ICP-MS data for the
reaction between the phosphine-modified proteins,  unmodified protein and Rh(I)  are
listed in table 4. 
Table 4 ICP-MS and metal loading of different artificial metalloenzymes.a
a: Slightly different reaction conditions for (almost) every metal complexation reaction. See experimental
section for details.  b:  n(metal)  /  n(Protein).  If  appropriate:  corrected for the 1/5 th removed for ESI-MS
analysis; 50% corresponds to 0.5 mol metal per 1 mol modified protein, 100% corresponds to 1 mol metal
per 1 mol modified protein and so on. c: Reaction not performed
It has to be noted that almost every metal complexation used slightly different initial
protein and metal concentrations. Therefore different metal concentrations in the ICP-
MS analysis  are to be expected.  A direct comparison between the different rhodium
concentrations  and the  calculated  metal  loadings  is  therefore  not  sensible  but  some
general conclusions can be drawn. 
The rhodium loading for the Rh-enzymes of linker modified lysozyme (entry 1) and
linker-phosphine  modified  lysozymes  (entries  2,  3,  4)  are  within  the  same  range
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Protein scaffold
Rh(I) precursor
ppb ppb ppb
7500 32
6000 31
9300 39
7900 34
SCP-2L A100C-1-P(para) 5500 39 15400 226 3400 77
SCP-2L A100C-1-P(meta) 7800 96
SCP-2L A100C-1-P(ortho) 5500 57
SCP-2L V83C-1-P(para) 11500 47
SCP-2L V83C-1-P(meta) 10200 62
SCP-2L V83C-1-P(ortho) 3200 57
Rh(acac)(CO)
2
[Rh(MeCN)
2
COD]BF
4
RhH(PPh
3
)
3
CO
% metal loadingb % metal loadingb % metal loadingb
Lysozyme-(1)
x -c -c -c -c
Lysozyme-(1)
x
-P(para) -c -c -c -c
Lysozyme-(1)
x
-P(meta) -c -c -c -c
Lysozyme-(1)
x
-P(ortho) -c -c -c -c
-c -c -c -c
-c -c -c -c
-c -c -c -c
-c -c -c -c
-c -c -c -c
regardless of the modification. This strongly suggests that rhodium is coordinating to
(unspecific) amino acids of the protein scaffold, but not the phosphine ligands. 
The rhodium loading of phosphine modified SCP-2L scaffolds is higher in most cases
than for  the  lysozyme based scaffolds.  This  indicates  a  better  coordination of  these
phosphine  modified  scaffolds.  When  SCP-2L  A100C-1-P(para)  was  treated  with
different  Rh(I)  precursors  the  resulting  metal  loading  is  unexpected.  When
[Rh(MeCN)2(COD)]BF4 is  used  as  precursor  an  average  of  2.2  rhodium atoms  are
coordinating to every protein scaffold. Unless the protein scaffold itself undergoes some
radical structural change in the presence of this rhodium precursor it is probably fair to
assume that the precursor forms multimers (probably dimers and trimers) which are
coordinating to the phosphine.
ESI-MS of phosphine based artificial metalloenzymes (excluding rhodium)
As listed in table 3 SCP-2L A100C-1-P(para) and SCP-2L V83C-1-P(para) were treated
with  a  large  variety  of  different  metal  precursors  and  analysed  by  LC-MS.  As  a
comparison the unmodified SCP-2L A100C and SCP-2L V83C were treated with these
metal salts as well (SCP-2L V83C was not treated with Ir(I), Pt(II), Ru(III) and Re(I)).
In most cases no higher masses than the (un) modified protein could be detected by ESI-
MS indicating a rather weak interaction between the protein scaffold and the metal. In
case of Pd(II) all spectra had a low signal to noise ratio making it impossible to draw
any conclustions. Only when SCP-2L A100C-1-P(para) was treated with (Ir(acac)(CO)2,
which is the higher homologue of Rh(acac)(CO)2, results similar to the reaction between
Rh(acac)(CO)2 and P(para)-modified proteins are observed: A new peak with a mass
corresponding to a Ir(CO)-fragment is detected (see fig. 17 in the appendix) indicating
strong coordination of iridium to the introduced phosphine.
ICP-MS of phosphine based artificial metalloenzymes (excluding rhodium)
After extensive washing of each of these metallo-enzymes using molecular weight cut-
off technique to retain both the (un)modified enzyme and the metallo-enzyme the metal
content was determined by ICP-MS (see experimental section for details). The ICP-MS
data for the reaction between the P(para)-modified mutants SCP-2L V83C and SCP-2L
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A100C as well as the unmodified protein SCP-2L A100C and the different metal salts
are listed in table 5. 
Table 5 ICP-MS and metal loading of different artificial metalloenzymes a
a: Reaction conditions for SCP-2L A100C and SCP-2L A100C-1-P(para): To 0.1 µmol (un)modified protein
in 1.6 mL buffer 3 eq. of metal salt are added from a stock solution. In case of SCP-2L V83C-1-P(para) : To
0.22 µmol modified protein in 2.2 mL buffer 3 eq. of metal  salt are added from a stock solution. After one
day the buffer was exchanged, a fifth removed for ESI-MS analysis and the rest analysed by ICP-MS. See
experimental section for all details  b: n(metal) /  n(Protein), corrected for the 1/5th removed for ESI-MS
analysis; 50% corresponds to 0.5 mol metal per 1 mol (un)modified protein, 100% corresponds to 1 mol
metal  per  1  mol  (un)modified  protein  and  so  on.  c:  Probably  due  to  inaccuracies  in  the  ICP-MS
determination.
It should be kept in mind that SCP-2L A100C is not a perfect reference as its thiol is
likely to coordinate metals, the wild type SCP-2L would have been a better reference.
Additionally the reaction conditions were slightly different between the (un)modified
SCP-2L A100C and SCP-2L V83C.
The high metal loading determined when Ir(I) was used as metal precursor (entry 1) are
quite  striking.  Regardless  of  the  protein  scaffold  used  its  coordination  capacity
regarding  Ir(I)  is  high  even  for  the  unmodified  SCP-2L A100C mutant.  The  metal
loading of SCP-2L A100C-1-P(para) is roughly 100% higher than the metal loading
between  the  unmodified  SCP-2L A100C and  Ir(I).  This  strongly indicates  the  high
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entry metal salt
Protein Scaffold
SCP-2L A100C SCP-2L A100C-1-P(Para) SCP-2L V83C-1-P(para)
ppb ppb ppb
1 23000 75 51000 166 189000 279
2 1500 9 1200 7 3500 9
3 1900 6 4700 15 11100 16
4 500 4 500 2
5 800 9 400 2
6 15600 140 15000 168 12700 65
7 100 1 500 3 22000 61
8 700 4 9500 59 200 1
9 1000 3 1300 5 14000 21
10 21000 66 3500 7 12000 18
11 600 6 600 6 900 4
12 200 3 100 0
% metal loadingb % metal loadingb % metal loadingb
Ir(acac)(CO)
2
Pd(OAc)
2
Pt(OAc)
2
Zn(OAc)
2 -600
c -6c
Mn(OAc)
2 -100
c -1c
Fe(OAc)
2
RuCl
3
Ru(acac)
3
Re(CO)
5
Br
Cu(OAc)
2
Ni(OAc)
2
Co(OAc)
2 0
c 0c
binding capacity of the introduced phosphine ligand. When SCP-2L V83C-1-P(para) is
used almost all iridium initially added is coordinating to the protein scaffold (almost 3
mol iridium per mol protein). These high iridium loadings of SCP-2L V83C-1-P(para)
indicate the formation of (at least) one new iridium coordination site upon modification
of  the  mutant.  Alternatively the  SCP-2L V83C mutant  might  contain  (at  least)  one
iridium coordination site which is not present in the SCP-2L A100C mutant.
The metal loadings are negligible when Zn(II) (entry 4), Mn(II) (entry 5), Ni(II) (entry
11) and Co(II) (entry 12) were used as metal precursors. 
When Pd(II) is used as metal precursor (entry 2) the metal loadings detected are quite
similar regardless of the scaffold used, indicating that the ion is coordinating to random
amino acids of the prtotein.
When Pt(II) is used (entry 3) the metal loading is significantly higher for the Phosphine-
modified  scaffolds  than  for  the  unmodified  protein,  which  is  a  good indication  for
coordination of Pt to the introduced phosphine ligand. 
When Fe(II) (entry 6) is used the metal loading is only slightly higher for one of the
phophine  modified  scaffolds  and  even  lower  for  the  second  in  comparison  to  the
unmodified mutant which is a strong indication of Fe(II) coordination to the free thiol of
the mutant. 
The metal loading for Ru(III) (entries 7 & 8) are unexpected. The interaction of the
unmodified protein to either of the Ru(III) precursors used is quite small (<5% metal
loading). The metal loading when SCP-2L A100C-1-P(para) was treated with RuCl3 is
small as well but when it is treated with Ru(acac)3 a high metal loading is detected. The
metal  loadings  for  SCP-2L  V83C-1-P(para)  treated  with  the  same  Ru(III)-salts  is
exactly the opposite:  A high metal loading for RuCl3 and a small  metal loading for
Ru(acac)3  is  detected.  Probably the most  convenient  explanation  is  a  mislabeling  of
samples as it seems unlikely that the different precursors behave so different regarding
of the scaffold used.
When Re(I) (entry 9) is used the metal loading is small for the unmodified protein as
well as for SCP-2L A100C-1-P(para). The metal loading is significantly higher for the
scaffold SCP-2L V83C-1-P(para). 
When Cu(II) (entry 10) is used the metal loading is high for the unmodified protein
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while  much  smaller  for  the  modified  protein.  This  is  a  strong  indication  of  Cu(II)
coordination to the free thiol of the mutant. The Cu(II)-loading is significantly higher
for the scaffold SCP-2L V83C-1-P(para) than for SCP-2L A100C-1-P(para). 
2.4 Conclusion and future work
In this chapter it could be shown that the crystal structure of SCP-2L A100C is similar
to its wild type. The hydrophobic tunnel present within this mutant is by far the largest
hydrophobic  area.  By  comparison  with  the  wild  type  it  could  be  shown  that  the
hydrophobic tunnel of the mutant is slightly larger in diameter at the end where the
mutation took place.
Only a small fraction of the artificial metalloenzymes analysed could be detected by
ESI-MS  indicating  that  most  metals  are  only  weakly  coordinating  to  the  protein
scaffold. The analysis by ICP-MS was used to further quantify the metal loading of the
artificial metalloenzymes synthesised. By combining the information obtained by ESI-
MS and ICP-MS some promising new artificial metalloenzymes could be identified.
Several new promising Rh-protein adducts were identified by ESI-MS and showed high
rhodium  loadings.  Phosphine  modified  SCP-2L V83C  was  found  to  be  a  suitable
scaffold for Rh-enzymes regardless of the phosphine introduced. In case of phosphine
modified SCP-2L A100C the P(para) modified protein is the most promising scaffold.
PYP R52G-1-P(para)  was  also  identified  as  a  promising  rhodium-binding  scaffold.
Additionally iridium was found to form stable  complexes with the P(para)-modified
SCP-2L A100C mutant (both by ESI-MS and ICP-MS), making it a promising metal
complex for catalysis. 
The Phen-modified SCP-2L A100C mutants were found to be promising scaffolds for
Pd(II), Cu(II) and Ni(II)-enzymes as they could be detected by ESI-MS indicating a
strong binding and possessed a high metal loading according to ICP-MS as well. Phen-
modified SCP-2L V83C showed the same promising ESI-MS results for these metals as
well. The corresponding metal loadings were not determined but can be expected to be
similar. The results for the Co-enzyme of the Phen modified SCP-2L mutants tested is
ambiguous. While SCP-2L V83C-Phen-Co was detected by ESI-MS, SCP-2L A100C-
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Phen-Co could not be detected by ESI-MS although this Co-enzyme showed a high
metal loading by ICP-MS. The comparison of the metal loading between proteins with
different modifications as well as unmodified indicate metal binding to the introduced
ligand.  Picol-modified  SCP-2L seems  a  less  viable  protein  scaffold  than  the  Phen-
modified SCP-2L for  the metals  tested.  Only the  Pd-enzymes of  the  picol-modified
SCP-2L mutants were deemed to be promising complexes for catalysis.
Future work should comprise the refinement and analysis  of the crystal  structure of
SCP-2L V83C.  Obtaining  crystal  structures  for  artificial  metalloenzymes  would  be
ideal, but it is probably more viable to aim for crystal structures of N-ligand modified
proteins.  These could be used to model corresponding artificial  metalloenzymes and
identify  amino  acids  interacting  with  the  metal.  This  would  allow to  fine-tune  the
artificial  metalloenzymes  by mutagenesis.  A similar  approach  might  be  feasible  for
phosphine modified proteins. The crystal structures of the phosphine modified protein
or of an artificial metalloenzyme of a phosphine modified protein will not be easy to
obtain due to their air sensitivity. Therefore it seems more feasible to further investigate
the  approach used  within  this  chapter  and obtain  crystal  structures  for  sulphide  (or
otherwise) protected phosphines. In case these structures cannot be obtained it might be
worthwhile to use the crystal structures of the mutants to determine the structure of the
modified enzymes by computational means. Regardless of the approach these structures
should then be used to model the corresponding artificial metalloenzymes. This would
allow to gain insight into the structural properties next to the introduced ligand and fine-
tune this active site in regard to its metal- and substrate coordination.
It might be worthwhile to further investigate the Ir-enzymes. One should investigate
them by 31P-NMR to verify the coordination of iridium to the phosphine. They should
also be tested in a suitable reaction (like an asymmetric hydrogenation). As the  picol-
and phen- modified SCP-2L mutants were found to be promising scaffolds for Pd(II)-
enzymes, it might be worthwhile to investigate these Pd-enzymes further and test them
in a suitable reaction (for example a coupling reaction). Some of the promising Cu-,
Co-, and Ni- enzymes were tested in a Diels-Alder reaction within the scope of this
thesis (see chapter 4).
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2.5 Experimental
General
Equipment, Chemicals and suppliers
4-(diphenylphosphino)benzaldehyde  (P(para))  was  synthesised  within  the  Kamer
workgroup by Dr. P. Deuss according to a literature known procedure.[30] P(meta) was
syntesised  within  the  workgroup  by  M.  Drysdale  according  to  a  literature  known
procedure.[31] PYP R52G-1-P(para) was made available by Dr. W. Laan, following a
literature known procedure.[6] The N-ligands used for protein conjugation (Phen[32,33] and
Picol[5])  were  synthesised  by  E.  de  Waard  and  M.  Drysdale  according  to  known
literature procedures.
Acetonitrile was distilled over calcium hydride under nitrogen and degassed using three
freeze/thaw cycles under argon. Methanol was distilled over Mg/I2 under nitrogen and
subjected to three freeze/thaw cycles under argon. Toluene was distilled over Na under
nitrogen and subjected to three freeze/thaw cycles under argon. THF and DMF were
subjected to three freeze/thaw cycles under argon before usage. 
Programs
Protein images were processed by Pymol 0.99rc6. ESI-MS results were analysed by
MassLynx V. 4.0 and its MaxEnt algorithm. General image manipulations (for example
the addition of arrows as well as the information about "found mass" and "calculated
mass" in MS spectra) were performed by GIMP 2.6.11. Distances between Triton X-100
and the amino acids were determined by UCSF Chimera 1.9.
Methods
Protein  concentrations  were  determined  using  the  Bradford  assay.[34] Unless  stated
otherwise  standard  Schlenk  technique  was  used.  The  separation  by  centrifugation
performed after each protein modification step could not be performed under Schlenk
conditions.  ICP-MS  data  was  either  determined  by  Mrs.  Sylvia  Williamson  at  the
University of St Andrews or by Dr. Lorna Eades at the University of Edinburgh.
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Buffer exchange
Unless stated otherwise centrifugal concentrators with a molecular weight cut-off of 10k
Da were used for the buffer exchange. A buffer exchange consists of three consecutive
rounds of concentrating the solution from >10 mL to <1 mL and subsequent addition of
buffer to a total volume >10 mL again. The concentrators can only be filled up to a
maximum volume of 15 mL and solutions within cannot be concentrated to volumes
<0.25 mL. A schematic presentation of a centrifugal concentrator is given in figure 5. 
Fig. 5: Schematic representation of a centrifugal concentrator.
Media
The media  LB,  PB as  well  as  PBS were  prepared and sterilised  by the technicians
within the University of St. Andrews. 
Production Broth (PB) medium contains:
20 g/L tryptone,  10 g/L yeast extract, 5 g/L dextrose,  5 g/L NaCl, 8.7 g/L K2HPO4,
pH=7.0.
Lysogeny Broth (LB) medium contains:
10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, pH=7.0.
Phosphated buffered saline (PBS) contains:
8.0 g/L NaCl, 0.2 g/L KCl, 1.44 g/L NaH2PO4, 0.2 g/L KH2PO4, pH=7.3.
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The pH of buffers was adjusted using aqueous solutions of sodium hydoxide and / or
hydrochloric acid.
Molecular weight and amino acid sequence of relevant proteins
Amino acids in blue are not visible in the crystal structure, mutation highlighted in red.
SCP-2L 
MEGGKLQSTF VFEEIGRRLK DIGPEVVKKV NAVFEWHITK GGNIGAKWTI
DLKSGSGKVY QGPAKGAADT TIILSDEDFM EVVLGKLDPQ KAFFSGRLKA
RGNIMLSQKL QMILKDYAKL
M=13244 Da
SCP-2L A100C 
GAMEGGKLQS TFVFEEIGRR LKDIGPEVVK KVNAVFEWHI TKGGNIGAKW 
TIDLKSGSGK VYQGPAKGAA DTTIILSDED FMEVVLGKLD PQKAFFSGRL 
KCRGNIMLSQ KLQMILKDYA KL
M=13405 Da
SCP-2L V83C 
GAMEGGKLQS TFVFEEIGRR LKDIGPEVVK KVNAVFEWHI TKGGNIGAKW 
TIDLKSGSGK VYQGPAKGAA DTTIILSDED FMEVCLGKLD PQKAFFSGRL 
KARGNIMLSQ KLQMILKDYA KL
M=13377 Da
PYP R52G 
MRGSHHHHHH GSDDDDKMEH VAFGSEDIEN TLAKMDDGQL DGLAFGAIQL 
DGDGNILQYN AAEGDITGGD PKQVIGKNFF KDVAPCTDSP EFYGKFKEGV 
ASGNLNTMFE YTFDYQMTPT KVKVHMKKAL SGDSYWVFVK RV
M=15761.4 Da
lysozyme
KVFGRCELAA AMKRHGLDNY RGYSLGNWVC AAKFESNFNT QATNRNTDGS 
TDYGILQINS RWWCNDGRTP GSRNLCNIPC SALLSSDITA SVNCAKKIVS 
DGNGMNAWVA WRNRCKGTDV QAWIRGCRL
M=14313.1 Da
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Crystallisation
Crystallisations  of  SCP-2L A100C, SCP-2L A100C-1-P(para)=S,  SCP-2L V83C and
SCP-2L V83C-1-P(para)=S were performed by Dr. Branigan based on the crystallisation
procedure  for  the  wild  type  protein.[3] Crystals  were  obtained  for  the  unmodified
mutants SCP-2L V83C and SCP-2L A100C. Structure determination and refinement
was  performed  by Dr.  Branigan.  While  the  refined  structure  of  SCP-2L A100C is
discussed in this chapter the structure of SCP-2L V83C was not completely refined. 
ESI-MS of artificial metalloenzymes
Metal(X) salts  were used as source (with X being a charge of "+1", "+2" or "+3"),
therefore it is most likely that the metal coordinating to the protein will be present as
metal(X) as well. It can be anticipated that the counterion is dissociating first in the MS
conditions  (positive  ionisation),  resulting  in  a  cationic  metallo-enzyme.  If  this
assumption is correct the detected mass of all artificial metalloenzymes is X Da lower
than the calculated mass, as the program (MassLynx MaxEnt algorithm) assumes the
presence of neutral starting species when processing the raw data and calculates as if
each positive charge results from "H+".
The masses mentioned in text and figures only correspond to peak maxima. In general
each peak has a width at half height which corresponds to about  ±5 Da of this value.
Additionally the LC-MS was only calibrated on an irregular basis therefore the obtained
masses may deviate by up to 16 Da from the calculated mass. As all conclusions are
based on the mass differences between two peaks this deviation is not relevant. 
Besides the assigned peaks most spectra show additional peaks which can be assigned
to oxidised species, sodium adducts (up to four Na+ (instead of H+ were detected) and
combinations thereof. These peaks are usually not explicitly mentioned.
LC-MS settings used
LC-MS(ES+) used for analysis  of protein and protein reactions was performed on a
Waters Alliance HT 2795 equipped with a Micromass LCT-TOF mass spectrometer,
using  positive  electrospray ionisation  and  applying a  Waters  MASSPREP® On-line
Desalting  2.1x  10  mm cartridge.  The  software  used  were  MassLynx  V4.0  and  the
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MaxEnt algorithm of Masslynx for processing.
The gradient listed in table 6 was used:
Table 6 Gradient used for LC-MS analysisa
a: Solvent A = 1% formic acid in acetonitrile, Solvent B = 1% formic acid in water.
The elution of the first 5 min. (containing salts which are potentially harmful to the
detector) was automatically discarded. The elution from 5-30 minutes was analysed by
ESI+, the (modified) protein usually eluting between minutes 15-25. 
MS Tune setting for LC-MS and ESI-MS
The  following  MS-tune  settings  were  used  for  both  LC-MS  and  direct  injection:
Capillary = 3000 V, Sample Cone = 50 V, Extraction Cone = 3 V, RF Lens = 350,
Dessolvation Temperature = 300 °C, Source Temperature = 100 °C, RF DC Offset 1 =
10, RF DC Ofset 2 = 8, Aperture = 10, Acceleration = 200, Focus = 0, Steering = 0.0,
MCP Detector = 2850, Manual Pusher = Yes, Max. Flight time = 70, Ion Energy = 32,
Tube Lens = 0, Grid 2 = 60, TOF flight tube = 4600, Reflection = 1788.
Electrostatic surface potential of SCP-2L A100C and SCP-2L
The electrostatic surface potential was calculated using the plug-in  Adaptive Poisson-
Boltzmann  Solver  ("APBS")  of  pymol.  The  plug-in  is  calculating  the  electrostatic
surface  by  solving  the  Poisson-Boltzmann  equation.  Three  amino  acids  of  SCP-2L
A100C had to be removed for the calculations. The amino acid sequence of SCP-2L
A100C is listed below. The amino acids in blue are not visible in the crystal structure,
the  amino  acids  highlighted  in  red  had  to  be  removed  for  the  calculation  and  are
therefore not present in the figure showing the electrostatic surface potential. Neither
blue nor red amino acids are therefore shown in the figure.  The colour code in the
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Time [min.] Solvent A [%] Solvent B [%] Flow [mL/min]
0.00 2 98 0.050
0.50 2 98 0.050
2.50 98 2 0.050
4.50 98 2 0.050
4.60 2 98 0.050
12.00 2 98 0.050
picture is ranging from -6 kT/e (in red) to +6 kT/e (in blue)
GAMEGGKLQS TFVFEEIGRR LKDIGPEVVK KVNAVFEWHI TKGGNIGAKW 
TIDLKSGSGK VYQGPAKGAA DTTIILSDED FMEVVLGKLD PQKAFFSGRL 
KCRGNIMLSQ KLQMILKDYA KL
Protein expression and purification
A simplified overview of the cell growth, protein expression and lysis is given in figure
6. The expression is performed under sterile conditions. 
Fig. 6 Simplified overview of the cell growth, protein expression and lysis. 
A small concentration of antibiotic resistant cells harbouring the desired plasmid were
grown in the appropriate media. At a certain cell concentration the protein expression is
triggered. In a last step the lysate (all proteins within the cells) was obtained. 
The lysate containing the SCP-2L mutants was purified according to figure 7. 
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Fig. 7: Protein purification used for the purification of SCP-2L mutants.
The lysate is loaded on a Ni-column and washed. The His-tagged protein and impurities
with high nickel affinity stick to the column while all other proteins are washed out. In a
next step the His-Tagged protein and the impurities with nickel affinity are eluted and
collected. TEV is added to cleave the His-Tag from the protein. The mixture obtained is
applied to another column and the flow through which contains the desired protein is
collected.
Protein Expression and purification of Tobacco Etch Virus (TEV)
Escherichia  coli  (E.  Coli)  cells  harbouring  the  plasmid  of  the  desired  protein  were
grown overnight at 37°C in 100 mL Lysogeny Broth (LB) medium containing 50 μg/mL
ampicillin. 10 mL of the overnight culture was used to inoculate 500 mL litre of LB
medium containing 50 μg/mL ampicillin. The cells were allowed to grow at 37°C and
300 rpm to  an  optical  density  (at  600 nm)  (OD600)  of  ≈  0.6.  The  temperature  was
reduced to 25°C and isopropyl-1-thio-b-D-galactopyranoside (IPTG) was added to a
final  concentration  of  1  mM  to  initiate  protein  expression.  The  culture  was  left
overnight (O/N) at 25°C and 300 rpm. The cells were harvested (4°C, 30 min., 7500 g)
and stored at – 80°C. Pellets worth 3 L of culture were resuspended in 50 mL lysis
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buffer (PBS, 300 mM NaCl,  10 mM imidazole,  1 mg DNase,  50 mg lysozyme and
either 2 EDTA free protease inhibitor tablets or 0.5 mM benzamidine). The suspension
was left for one hour at 4°C. Then it was sonicated at 4°C in portions of 10 mL with 0.5
second pulses  at  90% for  1  min.  (Hielscher  4P200S ultrasonic  processor).  The cell
extract  obtained after  centrifugation (4°C,  50 min.,  30000 g)  was filtered (0.22 µm
syringe filter, Millipore) and applied to a Ni-column (5 ml HisTrap FF columns, GE
Healthcare) previously equilibrated (PBS, 300mM NaCl, 30mM imidazole). The elution
was collected.  The column was washed extensively (~10 column volumes) with the
same buffer and the elution discarded. The protein was eluted (PBS, 300mM NaCl,
250mM imidazole) and collected. After equilibrating the column (PBS, 300mM NaCl,
30mM  imidazole)  the  previously  collected  flow  through  was  reapplied  and  the
procedure  repeated  until  no  protein  was  detected  in  the  elution  using  the  250 mM
imidazole buffer. The buffer was exchanged either by dialysis O/N at 4°C against 4L
buffer (50 mM Tris, 300 mM NaCl, pH = 7.5) or by using MWCO (including some
glycerol  to  prevent  precipitation).  The protein  was  concentrated  (in  the  presence  of
some glycerol)  to ≈ 4 mg/mL. It was diluted with an equal volume of glycerol and
stored at -80°C. Purity was >50% as determined by SDS-PAGE. Average yield  ≈ 10
mg/L culture. The activity of the TEV obtained when benzamidine was used was much
less than the activity of the TEV obtained when EDTA free protease inhibitor tablets
were used (an activity difference of ≈ 0.1-0.5).
Expression and Purification of SCP-2L A100C and SCP-2L V83C
The expression and purification is based on a published procedure.[6]
PB medium with 50 μg/mL kanamycin and 34 μg/mL chloramphenicol (in ethanol) was
used for protein production. 10 mL of an overnight culture (in case of SCP-2L A100C ≈
36 hours were neccessary) of E. coli BL21 (Rosetta) cells harbouring the plasmid of the
desired protein was used to inoculate 0.5 L of PB medium. The cells were allowed to
grow at 37°C to an OD600 of 0.6 after which the temperature was lowered to 16°C. IPTG
was added after one hour to a final concentration of 0.2 mM from a 0.2 M stock solution
to initiate the expression of the protein. The culture was left overnight at 16°C. The cells
were harvested by centrifugation (4°C, 20 min., 7500 g), washed with 500 mL of buffer
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solution (16 mM K2HPO4, 120 mM NaCl, pH = 7.4) and centrifuged (4°C, 20 min.,
7500 g). The pellet from 2 L cell culture was resuspended at 4°C in 100 mL of buffer
solution (50 mM Tris・HCl, 20 mM imidazole, 150 mM NaCl, 0.5 mM benzamidine,
pH = 8) and frozen at -80°C. After defrosting 20 mg of lysozyme, 1 mg of DNase and 1
ml of 1M MgCl2 was added to the suspension. The suspension was left for 1 hour at 4°C
and then sonicated (Hielscher 4P200S ultrasonic processor) in portions of 10 ml with
0.5 second pulses for 1 min. at 90%. The cell-extract, obtained after centrifugation (4°C,
50 min., 30000 g) was filtered (0.22 µm syringe filter, Millipore) and applied to a nickel
column  (5 ml HisTrap FF columns, GE Healthcare)  equilibrated with 30 mM Tris・
HCl,  20  mM  imidazole,  150  mM  NaCl,  pH  =  8  (wash  buffer).  The  elution  was
collected. The column was washed with 5 column volumes of wash buffer, 5 column
volumes of high salt buffer (wash buffer containing 1M NaCl) and another 5 column
volumes of wash buffer. The protein was obtained by eluting with 6 column volumes
elution buffer (wash buffer containing 330 mM imidazole) in an equal volume of wash
buffer (to prevent precipitation of the protein).  The previously collected elution was
reloaded onto the equilibrated column and the procedure repeated until no protein could
be detected when eluting with the 330 mM imidazole buffer. The combined fractions
containing the proteins with nickel affinity were dialysed against 4 L buffer solution (30
mM Tris・HCl, 10 mM imidazole, 150 mM NaCl, pH = 8) at 4°C. If precipitate had
formed the resulting mixture was centrifuged (30000 g, 50 min.)  and the precipitate
discarded. 0.014 equivalents of TEV-protease and final concentrations of 1 mM DTT
and 0.5 mM EDTA were added to the solution. The mixture was left O/N at RT. The
reaction was analysed by SDS-page or LC-MS and upon full cleavage any precipitate
was removed by centrifugation (4°C, 50 min., 30000 g) before filtration. The solution
was applied to a nickel column equilibrated with wash buffer. The elution containing
pure protein was collected, concentrated and the buffer was exchanged to the storage
and coupling buffer (degassed 20 mM MES 50 mM NaCl pH 6) using a centrifugal
concentrator. Purity was >99% as determined by SDS-PAGE.
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ICP-MS
All samples containing Pd, Fe, Pt, Ru, Re, Ir, both blanks as well as the following four
samples:  i)  SCP-2L A100C + Zn,  ii)  SCP-2L A100C + Cu,  iii)  SCP-2L A100C-1-
P(ortho) + Rh and iv) SCP-2L A100C-1-P(meta) + Rh were determined in Edinburgh by
Dr. Eades using a Perkin Elmer Elan 6100 DRC Quad and a Thermo-Finnegan Element
2.  Samples  were  diluted  with  an  internal  standard.  The  following  isotopes  were
determined: 55Mn, 56Fe, 57Fe, 59Co, 60Ni, 63Cu, 66Zn, 68Zn, 99Ru, 101Ru, 103Rh, 105Pd, 185Re,
191Ir, 193Ir, 194Pt, 195Pt. The average of three measurements of each isotope is used. in case
two isotopes  of  the  same element  were  determined their  average  is  used.  All  other
samples were determined by Mrs. Williamson in St Andrews.
All data was corrected for the metal content determined in the corresponding blank.
When Protein-Picol and Protein-Phen were used as scaffold the metal concentrations
determined were corrected by the "N-Ligand blank" value. When other protein scaffolds
were used the concentrations obtained were corrected by the "metal blank" value. 
Table 7 List of blank ICP-MS-values
a:  N-ligand  blank:  5  mL buffer  (20  mM MES,  50  mM NaCl,  pH  =  6)  was  subjected  to  three  buffer
exchanges using 20 mM NH4OAc, pH = 6 buffer.  4µL from an EDTA stock solution (0.5 M, pH = 8) was
added. The mixture was buffer exchanged (using 20 mM NH4OAc, pH = 6) and the flow through collected.
This was repeated three times. The fractions were combined, concentrated to dryness, topped up with
water to a known total volume (1.00 mL) and analysed by ICP-MS on the metals listed. b: Concentrated
nitric acid and hydrogen peroxide solution (30 wt. %) (1 mL each) were mixed. The solution was carefully
evaporated to dryness, topped up with water, evaporated to dryness. It was quantitative transferred to a 1
mL volumetric flask, topped up with water and analysed by ICP-MS on the metals listed.
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entry metal
1 Mn 23 10
2 Fe 1083 874
3 Co 378 64
4 Ni 300 113
5 Cu 996 97
6 Zn 956 705
7 Ru -1
8 Pd 1 3
9 Re -1
10 Ir 1
11 Pt 0
N-ligand blank [ppb]a metal blank [ppb]b
Modification of lysozyme (from chicken egg white)
a) Using dithiothreitol (DTT) without stirring
141 mg (9.5 µmol) lysozyme and 45 mg (294 µmol, 29 eq) DTT were dissolved in 35
mL degassed buffer and incubated at 4 °C for 70h. The reaction mixture was subjected
to a filtration removing any molecule with a molecular weight < 10k Da and 8.7 mg (4
eq.)  of  the  linker  maleimidpropionic  acid hydrazide  hydrochlorid (1)  dissolved in  a
small amount of degassed buffer was added and the reaction incubated over night at
room temperature. The solution was analysed by LC-MS and the two species lysozyme
and lysozyme(1)2 were detected in a ratio of about 100 : 20. 
b) Using DTT with stirring
142 mg (9.5 µmol) lysozyme and 40 mg DTT (259 µmol, 27 eq) were dissolved in 25
mL degassed  buffer  and  the  reaction  stirred  over  night.  The  reaction  mixture  was
subjected to a filtration removing any molecule with a molecular weight < 10k Da and
the protein solution filtered to remove precipitated protein. To this solution 33.8 mg
(154 µmol, 16 eq) of the linker maleimidpropionic acid hydrazide hydrochloride (1)
dissolved in a small amount of degassed buffer was added and the solution stirred over
night.  The  solution  was  analysed  by  LC-MS  and  three  species  detected  which
correspond to lysozyme, lysozyme-1 and lysozyme-(1)2 in a ratio of about 70:100:20.
After  stirring  for  another  night  and  analysis  by  LC-MS  the  amount  of  modified
lysozyme  increased  and  lysozyme(1)3 could  be  detected  as  well.  Unfortunately  a
significant peak with a mass smaller than unmodified lysozyme could be detected as
well, indicating the degradation of lysozyme. 
c) Using Tris(2-carboxy-ethyl)phosphine hydrochloride (TCEP)
A solution of 61 mg (4.3 µmol) lysozyme and 32 mg (112 µmol,  26 eq) in 40 mL
degassed buffer  was incubated over  night.  The reaction mixture  was subjected  to  a
filtration removing any molecule with a molecular weight < 10k Da and 120 mg (546
µmol,  127  eq)  of  the  linker  maleimidpropionic  acid  hydrazide  hydrochlorid  (1)
dissolved in a small amount of degassed buffer was added and the reaction incubated
over night at room temperature. The solution was analysed by LC-MS and four species
detected which correspond to lysozyme, lysozyme-(1)2,  lysozyme-(1)3  and lysozyme-
(1)4 in a ratio of about 5:100:30:10. (Referred to as lysozyme-(1)x).  The buffer was
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exchanged to remove any excess of TCEP prior to subsequent modifications (see fig. 18
in the appendix for the ESI-MS of lysozyme-(1)x.
N-Ligand modification of proteins 
Protein modification of SCP-2L A100C and SCP-2L V83C with  Phen or  Picol were
performed following a known procedure[5]: In a typical experiment 2 µmol protein in 40
mL buffer (20 mM MES, 50 mM NaCl, pH = 6) 7.2 mg (26 µmol, 13 eq) of the  N-
ligand derivative dissolved in a small volume of DMF was added. The reaction mixture
was shaken gently and left at room temperature over night. When LC-MS showed full
conversion to the modified protein, the filtered reaction mixture was buffer exchanged
to  remove  the  excess  of  the  free  N-ligand  derivative.  It  was  filtered  to  remove
precipitated protein. On average 1.4 µmol (70%) of the modified protein was obtained.
Linker modification of protein (Protein + 1)
Protein  modification  of  SCP-2L  A100C,  SCP-2L  V83C  with  the  linker  "1"
(maleimidopropionic acid hydrazide) were performed based on a known procedure.[6]
Modification of linker modified protein with phosphine [P(para), P(meta) or 
P(ortho)]
Protein modification of linker modified SCP-2L A100C, SCP-2L V83C and ysozyme 
with the phosphine were performed following a literature known procedure.[6]
As the modification of lysozyme-(1)x  was virtually unsuccesfull using these standard
conditions higher equivalents of phosphine (up to 80 eq.)  as well as longer reaction
times (up to eight days) were tested. The phosphine modified protein was only obtained
in small quantities, when P(meta) was used the modification was virtually unsuccesful.
The ESI-MS of the modification with P(para) and P(ortho) is depicted in the appendix
(fig. 19 and fig. 20). Phosphine modified species were not detected under the analysis
condtions  but  the  corresponding  phosphine  oxides,  indicating  that  the  phosphine
modified  protein  is  much  more  oxygen  sensitive  than  the  SCP-2L and  PYP based
phosphines and readily oxidised under the analysis conditions.
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N-Ligand modified protein + M[OAc]2
The following acetate  salts  were used:  Zn(II),  Cu(II),  Mn(II),  Pd(II),  Fe(II),  Co(II),
Ni(II). (See appendix for purity and supplier)
This  procedure  was  used  for  SCP-2L A100C-Picol,  SCP-2L A100C-Phen,  SCP-2L
V83C-Picol, SCP-2L V83C-Phen. All possible combinations were sythesised.
DMF  stock  solutions  of  Pd(II)  and  Cu(II)  were  used.  For  the  other  metals  stock
solutions in buffer (20 mM MES, 50 mM NaCl, pH = 6) were prepared. All metal stocks
had a concentration of about 25 µmol / mL.
To 0.1 µmol modified protein in 5 mL (c = 0.02 µmol/mL) buffer (20 mM MES, 50 mM
NaCl, pH = 6) 2 eq. of metal salt was added from a stock. The mixture was occasionally
shaken gently over the course of 1 day. The buffer was exchanged to 20 mM NH4OAc,
pH = 6 and a fifth analysed by ESI-MS. 
4µL from an EDTA stock solution (0.5 M, pH = 8) was added. The mixture was buffer
exchanged (using 20 mM NH4OAc, pH = 6) and the flow through collected. This was
repeated three times. The fractions were combined, concentrated to dryness, topped up
with water to a known total volume (1.00 mL) and the metal content determined by
ICP-MS.  In  case  the  ESI-MS previously  contained  an  unidentified  peak  or  a  peak
corresponding to the artificial metalloenzyme the supernatant after EDTA-treatment was
analysed by ESI-MS again.
Unmodified protein (SCP-2L A100C & SCP-2L V83C) + M[OAc]2
DMF  stock  solutions  of  Pd(II)  and  Cu(II)  were  used.  For  the  other  metals  stock
solutions in buffer (20 mM MES, 50 mM NaCl, pH = 6) were prepared. All metal stock
solutions had a concentration of about 25 µmol / mL.
This  procedure  was  used for  both  SCP-2L V83C and SCP-2L A100C.  All  possible
combinations were prepared and analysed by ESI-MS. All metal complexes of SCP-2L
A100C were analysed by ICP-MS as well.
To 0.1 µmol unmodified protein in 1.6 mL (c = 0.063 µmol/mL) buffer (20 mM MES,
50 mM NaCl, pH = 6) 3 eq. of metal salt was added from a stock solution. The mixture
was occasionally shaken gently over the course of 1 day. The buffer was exchanged to
20 mM NH4OAc, pH = 6 and a fifth analysed by ESI-MS. 
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4µL from an EDTA stock solution (0.5 M, pH = 8) was added. The mixture was buffer
exchanged (using 20 mM NH4OAc, pH = 6) and the flow through collected. This was
repeated three times. The fractions were combined, concentrated to dryness, topped up
with water to a known total volume (1.00 mL) and the metal content determined by
ICP-MS.
SCP-2L A100C-1-P(para) + metal[X]
The following metal stock solutions were used (about 25 µmol/mL):
In  degassed  DMF:  Ir(acac)(CO)2, Rh(acac)(CO)2, Re(CO)5Br,  Ru(acac)3,  Pt(acac)2  ,
Pd(OAc)2 
In degassed MeCN: RuCl3, [Rh(MeCN)2COD] BF4, [Rh(PPh3)3CO]H
In  degassed  buffer  (20  mM  MES,  50  mM  NaCl,  pH  =  6): Mn(OAc)2,  Ni(OAc)2,
Zn(OAc)2, Cu(OAc)2, Fe(OAc)2, Co(OAc)2.
The combinations mentioned in the text were prepared and analysed by LC-MS and
ICP-MS. 
The  two  Rh-salts  [Rh(MeCN)2COD]  BF4  and [Rh(PPh3)3CO]H were  only tested  on
SCP-2L A100C-1-P(para) using 0.07 µmol/mL modified protein and 3 eq of metal salt
and subsequent analysis. 
SCP-2L  A100C-1-P(para):  To  0.1  µmol  modified  protein  in  1.6  mL  (c  =  0.063
µmol/mL) buffer (20 mM MES, 50 mM NaCl, pH = 6) 3 eq. of metal salt was added
from a stock solution. 
SCP-2L V83C-1-P(para): To 0.22 µmol modified protein in 2.2 mL (c = 0.1 µmol/mL)
buffer (20 mM MES, 50 mM NaCl, pH = 6) 3 eq. of metal  salt was added from a stock
solution.
The mixture was occasionally shaken gently over the course of 1 day. The buffer was
exchanged (3 times from >10 mL to <1 mL). A fifth of the concentrated solution was
analysed by LC-MS.
The  rest  was  carefully  treated  with  concentrated  nitric  acid  and  hydrogen  peroxide
solution (30 wt.  %) (1 mL each).  The solution was carefully evaporated to dryness,
topped up with water, evaporated to dryness. It was quantitative transferred to a 1 mL
volumetric flask and topped up and analysed by ICP-MS.
74
In  case  of  Rh(acac)(CO)2  the  following  experimental  settings  were  used:  To  0.064
µmol/mL phosphine modified protein in 32 mL degassed buffer (2.06 µmol) 25 µL of a
9.8 µmol/mL Rh(acac)(CO)2 stock solution in  DMF was added (0.245 µmol).  After
buffer exchange the solution was concentrated to 3 mL. 0.5 mL of which were treated
with nitric acid and hydrogen peroxide solution (30 wt. %) (1 mL each) (as above) and
analysed by ICP-MS.
PYP R52G-1-P(para) + Rh
To 20 mL of a solution (20 mM MES 50 mM NaCl pH 7) of PYP R52G-1-P(para) (3.0
μmol) Rh(acac)(CO)2  (1.5 μmol,0.5 eq) was added from a 3.9 mM stock solution in
degassed DMF under argon. The pink solution turned quickly yellow and was stirred for
three  hours  at  room temperature  at  200  rpm.  No  precipitate  formed.  The  reaction
mixture  was  washed  three  times  with  the  same  degassed  buffer  using  MWCO
equipment to remove uncomplexed rhodium and concentrated before LC-MS analysis. 
Rh-enzymes based on lysozyme 
This  procedure  was  used  for lysozyme-(1)x,  lysozyme-(1)x-P(para),  lysozyme-(1)x-
P(ortho) and lysozyme-(1)x-P(meta):
To 3.8 µmol modified protein in 30 mL degasses buffer (20 mM MES, 50 mM NacL,
pH=6) 3.8 µmol Rh(acac)(CO)2 dissolved in a small volume of degassed MeCN was
added. The mixture turned yellow, was gently shaken and left over night. After buffer
exchange the mixture was analysed by LC-MS and buffer exchanged.
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Synthesis of 4-(diphenylphosphinsulphide)benzaldehyde [P(para)=S]
The synthesis of P(para)=S is shown in scheme 3.
Scheme 3: Synthesis of 4-(diphenylphosphinsulphide)benzaldehyde [P(para)=S]
3.0 mg (10.3 µmol) of the phosphine was dissolved in 1.0 mL dry DCM. 9.32 mg (291.3
µmol, 28 eq) of elemental sulphur was added and the reaction stirred at RT. The reaction
was monitored by TLC and upon completion of the reaction it was used without further
purification.
Synthesis of SCP-2L A100C-1-P(para)=S and SCP-2L V83C-1-P(para)=S
Protein  modification  of  linker  modified  SCP-2L  A100C  and  SCP-2L  V83C  were
performed  following  a  literature  known  procedure  but  using  P(para)=S  instead  of
P(para).[6] Upon completion  (reaction  followed by LC-MS) the  excess  of  phosphine
ligand  (and  excess  sulphur  still  present)  was  removed  by  buffer  exchange.  The
conversion of SCP-2L A100C-1 to the product was successful (see fig. 8).
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P
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P(para) P(para)=S
Fig. 8 ESI-MS of SCP-2L A100C-1-P(para)=S.
The conversion of SCP-2L V83C-1 with P(para)=S to the respective product was less
successful. Besides the species with the expected mass several additional unassigned
species with higher masses could be detected as well (see fig. 9). As the crystallisation
of SCP-2L A100C-1-P(para)=S was unsuccessful no further attempt to synthesise this
SCP-2L V83C-1-P(para)=S was tried.
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Fig. 9 ESI-MS of SCP-2L V83C-1-P(para)=S.
Distances between Triton X-100 and SCP-2L A100C / SCP-2L
The distances were derived with Chimera and are listed in the following table:
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Table  8 Part  1  of  2:  Distances between Triton  X-100 and the wild  type SCP-2L &
distances between Triton X-100 and the mutant SCP-2L A100C.a
a: Distances between Triton X-100 and the wild type SCP-2L as well as the distance between Triton X-100
and SCP-2L A100C were determined using Chimera.[35] The crystal structure of SCP-2L was published
before.[3] Distances between either of the protein atoms and its Triton X-100 atoms ≤4.0 Å were taken into
account.  Bold values: Distance between the same atoms in the mutant (or wild type) are 0.3 Å further
away. Red values Distance is >4.0 Å. e: Distances to the SCP-2L A100C mutant in Å. b: Referring to the
labelling scheme of Triton X-100 introduced in fig. 4. c: amino acid (AA) as well as the atom of the amino
acid (using pdb file format nomenclature) are given. d: Distance between Triton X-100 to the wild type (wt)
protein in Å. e: Distances between Triton X-100 to the mutant in Å. 
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C2 GLN 111, CG 3.855 4.210
C2 LYS 115, NZ 3.990 4.924
C3 LEU 114, C 4.389 3.990
C3 LEU 114, CB 4.009 3.812
C3 LYS 115, N 4.244 3.716
C4 VAL 83, CA 3.978 4.177
C4 VAL 83, CG2 3.990 3.979
C7 TRP 36, CH2 3.983 3.737
C7 TRP 36, CZ2 3.981 3.730
C7 LEU 110, CD2 4.369 3.780
C7 LEU 114, CD1 3.675 4.362
C8 PHE 79, CE2 3.714 3.691
C8 PHE 79, CZ 3.749 3.652
C8 VAL 83, CG2 3.850 3.893
C9 TRP 36, CH2 3.609 3.533
C10 TRP 36, CH2 3.692 3.870
C10 LEU 110, CD2 4.207 3.963
C11 TRP 36, CH2 3.887 4.230
C11 SER 107, O 3.462 3.775
C11 GLN 111, CB 3.904 4.242
C12 TRP 36, CH2 3.952 4.237
C13 TRP 36, CH2 3.902 3.916
C13 VAL 82, CG1 3.909 3.704
C14 TRP 36, CH2 3.706 3.550
C14 TRP 36, CZ3 4.045 3.965
C14 VAL 82, CG1 3.763 3.742
O15 PRO 89, CB 3.846 3.699
C16 PRO 89, CB 3.683 4.458
C16 GLN 90, NE2 3.772 4.721
C16 SER 107, C 4.180 3.816
C16 SER 107, CB 4.397 3.639
C16 SER 107, O 3.769 3.477
C16 SER 107, OG 4.397 3.993
C16 GLN 111, OE1 3.181 4.711
Triton X-100b AA residue number, atomc Distance wtd Distance SCP-2L A100Ce
Table  8 Part  2  of  2:  Distances between Triton  X-100 and the wild  type SCP-2L &
distances between Triton X-100 and the mutant SCP-2L A100C.a
See legend on part 1 of the table
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C17 GLN 90, NE2 3.623 4.628
C17 LEU 98, CD2 5.167 3.736
C17 SER 107, CB 3.616 3.727
C17 SER 107, OG 3.205 3.552
C17 SER 107, O 3.786 4.568
C17 SER 107, C 3.724 4.530
C17 GLN 108, N 3.836 4.924
C17 GLN 111, OE1 3.841 5.418
O18 GLN 90, NE2 3.241 3.572
O18 LEU 98, CD2 4.464 3.903
O18 SER 107, OG 3.941 4.216
C19 GLN 90, NE2 4.057 3.973
C19 SER 107, OG 3.525 3.595
C20 GLN 90, NE2 3.937 3.393
C20 PHE 93, CB 3.583 4.310
C20 PHE 93, CG 3.569 4.367
C20 PHE 93, CD2 3.970 4.277
C20 PHE 93, CD1 3.986 5.128
O21 GLN 90, NE2 3.612 4.024
O21 GLN 90, CG 3.940 4.522
O21 GLN 108, CG 4.772 3.802
O21 GLN 108, NE2 4.163 3.965
O21 GLN 108, OE1 3.795 4.616
C22 PHE 93, CD2 3.961 4.218
C22 GLN 108, OE1 3.992 4.686
C23 MET 105, CE 4.050 3.635
C23 MET 105, CD 3.537 3.964
C23 GLN 108, CD 3.666 4.413
C23 GLN 108, NE2 3.815 3.591
C23 GLN 108, OE1 2.954 3.845
O24 GLN 90, CG 3.113 3.871
O24 PHE 94, CE2 3.932 4.369
O24 GLN 108, CD 3.405 4.343
O24 GLN 108, NE2 3.078 3.342
O24 GLN 108, OE1 3.027 3.416
C25 GLN 90, CG 3.963 4.100
C25 GLN 108, CD 3.732 4.380
C25 GLN 108, NE2 3.413 3.457
C25 GLN 108, OE1 3.226 3.355
Triton X-100b AA residue number, atomc Distance wtd Distance SCP-2L A100Ce
Calculation of the equilibrium constants
The steps involved from the addition of a metal salt to the determination of the metal
loading is shown in figure 10.
Fig.  10  Schematic  overview  from  the  addition  of  a  metal  to  a  protein  up  to  the
determination  of  the  metal  loading.  "P"=(un)  modified  protein,  "M"=metal  salt,
PM=protein-metal complex
In a certain volume protein ("P") and a metal salt ("M") are present (picture 1 in fig. 10).
"P" and "M" are in equilibrium with the protein-metal complex "PM" After some time
the equilibrium is reached (picture 2). Now the buffer is exchanged (pictures 3, 4 & 5).
This means in a first step the volume is decreased. While metal "M" can pass through
the membrane neither protein "P" nor the complex "PM" can pass through. Therefore
the new volume has a higher concentration of "P" and "PM" while the concentration of
"M"  is  constant  (picture  3).  The  equilibrium  is  unaffected  by  this  step  as  the
concentrations of "P" and "PM" are increased by the same factor. In the next step the
volume  is  increased  by  the  addition  of  new  buffer  (picture  4  in  fig.  10).  As  a
consequence  of  the  dilution  a  new  equilibrium is  obtained.  The  concentration  and
dilution steps are now repeated several times. The equilibrium obtained in the end is
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analysed on its metal concentration - regardless if the metal is present as "M" or as
"PM" (to be more precise only 4/5th was analysed on its metal content while 1/5th was
analysed by ESI-MS). In the work carried out in this thesis the following information is
known:
• The initial concentrations of "P" and "M" as well as the initial volume (initial
concentration of "PM" is known but zero)
• the volume after concentrating it
• the volume after topping it up
• how many times the concentration / topping up was repeated
• the sum of the final concentrations of "M" and "PM"
In theory this information can be used to calculate the equilibrium constant under the
following assumptions:
1. Total protein concentration stays constant, which is a simplification, as protein
precipitates over time.
2. Only 1:1 metal-protein complexes are taking into account.
3. The initial equilibrium between "P" and "M" was reached after the reaction time
of 1 day.
4. The temperature was considered as constant,  which is a simplification as the
ultracentrifugation took place in a cold room (4 °C), while all other steps took
place at room temperature.
5. No "P" or "PM" is passing through the filter during the centrifugation.
The reaction between (modified) protein and metal can be written as:
For the reaction above the law of mass action can be written as:
Eq. (1):
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When the following abbreviations
Eq. (2):
Eq. (3):
Eq. (4):
are used Eq. (1) can be rewritten as 
Eq. (5):
calculating the reciprocal value of equation 5 and subsequent multiplication by
results in equation 6:
Eq. (6):
expandation  of  the  left  and  subsequent  substraction  of  the  right  hand  side  of  the
equation results in equation 7:
Eq. (7): 
Equation (7) can be rewritten as:
Eq. (8):
As the general solution for a quadratic equation of the form 
Eq. (9):
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for unknown A is
Eq. (10):   A
The general solution of Eq. (10) is used for Eq. (8) to obtain Eq. (11).
Eq. (11):
"x" in Eq. (11) is defined as:
Eq. (12):
and c in Eq. (11) is defined as:
Eq. (13):
Combining Eq. (11), Eq. (12) and Eq (13) results in equation 14:
Eq. (14): 
The negative square root of Eq. (14) is giving the chemical meaningful results:
Eq. (15):
Eq.  (15)  can  be  used  to  calculate  the  equilibration  concentration  of  "PM".  The
equilibrium concentrations of "P" and "M" can be calculated afterwards using Eq. (3)
and Eq. (4) respectively. These equilibrium concentrations correspond to picture 2 in
figure 10.
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In the subsequent buffer exchange "M" is removed from the reaction. There are two
extreme cases for the equilibrium during the buffer exchange (picture 5 in fig. 10):
a) The equilibration of the reaction is much slower than the buffer exchange
b) The equilibration of the reaction is much faster than the buffer exchange
Additionally there are two extremes for the buffer exchange as the volume removed and
added  was  within  a  certain  range.  For  a  buffer  exchange  the  reaction  mixture  is
concentrated from "X" mL to "Y" mL. Within this thesis "X" was a value between 10-
15 and "Y" a value between 0.25-1. 
The calculations for a slow equilibration (case a) is much more straightforward:
After calculation of the equilibration concentrations of "P", "M" and "PM" using Eq.
(3),  (4)  and  (15)  [obviously  starting  with  Eq.  (15)!]  the  calculated  equilibrium
concentration of "M" is reduced due to the buffer exchange. 1/10 th to 1/60th of "M" is
removed  per  buffer  exchange  and  three  consecutive  rounds  of  buffer  exchange  are
performed,  therefore  (1/10)3 to  (1/60)3 of  the  equilibrium  concentration  of  "M"  is
remaining after the buffer exchange.
Eq. (16):
Additionally  the  final  volume of  the  reaction  mixture  is  different  (0.25  mL in  this
example, see experimental section for details) from the initital volume (5.0 mL in this
example,  see  experimental  section  for  details).  Therefore  the  previously  calculated
equilibration concentrations of "P" (Eq. 3), "PM" (Eq. 15), as well as the concentration
of  "Mremaining"  (Eq.  16)  need  to  be  adapted  by multiplication  of  the  factor  20  (=5.0
mL/0.25 mL) to obtain the new theoretical concentrations:
Eq. (17):
Eq. (18):
Eq. (19):
These concentrations are used to calculate the new equilibrium concentrations. Eq. (15)
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can not be used directly, as it is only suitable if no "PM" is present. Therefore Eq. (20)
and  Eq.  (21)  are  used  to  define  new initial  concentrations  of  "P"  and  "M" (just  a
mathematical trick, calculating as if a total back reaction of "PM" to "P" and "M" is
happening so Eq. (15) can be used again)
Eq. (20): 
Eq. (21):
With these initial concentrations Eq. (15) can be used to determine the new equilibrium
concentration of "PM" as the initial  concentration of "PM" is now (mathematically)
zero.
The  so  calculated  equilibrium concentration  of  "PM"  can  be  used  to  calculate  the
equilibrium concentrations of "M" and "P" when the initial concentrations calculated
from Eq. (20) and Eq. (21) are inserted into Eq. (4) and Eq. (5). 
When the equation is solved for different K values (under certain reaction conditions)
the corresponding concentrations of "P", "M" and "PM" in the final equilibrium (picture
6 in fig. 10) are obtained. These equilibrium concentrations can be depicted in a figure
(see figure 11).
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Fig.  11 Concentration  over  K  for  a  slow equilibrium.  Same conditions  as  used  for
A100C + Metal and A100C-1-P(para) + Metal reactions: V(initial) = 1.6 mL, V(final) =
0.25 mL, c0 (P) = 0.0625 µmol/mL , c0(M) = 0.1875 µmol/mL, three rounds of buffer
exchange: Topped up to 10 mL, concentrated to 1 mL.
In case the re-equilibration of the reaction is much faster than the buffer exchange new
equilibrium concentrations need to be calculated after every dilution and after every
single buffer exchange, reducing the total metal content not just once as described above
but three times. The concept and formulas described above remain the same though but
all calculations need to be repeated three times. As a result a figure as depicted in figure
12 can be obtained.
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Fig. 12 Concentration over K for a fast equilibrium. Same conditions as used for A100C
+ Metal and A100C-1-P(para) + Metal: V(initial) = 1.6 mL, V(final) = 0.25 mL, c0 (P) = 
0.0625 µmol/mL , c0(M) = 0.1875 µmol/mL, three rounds of buffer exchange: Topped up
to 10 mL, concentrated to 1 mL.
The total metal content is determined by ICP-MS, due to different molecular weights
these  values  are  used  to  calculate  a  more  general  value  -  the  "% metal"  which  is
determined as
Eq. (22):
when an excess of metal to protein is added.
When substochiometric amounts of metal (to protein) are added it is defined as:
Eq. (23):
Equilibrium constants for different % metal values were calculated for all four cases: 
• A fast equilibration with the minimal buffer exchange (from 10 mL to 1 mL) 
• A fast equilibration with the maximal buffer exchange (from 15 mL to 0.25 mL)
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• A slow equilibration with the minimal buffer exchange (from 10 to 1 mL)
• A slow equilibration with the maximal buffer exchange (from 15 mL to 0.25
mL). 
The difference between the minimal and the maximal buffer exchange was found to be
negligible. Different K-values can now be used to calculate the corresponding % metal
values for all four cases. For a certain reaction setup figure 13 is obtained.
 
Fig. 13 Calculated values for K versus % metal. Same conditions as used for A100C +
Metal and A100C-1-P(para) + Metal: V(initial) = 1.6 mL, V(final) = 0.25 mL, c0 (P) =
0.0625 µmol/mL , c0(M) = 0.1875 µmol/mL, three rounds of buffer exchange. for four
different  cases:  The equilibration  of  the  reaction  is  a)  much  faster  than  the  buffer
exchange  calculating  with  a  buffer  exchange  from 10  mL to  1  mL each  time (the
theoretical  minimal),  represented  by  "X"  b)  much  faster  than  the  buffer  exchange
calculating with a buffer exchange from 15 mL to 0.25 mL (the theoretical maximum),
represented by a star c) much slower than the buffer exchange calculating with a buffer
exchange from 10 mL to 1 mL each time (the theoretical minimal), represented by a
square d) much slower than the buffer exchange calculating with a buffer exchange
from 15 mL to 0.25 mL (the theoretical maximum), represented by a triangle.
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The % metal values calculated from the ICP-MS concentrations detected can be used to
derive the corresponding equilibrium constant for the complex formation between “P”
and “M”. For example a % metal value of 60 would be (roughly) in between 104-106
[Lmol-1]
These  calculations  were  performed  for  the  ICP-MS  data  of  the  N-ligand  modified
proteins of SCP-2L A100C. The (range) of the equilibrium constants are listed in table
9. The equilibrium constants between (most) of the metals and 1,10-Phenanthroline as
well as di-(2-picolyl)amine are literature known. These equilibrium constants are listed
as well. 
Table 9 calculated log K-data for  N-modified SCP-2L A100C and different metals as
well as the literature known log K data between N-ligands and different metals.a
a: Calculated for the conditions mentioned in fig. 13. Unit of K is in Lmol-1 b: The range is given.
c:  Data taken  from:[26–28] Conditions:  20  °C,  ionic  strength  =  0.1  M (NaNO3),  Phen =  1,10-
Phenanthroline, Picol = di-(2-picolyl)amine d: No literature data available e: The logarithm of the
complexation constant  of  the 3:1 (ligand : metal)  complex was determined to be 21.3.  The
logarithm of the complexation constant for the 1:1 complex is therefore >7.1. 
The calculated range for the complexation constants of the N-ligand modified proteins
are in general several orders of magnitude lower than the corresponding complexation
constants between the free ligand and the corresponding metals. The only exceptions are
the Mn(II)-complexes (entry 3) and SCP-2L A100C-Phen + Cu(II) (entry 5). The large
differences cannot be attributed to the deviation of the different pH in the literature
values as the complexation constant between Phen and H+ was determined to be several
orders of magnitude smaller than the complexation constant for the corresponding metal
complexes except for Mn(II). In case of the Mn(II) complexes it was shown that the
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entry metal
1 Pd(II) 3.9-5.4 5.8-7.8
2 Zn(II) 3.4-5.1 6.55 3.5-5.1 7.63
3 Mn(II) 3.2-4.9 4.13 3.6-5.2 3.52
4 Fe(II) 5.0-6.5 4.3-5.8 6.15
5 Cu(II) 4.1-5.6 9.25 3.6-4.9 13.85
6 Ni(II) 3.5-5.1 8.80 3.3-5.0 9.30
7 Co(II) 4.0-5.5 7.25 2.9-4.7 8.05
SCP-2L A100C-Phenb Phenc SCP-2L A100C-Picolb Picolc
-d -d
>7.1e
complexation between the unmodified SCP-2L A100C and Mn(II)  contained similar
quantities of Mn(II) after the workup as the N-ligand modified SCP-2L A100C-scaffolds
indicating  that  a  large  proportion  of  the  complexation  might  be  due  to  the  protein
scaffold itself and not the introduced N-ligand. Although it might be that the presence of
the protein scaffold results in a reduction of the protein-metal complexation constant in
comparison to the free ligand-metal complexes due to steric hindrance or other reasons
it  seems  more  likely  that  the  approach  for  the  determination  of  the  complexation
constants is too inaccurate (see the five assumptions made beforehand). Additionally the
range  of  the  calculated  equilibrium  constants  is  in  between  1.5  to  2.0  orders  of
magnitude. Therefore no additional equilibrium constants were calculated.
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Chapter 3: Rh-enzymes as catalysts in the aqueous biphasic
hydroformylation
3.1 Abstract
This  chapter  describes  the  catalytic  performance  of  artificial  rhodium  containing
enzymes (Rh-enzymes). The main focus is on Rh-enzymes based on the two mutants of
SCP-2L described in the previous chapter. Their performance in the aqueous biphasic
hydroformylation of long chain 1-alkenes is evaluated and compared to the Rh/TPPTS-
system.  In  order  to  rationalise  the  comparably  high  activity  and  selectivity  of  the
different  Rh-enzymes  their  mode  of  action  was  investigated  by  supplementary
experiments.  In  these  experiments  reaction  parameters  were  systematically  varied,
additional Rh-enzymes and different substrates were tested. 
93
3.2 Introduction
In  the  previous  chapters  the  development  and  characterization  of  metal  containing
artificial metalloenzymes based on various enzymes were described. Also an overview
of  the  aqueous  biphasic  hydroformylation  of  linear  1-alkenes  was  given  and  the
structural features of the protein SCP-2L were presented. In this chapter this information
will be merged with a study on the catalytic performance of artificial rhodium-enzymes
in the aqueous biphasic hydroformylation of 1-alkenes with a special emphasis on two
SCP-2L mutants which were used as protein scaffolds.
Artificial metalloenzymes as catalysts
Catalysis  is usually categorized in  terms of  homogeneous-,  heterogeneous- and bio-
catalysis. 
In homogeneous catalysis the catalyst and the substrate(s) are homogeneously dissolved
in one phase – most often a liquid phase.[1] The inner reaction sphere of the catalyst is
well defined by the ligands. The outer reaction sphere consists of randomly distributed
counter ions and solvent molecules and is less well defined. As a consequence the outer
reaction sphere has hardly any influence on the reaction. 
In heterogeneous catalysis the catalyst, which in many cases is a metal is in general
immobilised on a solid support. With heterogeneous catalysts it is almost impossible to
tune  steric  and  electronic  effects  of  the  inner  reaction  sphere.  The  activity  of
heterogeneous catalysts is usually lower than that of their homogeneous counterparts
under the same conditions.  Another major drawback in heterogeneous catalysis is the
troublesome determination of  the  actual  catalytic  species  and the  mechanism of  the
catalytic process.[2] 
Biocatalysis refers to all reactions catalysed by biological systems for example whole
organisms, cells or purified enzymes.[3] In protein catalysed reactions the inner reaction
sphere is represented by the active site of the protein. The outer reaction sphere consists
of other parts of the protein and is much better defined than in man-made catalysts and
it has a big influence on the catalytic activity as well as on the stereochemistry of the
reaction products but it can also hamper the substrate scope. 
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As enzymes catalyse many different chemical reactions and often outperform synthetic
catalysts in respect of stereo-, regio-, chemo- or enantioselectivity, low toxicity and high
reaction rates especially at  moderate temperatures, the number of enzymatic processes
in industry is constantly increasing.[4] For some industrially relevant processes, as for
example the hydroformylation, no catalytically active enzymes have been discovered, so
far. 
Artificial metalloenzymes consist of a combination of metal and protein which are non-
existent  in nature  and  might  close  the  gap  between  enzymatic  and  homogeneous
catalysis by "merging the best of two worlds"[5] - Even though the first studies using
artificial metalloenzymes as catalysts were already published in the late 1970s[6,7] this
emerging field at the borders of organic- and inorganic chemistry as well as biology
only became popular at the end of the millennium.
The  existing  strategies  of  metal  incorporation  into  enzymes  as  well  as  the  use  of
artificial  metalloenzymes  in  the  hydroformylation  reaction  will  be  subsequently
reviewed.  Peptide-,  antibody-,  and  DNA-  based  catalysts  which  are  sometimes
considered as artificial metalloenzymes [5,8] will not be covered.
The metal anchoring strategies used to obtain an artificial metalloenzyme are usually
divided  into  the  following  subcategories:  dative-,  supramolecular-  and  covalent
anchoring.[8] 
Dative anchoring
The  first  strategy  ever  employed  to  obtain  an  artificial  metalloenzyme  was  dative
anchoring.[9] In this strategy the binding capability of amino acids towards metals is
exploited. The most straight forward approach comprises the simple addition of metal
salts to a protein scaffold yielding an artificial metalloenzyme. As most proteins have
multiple binding sites the resulting metal containing species cannot be predicted. Also
the precise location of the metal(s) is difficult to analyse. 
In order to obtain better defined species additional and more sophisticated approaches
towards enzymes suitable for dative anchoring are employed. The four approaches are
outlined in figure 1.
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Figure 1 Approaches towards artificial  metalloenzymes using dative anchoring.  D =
donor sites (oxygen, nitrogen, sulphur) present in the side chain of amino acids. M =
transition metal 
The first approach comprises the design and synthesis of a well-defined active site from
scratch. The resulting active site is then incorporated into a suitable protein scaffold.
Usually computational support is applied in this approach. So far, the enzymes obtained
by  this  route only  result  in  small  rate  accelerations  in  comparison  to  uncatalysed
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reactions but they often prove as a decent starting point for further optimisations.[10]
In the second approach a suitable binding site is introduced into a protein for example
by mutagenesis. This approach requires knowledge about the structure of the protein
and usually uses a combination of chemical intuition, trial and error and computational
methods.[11–13] 
A third approach comprises the replacement of a metal present in a metalloenzyme by a
different metal.[14,15]
Artificial metalloenzymes obtained by dative anchoring have been successfully used in
various  reactions  like  asymmetric  epoxidation[14,15],  hydrogenation[16],
hydroformylation[17–19] and asymmetric Diels-Alder reaction[11].  A major advantage of
dative anchoring strategies is that a wide array of proteins can be used as scaffold. A
major drawback of this approach is that the actual environment of the metal is often
unknown and most likely a mixture of many different species is obtained instead of one
well  defined  one.  To  overcome  this  issue  other  potential  binding  sites  need  to  be
removed by chemical and/or biological means in order to obtain a single catalytically
active species.[19]
Supramolecular anchoring
Supramolecular  anchoring  was  first  employed  in  the  1970s  to  obtain  an  artificial
metalloenzyme.[20] This approach exploits the high binding constants between (some)
proteins and smaller  chemical  molecules (from now on summarised as “cofactors”).
Instead of using the genuine cofactor a modified cofactor which bears a metal or is
capable of binding to a metal is used (schematic representation in figure 2). 
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Figure  2  Principle  of  supramolecular  anchoring.  Left:  Enzyme  and  corresponding
cofactor. Right: Enzyme and a modified cofactor bearing a metal.
Probably the  most  exploited  combination  is  the  one  between  the  modified  cofactor
biotin to either the protein avidin or streptavidin. The binding constant between biotin to
(strept)avidin was determined as ≈1015 M-1[21] which is one of the highest non covalent
binding  constants  in  nature.  Artificial  metalloenzymes  obtained  by  supramolecular
anchoring  have  been  successfully  used  in  various  reactions  like  asymmetric
hydrogenation[20,22,23], transfer hydrogenation[24–27], allylic alkylation[22] and sulfoxidation.
[28] They are  also  known to  catalyse  C-H-activations[29] and  metathesis[30] While  the
catalysts obtained by supramolecular anchoring possess a well defined outer reaction
sphere the potential pool of enzymes is limited to specific sets of proteins and cofactor
analogues. 
Covalent modification
In covalent modification a binding site is covalently introduced at a specific position of
the protein scaffold. This is usually achieved by the introduction of a single amino acid
with a specific reactivity at the desired location by mutation of the wild type protein. In
case the protein contains one ore more of these amino acids multiple modification will
occur. Therefore the undesired amino acids have to be substituted by unreactive amino
acids via mutagenesis in the first place. Virtually any protein can be used as scaffold in
the  covalent  approach.  Additionally  a  well  defined  species  is  obtained,  therefore
covalent  modification  combines  the  advantages  of  dative-  and  supramolecular
anchoring.  Supramolecular-  and  covalent  anchoring  have  also  been  merged  in  dual
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anchoring, which have the disadvantage that the optimisation of the resulting catalysts is
not  straightforward.[31] Artificial  metalloenzymes  obtained  by  covalent  modification
have  been  successfully  tested  in  many  different  reactions  like  Diels-Alder[32],
hydroformylation[33], sulfoxidation[34] and polymerisation[35]. Reaction schemes in which
the covalent modification of a protein are outlined are depicted in various parts of this
thesis.
Catalyst optimisation
The artificial metalloenzymes obtained by any of the methods mentioned are usually
subjected to optimisation steps in order to improve key features like rate enhancement,
enantioselectivity  or  stability.  The  optimisation  methods  comprise  chemical, [36] or
biological means.[37–42]
Mechanism of the rhodium catalysed hydroformylation
In 1970 Wilkinson and co-workers suggested a mechanism for the hydroformylation of
1-olefins (Wilkinson's dissociative mechanism) which is still accepted nowadays.[43–46]
The reaction cycle is depicted in scheme 1.
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Scheme 1 Simplified catalytic cycle for the Rh-catalysed hydroformylation of a 1-alkene
(P=PPh3).[43–46]
According  to  scheme  1  the  first  reaction  step  is  the  dissociation  of  a  ligand  from
complex 1 or a similar precursor to form the square planar rhodium complex 2 which is
considered as the catalytically active species. Upon coordination of a 1-alkene to its
vacant site complex 3 is obtained. Hydride migration yields complex 4 or its branched
analogue (not shown in the scheme). By the addition of CO complex 5 is formed. This
species  can  undergo  migratory  insertion  of  the  alkyl  chain  to  form  6.  Upon
hydrogenation  of  6 the  linear  aldehyde  and  the  catalytically  active  species  2 are
obtained.
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Instead of “P”-ligands “CO” (or other ligands) might coordinate to the metal as well.
The  prediction  of  the  linear  to  branched  ratios  is  not  straightforward.  The  general
accepted explanation for the formation of linear aldehydes is that the steric hindrance of
the (substituents on the) phosphine favours the formation of linear aldehydes. [47]
Artificial metalloenzymes in hydroformylation
Due to the high toxicity of carbon monoxide to organisms unsurprisingly not a single
naturally occurring enzyme is known to catalyse the hydroformylation and only a few
artificial metalloenzymes have been reported as active catalysts in this reaction.[17–19,33,48]
Due to its significantly increased hydroformylation activity in comparison to any other
metal[39]  rhodium is used as the active transition metal in all of these examples. The
artificial  Rh-enzymes  were  prepared  by  dative  anchoring[17–19] and  by  covalent
modification.[33,48] No artificial  metalloenzymes  employing  supramolecular  anchoring
has been reported for this reaction so far. Research was mainly focused on the substrates
styrene and linear 1-alkenes. In these studies the reaction was performed in an aqueous-
organic biphasic type of reaction with the Rh-enzyme in the aqueous phase and the
substrate in the organic phase.  In the biphasic  reactions  rhodium can leach into the
organic phase and catalyse the reaction. In order to account for this undesired catalysis
it  is  important  to  determine  the  Rh-content  of  the  organic  phase  after  the  reaction.
Unfortunately  this  aspect  was  not  considered  in  all  publications.  Table  1  gives  a
literature overview on artificial Rh-enzymes used in the hydroformylation of styrene
and long chain linear 1-alkenes.
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Table 1 Artificial metalloenzymes tested in hydroformylation.*
*: In case multiple examples within one reference were published the example in which Rh-leaching was
determined was used. If no such information was given the example with the highest TON is listed. a:
Turnover number (TON) – ratio of products to rhodium  b: linear to branched product ratio  c: Rhodium
concentration in the organic phase after the reaction; percentage of the total initial rhodium amount in
brackets. d: Data taken from [17] e: The protein human serum albumin (HSA) and Rh(acac)(CO)2 in a molar
ratio  of  ≈1:56.  f:  Data taken from  [18] g:  not  determined  h:  Data taken from  [48] i:  The protein  papain
chemically modified with a phosphite at cysteine 25 (the only cysteine) and treated with Rh(acac)(CO)2 in a
molar ratio of ≈1:29. The solution is filtered prior to catalysis to remove the excess of rhodium. The TON is
calculated on the assumption that no rhodium is removed by this filtration  j: Data taken from [19] k: The
protein  mutant  of  human carbonic  anhydrase II  with  the following mutations:  H4R,  H10R,  H17F,  The
histidines on the surface were chemically modified with Diethylpyrocarbonate. A Rh:protein ratio of 1.4 was
detected  l: The protein papain treated with Rh(acac)(CO)2 in a molar ratio of  ≈1:20  m: The protein egg
albumin treated with Rh(acac)(CO)2 in a molar ratio of ≈1:38 n: Data taken from [33] o: The protein mutant
SCP-2L A100C covalently modified with linker and P(para) (introduced earlier in this thesis) treated with
Rh(acac)(CO)2 in a molar ratio of ≈2:1 p: The protein mutant SCP-2L V83C covalently modified with linker
and P(para) (introduced earlier in this thesis) treated with Rh(acac)(CO)2 in a molar ratio of ≈2:1.
As can be seen in table 1 styrene is converted into the corresponding aldehydes with
TON >600  when  the  Rh-enzyme  obtained  by combining  the  protein  human  serum
albumin (HSA) with a large excess (≈56 eq.) of Rh(I)  is used  (entry 1). The rhodium
concentration in the organic phase was determined as 8 ppm after the reaction indicating
significant  rhodium  leaching.  Covalent  modification  of  the  protein  papain  with  a
phosphite, treatment with an excess (≈29 eq.) of Rh(I) and subsequent filtration of the
mixture to remove the excess of Rh(I) yields a TON >680 in the hydroformylation of
styrene  (entry  3).  Unfortunately  rhodium leaching  was  not  determined.[48] All  other
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entry catalyst substrate
styrene >600 5 / 95 8 ppm (1.3-1.9 %)
styrene >250
styrene >680
styrene 213 89 / 11
styrene 8 / 92
styrene >250 10 / 90
1-octene >250
1-octene >600 47 / 53 8 ppm (1.3-1.9 %)
1-octene 55 / 45
1-octene 100 / 0
1-octene 124 87 / 13
1-decene 34 78 / 22 <0.5 ppm (<1.2 %)
TONa l / bb leachingc
1d HSA*Rhe
2f HSA*Rhe n.d.g n.d.g
3h papain-phospite-Rhi n.d.g n.d.g
4j hcAllk n.d.g
5f papain*Rhl ≈250 n.d.g
6f egg albumin*Rhm n.d.g
7f HSA*Rhe n.d.g n.d.g
8d HSA*Rhe
9f papain*Rhl ≈25 n.d.g
10f egg albumin*Rhm ≈5 n.d.g
11n SCP-2L A100C-1-P(para)-Rho n.d.g
12n SCP-2L V83C-1-P(para)-Rhp
experiments in  which styrene was used as substrate resulted in significantly smaller
TON. The uncomplexed Rh(acac)(CO)2 is known to give a linear to branched ratio of
about  17  /  83[19] which  is  similar  to  the  ratio  obtained  by most  Rh-enzymes  listed
(entries 1, 5, 6). The linear selectivity totally differs when the protein human carbonic
anhydrase is used as scaffold (entry 4) resulting in a preference for the linear product
and a linear to branched ratio of 89 / 11. This is a strong indication for the influence of
the protein scaffold.
The enantioselectivity of the reaction is only investigated in two of the examples. When
the papain-phosphite was used as catalyst a racemate is obtained (entry 3), The HSA-
Rh-complex (entry 1) yielded a “very low but definite enantiomeric excess”.[17] This
excess was not specified any further and was not mentioned in a subsequent publication
anymore.[18] 
When Rh-enzymes are used in the hydroformylation of linear 1-alkenes (1-octene and
1-decene) high TON (>600) are found when the HSA based Rh-enzyme is used (entry
8) while all other protein scaffolds yield much lower TON. The uncomplexed Rh(acac)
(CO)2 is known to give a linear to branched ratio of about 56 / 44 [33] which is similar to
the ratio obtained by most Rh-enzymes listed (entries 8, 9). The linear selectivity totally
differs  when  the  phosphine  modified  SCP-2L is  used as  scaffold  (entries  11,  12)
resulting in a profound preference for the linear product. This is a strong indication for
the influence of the protein scaffold in the reaction.
Most  of  the  artificial  metalloenzymes  are  described  as  unstable  under  the  reaction
conditions used. The only exceptions are the HSA-Rh-complex (entries 1, 2, 7, 8) which
is considered as  stable.[16,17]  For the phosphite  modified papain the stability was not
mentioned.[48]
Concept of SCP-2L as protein scaffold in the hydroformylation
The  protein  SCP-2L was  considered  as  a  protein  scaffold  suitable  for  the  aqueous
biphasic hydroformylation of long chain 1-alkenes due to its hydrophobic tunnel. This
flexible tunnel is known to bind a great variety of different substrates. It was proven in
the previous chapter that this tunnel is still intact within the mutant SCP-2L A100C. It
was also pointed out that the tunnel within the mutant SCP-2L V83C seems to remain
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intact as well.  These two mutants possess their  unique cysteine at  either end of the
tunnel. Therefore any covalently introduced modification will be in close proximity to
either end of the tunnel. The following concept was envisioned (see figure 3): 
• Under biphasic reaction conditions the apolar substrate will accumulate in the
tunnel, resulting in a much higher concentration than in the surrounding aqueous
phase.
• Due to the modification of the protein with a phosphine the transition metal
coordinating to this phosphine will be in close proximity to the substrate.
• The bulky protein  environment  is  expected  to  induce selectivity towards  the
linear product.
Figure 3 Envisioned concept for SCP-2L based Rh-enzymes used as hydroformylation 
catalysts.
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3.3 Results and Discussion
Synthesis of Rh-enzymes
Both scaffolds SCP-2L A100C and SCP-2L V83C were modified with three different
phosphines to obtain six different Rh-enzymes (see figure 4, the synthesis was discussed
in chapter 2). 
Figure 4 Synthesis of Rh-enzymes (detailed description in chapter 2).
The Rh-enzymes are tested in the hydroformylation of linear 1-alkenes (see scheme 2)
Scheme 2: Hydroformylation reaction with all substrates which were tested.
The Rh/TPPTS system
The Rh/TPPTS system was already briefly introduced in chapter 1. This system was
used as a reference in order to compare the catalytic performance of the Rh-enzymes.
The  catalytic  performance  of  the  Rh/TPPTS-system  in  the  aqueous  biphasic
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hydroformylation of long chain 1-alkenes was tested using reaction conditions similar to
the ones later used for the Rh-enzymes. The results are given in table 2.
Table 2 Hydroformylation of 1-alkenes using Rh/TPPTSa
a: 80 bar syn gas (1:1 mixture of H2 and CO), 48h, 35 °C, stirred at 625 rpm. 0.5 mL aqueous and organic
solution  each.  Each  data  point  represents  the  average  of  four  experiments.  A comparision  with  the
literature known data is given in the experimental section b: Preformed Rh/TPPTS (1:30), 260.56 nanomol
Rh in 0.5 mL 20 mM MES, 50 mM NaCl, pH=6 c: Substrate containing 9% (v/v) n-heptane and 1% (v/v)
diphenylether d: determined by GC e: below the detection limit. 
As known[33] and shown in table 2 the activity of the Rh/TPPTS-system is negligible for
long chain 1-alkenes due to their low water solubility.[1] Minimal conversions could only
be detected for the two shortest 1-alkenes (1-octene and 1-decene) tested with a linear
selectivity of around 72%. 
Evaluation of Rh-enzymes in the hydroformylation
The three Rh-enzymes based on the SCP-2L V83C mutant (see figure 4) were tested in
the  aqueous  biphasic  hydroformylation  of  1-octene,  1-decene,  1-dodecene,  and  1-
octadecene. The results are listed in table 3.
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entry
1 Rh / TPPTS 1-octene
2 Rh / TPPTS 1-decene <1
3 Rh / TPPTS 1-dodecene
4 Rh / TPPTS 1-octadecene
catalystb substratec TONd % linear selectivityd
1 ± 1 72 ±7
73 ± 3
-e -e
-e -e
Table 3 Hydroformylation of 1-alkenes using SCP-2L V83C-Phosphine-Rha
a: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. 0.5 mL aqueous and organic solution each. Each
data point represents the average of four experiments b: Substrate containing 9% (v/v) n-heptane and 1%
(v/v)  diphenylether  c:  determined by GC  d:  SCP-2L V83C-1-P(ortho)  :  Rh =  5.8;  30.89  nanomol  Rh
(determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM NaCl, pH=6 e:  SCP-2L V83C-1-P(meta) : Rh =
1.8; 99.12 nanomol Rh (determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM NaCl, pH=6  f:  SCP-2L
V83C-1-P(para) : Rh = 3.0; 46.58 nanomol Rh (determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM
NaCl, pH=6 g: below the detection limit
Although the rhodium concentrations are about a factor three to eight lower than in the
Rh/TPPTS system (table 2) considerably higher TON could be observed for most Rh-
enzymes.  The selectivity is  virtually the same regardless  of  the Rh-enzyme and the
substrate tested. All reactions (with conversion) result in about 75% linear selectivity.
No  products  could  be  detected  when  1-dodecene  and  1-octadecene  were  used  as
substrates in the Rh/TPPTS-system (table 2). The same was observed for one of the Rh-
enzymes listed in table 3 (entries 7, 10). The other two Rh-enzymes only yield small
TON for these substrates (entries 8, 9, 11, 12) but they are clearly detectable. 
The  results  can  be  summarised  as  a  decreasing  activity  with  increasing  number  of
carbon  atoms  of  the  starting  material  as  well  an  activity  following  the  order
P(para)>P(meta)>P(ortho).  The  least  active  Rh-enzymes  based  on  SCP-2L  V83C-
P(ortho) show an activity and selectivity comparably to the Rh/TPPTS-system while the
other  Rh-enzymes  are  several  orders  of  magnitude  more  active.  A constant  linear
selectivity of about 75% is observed.
In the next step the three Rh-enzymes based on the SCP-2L A100C mutant (see figure
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entry catalyst
1 1-octene
2 1-octene
3 1-octene
4 1-decene
5 1-decene
6 1-decene
7 1-dodecene
8 1-dodecene
9 1-dodecene
10 1-octadecene
11 1-octadecene
12 1-octadecene
substrateb TONc % linear selectivityc
SCP-2L V83C-1-P(ortho)-Rhd 1 ± 0 79 ± 1
SCP-2L V83C-1-P(meta)-Rhe 33 ± 2 74 ± 0
SCP-2L V83C-1-P(para)-Rhf 74 ± 9 78 ± 0
SCP-2L V83C-1-P(ortho)-Rhd -g -g
SCP-2L V83C-1-P(meta)-Rhe 27 ± 7 72 ± 0
SCP-2L V83C-1-P(para)-Rhf 39 ± 7 76 ± 0
SCP-2L V83C-1-P(ortho)-Rhd -g -g
SCP-2L V83C-1-P(meta)-Rhe 6 ± 3 73 ± 1
SCP-2L V83C-1-P(para)-Rhf 13 ± 5 75 ± 2
SCP-2L V83C-1-P(ortho)-Rhd -g -g
SCP-2L V83C-1-P(meta)-Rhe 4 ± 1 76 ± 1
SCP-2L V83C-1-P(para)-Rhf 2 ± 1 71 ± 3
4) were tested in the same set of reactions. The results are listed in table 4.
Table 4 Hydroformylation of 1-alkenes using SCP-2L A100C-Phosphine-Rha
a: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. 0.5 mL aqueous and organic solution each. Each
entry represents the average of four experiments b: Substrate containing 9% (v/v) n-heptane and 1% (v/v)
diphenylether  c:  determined  by  GC  d:  SCP-2L  A100C-1-P(ortho)  :  Rh  =  3.5;  26.87  nanomol  Rh
(determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM NaCl, pH=6 e: SCP-2L A100C-1-P(meta) : Rh =
2.2; 37.72 nanomol Rh (determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM NaCl, pH=6  f:  SCP-2L
A100C-1-P(para) : Rh = 1.5; 22.98 nanomol Rh (determined by ICP-MS) in 0.5 mL 20 mM MES, 50 mM
NaCl, pH=6 g: below the detection limit
The  TON decreases  with  increasing  numbers of  carbon  atoms  of  the  1-alkenes.  In
addition,  there is a significant difference between the three phosphines. The activity
ranking  of  the  phosphines  is  the  same  as  for  the  SCP-2L  V83C  mutant:
P(para)>P(meta)>P(ortho).  The activity of the SCP-2L A100C mutant modified with
P(ortho) was so small  that  conversions could only be detected for the shortest  (and
therefore most active) 1-alkene investigated. The selectivity of the reaction expressed by
the “% linear selectivity” in the table slightly decreases with the number of C-atoms and
follows the order P(para)>P(meta)≈P(ortho).
The TON are by a factor 3-5 higher than the corresponding TON with SCP-2L V83C as
scaffold  (excluding  those  results  in  which  either  TON  is  ≤  10).  It  needs  to  be
emphasised that the activity of the most active Rh-enzyme (SCP-2L A100C-1-P(para) is
several orders of magnitude higher in the hydroformylation of 1-octene and 1-decene
than  the  corresponding  Rh/TPPTS  system  (a  detailed  calculation  is  given  in  the
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entry catalyst
1 1-octene
2 1-octene
3 1-octene
4 1-decene
5 1-decene
6 1-decene
7 1-dodecene
8 1-dodecene
9 1-dodecene
10 1-octadecene
11 1-octadecene
12 1-octadecene
substrateb TONc % linear selectivityc
SCP-2L A100C-1-P(ortho)-Rhd 1 ± 1 70 ± 4
SCP-2L A100C-1-P(meta)-Rhe 106 ± 2 70 ± 1
SCP-2L A100C-1-P(para)-Rhf 409 ± 58 79 ± 6
SCP-2L A100C-1-P(ortho)-Rhd -g -g
SCP-2L A100C-1-P(meta)-Rhe 75 ± 8 66 ± 1
SCP-2L A100C-1-P(para)-Rhf 135 ± 16 74 ± 1
SCP-2L A100C-1-P(ortho)-Rhd -g -g
SCP-2L A100C-1-P(meta)-Rhe 46 ± 9 64 ± 0
SCP-2L A100C-1-P(para)-Rhf 66 ± 3 73 ± 0
SCP-2L A100C-1-P(ortho)-Rhd -g -g
SCP-2L A100C-1-P(meta)-Rhe 21 ± 4 64 ± 1
SCP-2L A100C-1-P(para)-Rhf 20 ± 7 72 ± 2
experimental section). While the Rh/TPPTS system requires high ligand to Rh ratios to
obtain high selectivities for the Rh-enzymes a good linear selectivity is obtained at only
a slight molar excess of the protein.
The results for the different SCP-2L based Rh-enzymes (table 3 and table 4) can be
explained  with  the  concept  suggested  in  figure  3:  The  different  activities  for  the
different  phosphines  used  could  be  explained  by  a  mismatch  of  the  coordinating
rhodium to the substrate. A large mismatch in the case of P(ortho), which is slightly less
in case of P(meta). In case of P(para) the coordinating rhodium might be in proximity to
the substrate  within  the  tunnel,  resulting in  excellent  TON. It  could  also be due to
different  protein  to  rhodium ratios.  The  different  activities  of  the  substrates  can  be
explained with a different binding preference within the tunnel. Finally the difference
between the two mutants as scaffold can be explained by a better pairing between the
complexed rhodium and the substrate. The linear selectivities observed can be explained
by the bulky environment  within the hydrophobic pocket of the protein.  One might
argue that the activity differences observed can be attributed to the different Protein :
Rh-ratios used. This is not the case, as different SCP-2L A100C-P(para) : Rh ratios are
investigated (fig. 7) and the activities are still high for high SCP-2L A100C-P(para) :
Rh.
The mode of action of the Rh-enzymes
So far, the high catalytic activities of the P(para) modified SCP-2L scaffolds provide
strong support for the validity of the envisioned concept put forward in figure 3. In
order to exclude catalysis by artefacts additional experiments were performed. In the
first step catalysis by rhodium leaching is addressed.
1) leaching
The mode of action investigated in this sub chapter is  concerned with the catalysis by
rhodium leached into the organic phase. Rhodium which migrates into the organic phase
can either originate from a back reaction of the Rh-enzyme. The “back reactions” which
might occure are the hydrolysis  of the hydrazone, the retro michael addition,  or the
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decomplexation of rhodium. Leached rhodium would result in high activity and low
selectivity but both pathways might result in leaching of a phosphine-rhodium-fragment
which would result in a more selective reaction. The concept is depicted in figure 5. 
Figure  5  Hydroformylation  catalysed  by  different  rhodium-species  leached  into  the
organic phase.
In  this  figure  the  catalytically  active  species  is  either  "free"  rhodium (for  example
HRh(CO)4) or a Rh-ligand fragment which is transferred into the organic phase. "Free"
rhodium results in a linear selectivity of ≈58% under the conditions used. This is much
lower  than  the  linear  selectivity  observed  when  Rh-enzymes  are  used  as  catalysts.
Therefore "free" rhodium cannot solely be the cause for the high activities observed. As
it is also plausible to assume that the amount of Rh leached is the same regardless of the
substrate used the comparably small conversions of 1-octadecene (for any Rh-enzyme
tested) show that the total amount of free rhodium leached has to be quite small. 
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Study of potentially occuring “back reactions” of the Rh-enzyme 
Analysis of SCP-2L A100C-1-P(para)-Rh by MALDI-TOF made it seem possible that
the Rh-enzymes might release a P-Rh-fragment during the reaction. The MALDI-TOF
spectrum of SCP-2L A100C-1-P(para)-Rh is depicted in figure 6.
Figure  6  MALDI-TOF  MS  spectrum  of  SCP-2L  A100C-1-P(para)-Rh  before
hydroformylation.
The spectrum contains three significant peaks. The peak at 13405 Da corresponds to the
mass of the unmodified SCP-2L A100C. The second peak at 13588 Da corresponds to
the  mass  of  the  linker  modified  SCP-2L  A100C-1.  The  third  peak  at  13863  Da
corresponds to the phosphine modified SCP-2L A100C-1-P(para). Various signals are
present  in  the  region  in  which  the  mass  of  the  Rh-enzyme  is  expected  but  no
distinguishable peak can be identified. The presence of both the unmodified protein as
well as the linker modified protein in the spectrum might be due to back reactions of the
Rh-enzyme or the phosphine modified enzyme during the analysis.  It  might also be
possible that these species are always present due to incomplete modification but can
only be detected by MALDI-TOF and not by the usually applied ESI-MS due to the
higher sensitivity of the former one. This finding makes it seem likely that Rh-enzymes
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SCP-2L A100C 
M = 13405 Da
SCP-2L A100C-
1 
M = 13588 Da
SCP-2L A100C-1-
P(para) 
M = 13860 Da
can undergo the back reaction under the reaction conditions. The back reaction would
release a P-Rh-fragment of the enzyme  which can migrate to the organic phase and
catalyse  the  reaction  in  a  monophasic  fashion  causing  the  high  activities  and
selectivities observed. In a previous publication the analysis of a Rh-enzyme (SCP-2L
V83C-1-P(para)-Rh)  by  LC-MS  recovered  from  the  aqueous  phase  after  the
hydroformylation did show small  quantities of both unmodified and linker modified
protein.[33] In  a  reproduction of  this  experiment  only the oxide  of  SCP-2L V83C-1-
P(para) was detected when SCP-2L V83C-1-P(para)-Rh was analysed by ESI-MS after
the reaction. The total concentrations of P-Rh-fragments released under the conditions
are therefore most likely quite small.
Variation of SCP-2L A100C-1-P(para) to Rh ratios
It  has  been  mentioned  that due  to  its  low  selectivity  "free"  rhodium  cannot  be
responsible  for  the  total  hydroformylation  activity  observed  and  is  at  the  most
responsible for a small fraction of the total conversion. In order to further evaluate this
amount a reaction series was performed in which the ratio of SCP-2L A100C-1-P(para)
to  Rh was systematically  varied.  In  this  series  the  Rh-concentration  in  the  reaction
mixture was kept constant. The results of these experiments are depicted in figure 7.
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Figure 7 Variation of the SCP-2L A100C-1-P(para) / Rh-ratios in the hydroformylation of
1-octene (at constant rhodium concentrations). 
Reaction conditions: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. Organic solution: 0.5 mL 1-
octene containing 9% (v/v) n-heptane and 1% (v/v) diphenylether. Aqueous solution: 0.5 mL 20 mM MES,
50 mM NaCl, pH=6. TON & linear selectivity determined by GC. 20.77 nanomol Rh (determined by ICP-
MS). Each data point represents the average of two experiments.
For a SCP-2L A100C-1-P(para) to rhodium ratio ≈1.4 figure 7 shows a high activity and
a low selectivity. Upon increasing this ratio the activity decreases and the selectivity
increases. These dependencies can be explained by a decrease of "free" rhodium and an
increase of the desired Rh-enzyme on increasing the ratio. The residual activity at high
enzyme/Rh-ratios will be caused by the Rh-enzyme. 
The  observations  could  also  be  explained  by  the  back  reaction  of  the  phosphine-
modified-enzyme which releases a P-fragment. This is coordinating to leached rhodium
and  causing  the  selectivity  observed.  As  the  concentration  of  this  P-fragment  is
proportional  to  the  starting  concentration  of  phosphine  modified  protein  a  higher
selectivity  is  observed with  increasing  enzyme/Rh-ratios.  On  the  basis  of  the
experimental evidence given in figure 7 it is not possible to decide between these two
possibilities.
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Performance of P-Rh-fragments in the monophasic hydroformylation
In order to mimic the catalytic activity of a P-Rh-fragment, the hydroformylation of 1-
octene was performed in the presence of rhodium and either of the three phosphine
ligands  P(ortho),  P(meta),  and  P(para)  used  in  the  protein  modification.  In  this
experimental series the concentration of rhodium was kept constant and the ratios of
P/Rh varied. The reactions were performed in a single organic phase (table 5).
Table 5 Hydroformylation of 1-octene with three different phosphines  at varying P/Rh
ratios (constant Rh)a 
a:  80 bar syn gas (1:1),  41h 15 min.,  35 °C, stirred at  625 rpm. 0.5 mL 1-octene containing internal
standard.  Each entry represents the average of  four experiments. b:  P(ortho) = 2-(diphenylphosphino)
benzaldehyde,  P(meta)  =  3-(diphenylphosphino)  benzaldehyde,  P(para)  =  4-(diphenylphosphino)
benzaldehyde c: Actual molar amounts used (in µmol) d: Determined by GC
When an excess of  rhodium is present  TON are about  300 -  700 and the % linear
selectivity is in the range 54 - 59% which corresponds to the linear selectivity of free
rhodium. Upon increasing the P/Rh ratio to values larger than 1 the linear selectivity
increases from 56% to 68% for P(ortho), from 55% to 76% for P(meta), and from 57%
to 78% for P(para). For the experiments with an excess of phosphine (except entry 4)
TON is in the range of 200-500. The only exception (entry 4) is the experiment with the
highest ratio of P(ortho) to Rh in which virtually no conversion took place.
Upon increasing the P/Rh ratio to values larger than 1 the selectivity increases to around
75% linear selectivity for P(para) and P(meta). In case of P(ortho) a larger excess of
114
entry
1 P(ortho) + Rh 0.15 / 0
2 P(ortho) + Rh 0.15 / 0.08
3 P(ortho) + Rh 0.15 / 0.21
4 P(ortho) + Rh 0.15 / 1.6
5 P(meta) + Rh 0.15 / 0
6 P(meta) + Rh 0.15 / 0.05
7 P(meta) + Rh 0.15 / 0.30
8 P(meta) + Rh 0.15 / 1.7
9 P(para) + Rh 0.14 / 0.02
10 P(para) + Rh 0.14 / 0.08
11 P(para) + Rh 0.14 / 0.16
12 P(para) + Rh 0.14 / 1.5
catalystb Rh / Pc TONd % linear selectivityd
312 ± 36 56 ± 0
728 ± 72 56 ± 0
386 ± 47 56 ± 0
1 ± 0 68 ± 1
530 ± 53 55 ± 1
691 ± 58 56 ± 0
311 ± 27 74 ± 1
521 ± 33 76 ± 0
467 ± 73 57 ± 0
486 ± 91 58 ± 1
238 ± 17 74 ± 2
487 ± 43 78 ± 0
phosphine is necessary to reach a linear selectivity of around 70%. About 200-500 TON
are detected, the only exception is the experiment with the highest ratio of P(ortho) to
Rh in which virtually no conversion took place.
For P(meta) and P(para) there are no systematic differences in activities. This is in total
contrast with the Rh-enzymes investigated for which the activity strongly depended on
the substitution pattern of the phosphines.
The activity and selectivity of the biphasic hydroformylation of 1-octene using SCP-2L
A100C-1-P-Rh (with P being either P(para) or P(meta)) is similar to the results of the
monophasic reaction when P(para) or P(meta) are used in a slight excess. 
The selectivity of the biphasic hydroformylation of 1-octene using SCP-2L V83C-1-P-
Rh  (with  P  being  either  P(para)  or  P(meta))  is  similar  to  the  selectivity  of  the
monophasic  reaction when P(para)  or P(meta)  are  used in a  slight  excess while the
activity of the monophasic reaction is much higher.
The results obtained for the Rh-enzymes can be explained by fragmentation (or back
reaction)  of  the  Rh-enzyme  and  release  of  a  P-Rh-fragment  as  the  P-Rh-fragments
investigated have a  selectivity comparable with the selectivity observed for  the Rh-
enzymes. In case of SCP-2L A100C-1-P(para-Rh basically all of the Rh coordinating to
the enzyme needs to be released as a P-Rh-fragment to obtain the detected activity. In
case of the other Rh-enzymes a fraction of the protein bound rhodium released as a P-
Rh-fragment  would  be  sufficient  to  cause  the  activity  observed  in  the  Rh-enzyme
catalysed reaction. 
A different  fraction  of  P-Rh-fragment  release  for  SCP-2L A100C-1-P(para)-Rh  and
SCP-2L V83C-1-P(para)-Rh seems unlikely as the chemical modification in those two
Rh-enzymes is the same. Additionally the back reaction should be the same regardless
of the phosphine used in protein modification. This would result in the same quantities
of P-Rh-fragments being released resulting in similar activities for the different Rh-
enzymes regardless of the phosphine used. In reality the activity of the Rh-enzymes was
highly dependant on the phosphine it was based upon. 
From this  background  it  is  unlikely  that  the  activities  and  selectivities  of  the  Rh-
enzymes are only caused by the degradation or by the back reaction of the Rh-enzyme
and  the  subsequent  release  of  a  Rh-containing  fragment  into  the  organic  phase.
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However,  one  cannot  exclude  that  these  fragments  are  partially  responsible  for  the
catalysis.
ICP-MS analysis of the organic phase
The rhodium and phosphorus contents of the organic phase after catalysis with different
Rh-enzymes  were  determined  by  ICP-MS.  The  phosphorus  concentrations  detected
were quite low (up to 200 ppb, all details in the experimental section). This is a strong
indication that any potentially existing P-Rh-fragments do not play an important role as
catalysts. 
The rhodium concentration was analysed in the same way but on more samples. No
correlation between the 1-alkene used and the rhodium concentration leached into the
organic  phase  could  be  found (details  in  experimental  section).  In  table  6  rhodium
concentrations from hydroformylation experiments in which different Rh-enzymes were
used are summarized. The rhodium concentrations in the organic phase were determined
by  ICP-MS  after  the  hydroformylation  reaction.  Also  the  ratios  of  rhodium
concentrations  in  the  organic  phase  over  the  corresponding  initial  rhodium
concentrations in the aqueous phase before the reaction are listed (expressed in %).
Table 6 Rhodium content in the organic phase after hydroformylation.a
a: All details are described in the experimental section. b: determined in organic phase by ICP-
MS. c: ratio of  the Rh concentration in the organic phase after the reaction over the initial Rh
concentration in the aqueous phase (as determined by ICP-MS) d: Number of experiments. 
The rhodium concentrations detected in the organic phase seems to depend on the initial
rhodium concentration in the aqueous phase as well as on the ratio between phosphine
modified protein to rhodium (see experimental section, details on table 6). Neither of
which was constant for the different Rh-enzymes listed above. The standard deviation
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entry Rh-enzyme
1 A100C-1-P(para)-Rh 138±69 6
2 A100C-1-P(meta)-Rh 3
3 A100C-1-P(ortho)-Rh 2
4 V83C-1-P(para)-Rh 6
5 V83C-1-P(meta)-Rh 5
6 V83C-1-P(ortho)-Rh 2
ppb Rhb % Rhc nd
5.8±2.9
158±156 2.0±2.0
15±1 0.3±0.0
22±13 0.5±0.3
261±127 2.6±1.3
43±-24 1.4±0.8
for the same reaction settings is quite large as well. The data obtained is insufficient for
an in depth comparison but some conclusions can be drawn:
Only  small  quantities  of  rhodium  were  detected  in  the  organic  phase  after  the
hydroformylation reactions. Although these quantities correspond to up to 6% of the
initial amount of rhodium present in the aqueous phase they cannot solely explain the
high  conversion  observed  when  SCP-2L based  Rh-enzymes  were  used  as  catalysts
unless the fragment leached is much more active than the one tested in the monophasic
reaction or the polarity of the fragment released into the organic phase is pressure and/or
temperature dependant resulting in a higher concentration during the reaction than after
the reaction when the  pressure is  released and the  temperature reduced  (see "smart
systems" in the introduction).
Investigation of the kinetics
This set of experiments investigates the potential existence of such a “smart” system
mentioned before. Parallel reactions using the same batch of SCP-2L V83C-1-P(para)
were used to catalyse the hydroformylation of 1-octene for different reaction times. If a
temperature or pressure dependant P-Rh-fragment (a fragment which is soluble in the
organic phase during the reaction but migrates into the aqueous solution at the end of
the reaction) is causing the activity observed the activity needs to increase over time as
the quantity of P-Rh fragment  would accumulate  in  the organic phase.  The activity
might also stay constant if the P-Rh-fragment is formed instantly at the beginning of the
reaction. If the protein scaffold is playing a role the activity is more likely to decrease
over time, as the enzyme is precipitating over time. The relative activity and % linear
selectivity for the different reaction times using SCP-2L V83C-1-P(para)-Rh as catalyst
in the hydroformylation of 1-octene are depicted in figure 8.
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Figure 8 Dependency of the relative activity and selectivity in the hydroformylation of 1-
octene over time using SCP-2L V83C-1-P(para)-Rh as catalyst.
Reaction conditions: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. Organic solution: 0.5 mL 1-
octene containing 9% (v/v) n-heptane and 1% (v/v) diphenylether. Aqueous solution: 0.5 mL 20 mM MES,
50 mM NaCl, pH=6. TON & linear selectivity determined by GC. 46.58 nanomol Rh (determined by ICP-
MS).  SCP-2L V83C-1-P(para) : Rh = 3.0;  Each data point represents the average of three experiments.
The first data point is set to a relative activity of 100.
The linear selectivity is around 78% for all measurement points. The relative activity is
set to 100 for the reaction time of 3.0 h. The second reading point after a reaction time
of 6.5h has a slightly higher activity while the last reading point after 16h reaction time
shows a slightly lower activity. The increase in activity between the first two reaction
times can be explained by an incubation period required to obtain a catalytically active
species (see scheme 1 – mechanism of the hydroformylation). The decrease in relative
activity between the second and third reaction time can be explained by a decrease in
catalytically  active  species  or  by a  decreasing  1-octene  concentration  if  catalysis  is
faster  than  the  phase  transfer  as  the  other  factors  (CO  pressure,  H2 pressure,
temperature) are virtually constant. The existence of a “smart system” can be excluded
and an involvement of the Rh-enzyme in the catalytic cycle is quite likely.
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Conclusion on this mode of action
When Rh-enzymes  based on SCP-2L are  used  as  catalysts  in  the  hydroformylation
reaction only a marginal fraction of the total hydroformylation activity can be attributed
to either "free" rhodium  or a Rh-phosphine-fragment leached into the organic phase.
The Rh-enzymes  do not  act  like  a  “smart  system” but  probably play a  role  in  the
catalytic cycle. 
2) Enrichment of 1-alkenes within the hydrophobic tunnel
The concept envisioned for artificial metalloenzymes based on the SCP-2L scaffold was
already discussed earlier (figure 3): The hydrophobic substrate does enrich within the
tunnel  during  the  reaction  bringing  it  in  close  proximity to  the  metal  centre.  As  a
consequence of the increased concentration of 1-alkene an activity increase induced by
the Rh-enzyme would be observed on the one hand. On the other hand a selectivity
inducement by the whole protein environment would be expected. 
Catalysis by different protein scaffolds
In the  concept  depicted  in  figure  3 the  tunnel  plays  a  decisive  roll  in  the  catalytic
activity of the enzyme. In order to elucidate the significance of the tunnel a protein
scaffold without a hydrophobic tunnel was used. Photoactive yellow protein (PYP) does
not have a tunnel but contains cysteine. The PYP R52G mutant was used and modified
to obtain the Rh-enzyme PYP R52G-1-P(para)-Rh. This Rh-enzyme was subsequently
used as a catalyst in hydroformylation experiments in which the chain lengths of the 1-
alkenes were varied between C6 to C18 (see table 7). 
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Table 7 Hydroformylation of 1-alkenes using SCP-2L V83C-Phosphine-Rha
a: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. 0.5 mL aqueous and organic solution each.  b:
Substrate  containing  9%  (v/v)  n-heptane  and  1%  (v/v)  diphenylether  c:  determined  by  GC  d:  ≤140
nanomol Rh (not determined by ICP-MS). PYP R52G-1-P(para) : Rh ≥ 2; the Conversion of 1-hexene and
1-octene are based on two experiments, all other entrys are based on one experiment.
The % linear selectivity is around 75% for 1-hexene, 1-octene and 1-octadecene. It is
around 55% for 1-decene and 1-dodecene. The activity decreases with increasing chain
lengths  with  1-decene  and  1-dodecene  being  the  exception  to  this  trend.  The  low
selectivity and comparably high activity for 1-decene and 1-dodecene is most likely due
to higher quantities of "free" rhodium in the organic phase for these reactions and will
not  be  considered  any further  (very likely oxidation  of  the  phosphine  due to  “old”
batches  of  both  1-decene  and  1-dodecene).  The  selectivity  for  this  PYP based  Rh-
enzyme is similar to the selectivity obtained for the two corresponding SCP-2L based
Rh-enzymes (tables 3 and 4) and its activity is in between them. Although neither PYP
nor the  mutant  PYP R52G exhibit  a  hydrophobic  tunnel  as  SCP-2L they possess  a
hydrophobic  pocket  next  to  their  cysteine  and  therefore  next  to  the  introduced
modification.[50] 
In order to exclude that this hydrophobic pocket has a similar effect as the hydrophobic
tunnel of the SCP-2L an attempt on the synthesis of another class of Rh-enzymes based
on  "Lysozyme"  was  performed.  Unfortunately  they  could  not  be  characterised
successfully (see chapter 2) and when tested in the hydroformylation reaction the results
obtained are quite disappointing as the conversion is barely detectable (<1 TON) turning
any conclusions based on these results into sheer speculations.
Competitive binding
In order to verify the assumption that the high activities are due to the accumulation of
1-alkene within the hydrophobic tunnel  of the protein competitive binding reactions
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entry catalyst
1 1-hexene
2 1-octene
3 1-decene 116 56
4 1-dodecene 138 56
5 1-octadecene 33 76
substrateb TONc % linear selectivityc
PYP R52G-1-P(para)-Rhd 285 ± 15 78 ± 1
PYP R52G-1-P(para)-Rhd 101 ± 6 76 ± 0
PYP R52G-1-P(para)-Rhd
PYP R52G-1-P(para)-Rhd
PYP R52G-1-P(para)-Rhd
were performed to block the tunnel. Three different sets of experiments were performed
in which either palmitic acid or pyrene decanoic acid were used. The experiments with
palmitic acid were performed with the two Rh-enzymes  SCP-2L V83C-1-P(para)-Rh
and SCP-2L A100C-1-P(para)-Rh whereas in the series with pyrene decanoic acid only
SCP-2L V83C-1-P(para)-Rh was used.
In the first set of experiments the Rh-enzyme SCP-2L V83C-1-P(para)-Rh was used and
the amount of palmitic acid was varied (table 8). Although it is known that different
SCP-2  enzymes  bind  palmitic  acid  inside  the  hydrophobic  tunnel[51–57] the  binding
affinity of the modified proteins under reaction conditions is unknown. If the assumed
principle is correct and the binding affinity towards palmitic acid is higher than to 1-
octene  increasing  amounts  of  palmitic  acid  would  decrease  the  hydroformylation
activity as the tunnel is blocked. Additionally a lower selectivity would seem likely as
well as the outer reaction sphere of the protein cannot influence the outcome of the
reaction anymore. The influence of different quantities of palmitic acid in the biphasic
hydroformylation of 1-octene with SCP 2L V83C-1-P(para)-Rh as catalyst are depicted
in table 8. 
Table  8 Hydroformylation of  1-octene using SCP-2L V83C-1-P(para)-Rh at  different
palmitic acid quantities.a
a:  80 bar  syn  gas  (1:1),  48h,  35 °C,  stirred  at  625  rpm.  Organic  solution:  Total  of  0.5  mL 1-octene
containing 9% (v/v) n-heptane and 1% (v/v) diphenylether. Aqueous solution: 0.5 mL 20 mM MES, 50 mM
NaCl, pH=6. Maximum of 185 nanomol Rh per reaction (actual value after work-up not determined) SCP-
2L V83C-1-P(para) : Rh ≥ 2.0. Entries 1 & 4 represent the average of two experiments, other entries based
on single experiments b: equivalent palmitic acid, added from a stock in 1-octene and internal standard
(total volume of organic solution is constant) c: relative activity in entry 1 is set to 100,d: determined by GC
In table 8 the highest activity is found when no palmitic acid is present. It is still high
when sub-stoichiometric amounts are used but drops to an activity of about 60-70%
when equimolar or higher equivalents of palmitic acid are present. The change in linear
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entry
1 0 100±23 77±2
2 0.5 86 75
3 1 63 76
4 5 72±3 74±1
5 100 70 75
eq. palmitic acidb rel. activityc,d % linear selectivityd
selectivity is not significant.
A similar set of reactions was performed using pyrene decanoic acid instead of palmitic
acid with the same Rh-enzyme (table 9). Pyrene decanoic acid is a fluorescent fatty acid
analogue known to bind to the hydrophobic tunnel of the mutant SCP-2L V83C as well
as to SCP-2L itself.[33]
Table  9 Hydroformylation of  1-octene using SCP-2L V83C-1-P(para)-Rh at  different
pyrene decanoic acid quantities.a
a:  80 bar  syn  gas  (1:1),  48h,  35 °C,  stirred  at  625  rpm.  Organic  solution:  Total  of  0.5  mL 1-octene
containing  9%  (v/v)  n-heptane  and  1%  (v/v)  diphenylether,  40  µL  methanol.  Pyrene  decanoic  acid
dissolved in the organic mixture. Aqueous solution: 0.5 mL 20 mM MES, 50 mM NaCl, pH=6. Maximum of
150 nanomol Rh per reaction (actual value after work-up not determined) SCP-2L V83C-1-P(para) : Rh ≥
1.2. All entries based on a single experiments,  b: Equivalent pyrene decanoic acid  c: relative activity in
entry 1 is set to 100, d: determined by GC
According to  table 9 the selectivity is basically unaffected by the quantity of pyrene
decanoic acid added. Additionally the relative activity is almost unchanged for up to 5
equivalents of pyrene decanoic acid. When 10 equivalents are added the relative activity
increases by a factor two.
The influence of palmitic acid on the performance of SCP 2L A100C-1-P(para)-Rh in
the hydroformylation of 1-octene is shown in table 10. 
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entry
1 0 100 76
2 1 75 71
3 5 100 76
4 10 198 77
eq.b rel. activityc,d % lineard
Table 10 Hydroformylation of 1-octene using SCP-2L A100C-1-P(para)-Rh at different
palmitic acid quantities.a
a:  80 bar  syn  gas  (1:1),  48h,  35 °C,  stirred  at  625  rpm.  Organic  solution:  Total  of  0.5  mL 1-octene
containing 9% (v/v) n-heptane and 1% (v/v) diphenylether. Aqueous solution: 0.5 mL 20 mM MES, 50 mM
NaCl, pH=6. ≤450 nanomol Rh per reaction (actual value after pre-formation and work-up not determined
by ICP-MS) SCP-2L A100C-1-P(para) : Rh ≥ 2.0. Entry 1 represent the average of two experiments, other
entries based on single experiments b:  equivalent  palmitic  acid,  added from a stock in  1-octene and
internal standard (total volume of organic solution is constant) c: relative activity in entry 1 is set to 100 d:
determined by GC
As can be seen from a comparison of the results from table 8 and 10 increasing amounts
of palmitic acids cause opposite effects regarding the activity for the two tested Rh-
enzymes. Pyrene decanoic in the presence of SCP-2L V83C-1-P(para)-Rh has a similar
effect  on  the  activity  as  palmitic  acid  on  SCP-2L  A100C-1-P(para)-Rh.  These
contradicting results make it impossible to draw conclusions on the potential mode of
the tunnel within the protein.
Enantioselectivity
If the reaction takes place in the tunnel the chirality of the protein scaffold might induce
chirality on  the product. Unfortunately the hydroformylation of 1-alkene favours the
formation of linear aldehydes while the (potentially chiral) branched aldehyde is only
formed  in  small  quantities.  Therefore  the  hydroformylation  of  styrene  using  Rh-
enzymes was performed as styrene is  known to yield mainly the (potentially)  chiral
branched aldehyde under hydroformylation conditions.
When  SCP-2L A100C-1-P(para)-Rh  was  used  as  catalyst  extremely  high  branched
selectivities  of  98% were obtained.  When SCP-2L V83C-1-P(para)-Rh was used as
catalyst  similarly  high  branched  selectivities  of  around  94%  were  obtained.
Unfortunately  no  enantiomeric  excess  of  the  formed  2-phenylpropionaldehyde  was
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entry
1 0 100±2 80±0
2 0.1 84 89
3 0.5 107 82
4 1 81 80
5 5 166 84
6 10 164 82
7 100 165 81
eq. palmitic acidb rel. activityc, d % linear selectivityd
found in either reaction.
It  might  be  that  the  hydroformylation  of  styrene  is  totally  different  from  the
hydroformylation  of  1-alkenes  using  Rh-enzymes  with  the  former  substrate  not
interacting with the tunnel while the latter ones are. It might also be that the reaction
takes place within the tunnel but is not inducing any enantioselectivity.
Conclusion on this mode of action
One  of  the  competitive  binding  experiments  showed  a  decrease  in  activity  with
increasing concentration of competitive binder. This can be explained by competitive
binding  inside  the  tunnel.  On  the  contrary  the  other  two  competitive  binding
experiments did not result in a decrease of the activities. Instead the activities increase
with higher loadings of the competitive binder. This increase can be explained by the
formation of micelles in the aqueous phase, by an increase of the stability of the Rh-
enzymes or by the reaction taking place outside the enzyme / on the surface. 
The tested Rh-enzyme based on PYP has a similar reaction rate as the SCP-2L based
Rh-enzymes  for  most  1-alkenes  tested.  Although it  does  not  possess  a  hydrophobic
tunnel it is possible that its hydrophobic pocket has the same effect.
These results show that the concept envisioned in which the hydrophobic tunnel acts as
a accumulation point for the substrates is possible.
3) Protein acting as amphiphile
The theory that the Rh-enzyme is acting as an amphiphile emerged during the workup
of the Diels-Alder reactions (see chapter 4) where the phase separation after the reaction
was problematic. This indicates the presence of surface active molecules. Due to this
observation a special hydroformylation reaction was performed in which the reaction
time was kept short and the autoclave was not put on ice when releasing the pressure (as
usually). Some reaction vials of this experimental setup showed a bad phase separation,
indicating  that  the  Rh-enzymes  might  act  as  surface  active  compounds  under  the
reaction conditions used. The most simplified approach is to consider the hydrophobic
modification as oriented into the organic phase while the main part of the protein is
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located in the aqueous phase (see figure 9). This was further investigated. 
The  decreasing  activity  with  increasing  chain  length  of  the  1-alkene  which  was
observed could also be explained by a decreasing concentration of the 1-alkenes with
increasing chain length. as they were used neat at a constant total volume of the organic
phase. 
Figure 9 Rh-enzyme acting as amphiphile.
Variation of the Rh-enzyme concentration
In  order  to  test  this  hypothesis  increasing  Rh-enzyme  concentrations  were  used  to
catalyse  the  reaction.  Once  there  is  rhodium  saturation  at  the  interphase  further
increasing its concentration would not result in an increasing TON but a decreasing. The
results for the hydroformylation of 1-octene using SCP-2L V83C-1-P(para) at different
Rh-enzyme concentrations is depicted in figure 10.
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Figure 10 Hydroformylation of 1-octene using SCP-2L V83C-1-P(para)-Rh at different
Rh-enzyme concentrations.
Reaction conditions: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. Organic solution: Total volume
of 0.5 mL. 1-octene containing 9% (v/v) n-heptane and 1% (v/v) diphenylether, aqueous solution: 0.5 mL
20 mM MES, 50 mM NaCl, pH=6. conversion & linear selectivity determined by GC. SCP-2L V83C-1-
P(para) : Rh = 2.9. The Rhodium quantities used are (in nanomol): 44.82; 67.22; 89.63; 112.04; all data
points are based on four experiment. The relative activity of the firs data point is set to 100.
The  activity  decreases  with  increasing  concentration  of  the  Rh-enzyme  while  the
selectivity is basically unaffected. This could be explained with the saturation of Rh-
enzymes at the interphase. Unfortunately, it was observed that the stability of the Rh-
enzyme is decreasing with increasing concentration. 
Competitive hydroformylation of 1-alkene mixtures
When 1-alkene mixtures with the same concentrations of each 1-alkene are used as
feedstock the conversion should be unrelated to the chain length if the protein is acting
as amphiphile. The results for the hydroformylation of 1-alkene mixtures with SCP-2L
A100C-1-P(para)-Rh is listed in table 11.
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Table  11  Hydroformylation  of  1-alkene  mixtures  in  an  aqueous-organic  biphasic
environment using SCP-2L A100C-1-P(para)-Rh as catalyst.a
a: 80 bar syn gas (1:1), 48h, 35 °C, stirred at 625 rpm. Organic solution: Total of 0.5 mL 1-alkene mixture
containing 9% (v/v) n-heptane and 1% (v/v) diphenylether. aqueous solution: 0.5 mL 20 mM MES, 50 mM
NaCl, pH=6. ≤150 nanomol Rh per reaction (actual value after preformation and workup not determined by
ICP-MS) SCP-2L A100C-1-P(para) : Rh ≥ 1.1. Each entry represents the average of two experiments. b:
Carbon chain length of the linear 1-alkenes used c: concentration of each 1-alkene in the starting mixture
d: Conversion of the 1-alkene to aldehydes in relation to the conversion of 1-octene to the corresponding
aldehydes in the 1-octene & 1- decene mixture.
The relative activity for the hydroformylation of 1-octene is unchanged regardless of the
second 1-alkene present in the starting mixture. Additonally the activity is unchanged
when lower concentrations of 1-octene are used. The only exception when the starting
mixture  contains  all  four  different  1-alkenes.  In  this  case  the  activity  of  1-octene
decreases dramatically to almost half its initial activity, while the 1-octene concentration
is at about 40% of the initial concentration. The activity of the second 1-alkene is highly
dependant on the chain length of the second 1-alkene. Shorter 1-alkenes are more active
than longer ones. 
No conclusions could be drawn when SCP-2L V83C-1-P(para)-Rh was used as catalyst
in a similar set of reactions as the conversion is much lower when this Rh-enzyme is
used. An attempt on the hydroformylation of diluted 1-octene (in THF) using SCP-2L
V83C-1-P(para)-Rh was inconclusive. Therefore no attempt on the hydroformylation of
different 1-alkene mixtures diluted to the same concentration was performed.
Conclusion on this mode of action
The reactions performed make it seem highly unlikely that the protein is acting as an
amphiphile with the reaction taking place at the interphase as the activity is affected by
the 1-alkene chain length of the 1-alkene.
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1-octene 1-decene 1-dodecene 1-octadecene
%linear %linear %linear %linear
8&10 2.9
8&12 2.6
8&18 2.1
8&10&12&18 1.1
Starting mixb c[mol/mL]c activityd activityd activityd activityd
100±11 81.3±1.8 55±5 75.9±0.3
98±4 82.0±0.3 29±4 73.1±1.5
110±3 82.1±0.4 10±0 73.0±0.1
57±12 82.0±2.5 24±2 74.2±0.9 16±2 75.5±2.4 4±1 74.1±0.6
Various reactions
Protein stability
The aqueous solutions of the unmodified proteins SCP-2L V83C and SCP-2L A100C
lack stability under the storage conditions used (for example 20 mM MES, 50 mM
NaCl, pH=6, temperature either at room temperature or 4 °C) resulting in approximately
10-30%  protein  loss  due  to  precipitation  every  week.  The  chemical  modifications
applied  decrease  the  protein  stability  even  further.  Working  at  lower  protein
concentrations would increase the stability but is impractical. Parallel reactions showed
that neither the high syn gas pressure (80 bar), nor the temperature (35 °C), nor the
organic reactant present during the reaction have a noticeable effect on the stability. The
mechanical  influence  of  the  stirring  (with  a  stirring  bar)  results  in  a  much  faster
precipitation  of  the  enzymes  (whether  modified  or  not)  than  no  such  mechanical
disturbance. 
Influences of batch storage time and H2/CO pressure
A good example for  encountered problems are the hydroformylation experiments in
which the ratio of reaction gases was varied and SCP-2L V83C-1-P(para)-Rh acted as
catalyst. In the first set of experiments a ratio of 10 bar hydrogen to 40 bar CO for one
autoclave and 20:40 for the other autoclave was used. After the reaction the same batch
of Rh-enzyme (which had been stored at 4°C in the meantime) was immediately used to
obtain data points for hydrogen/CO-ratios of 30:40 and 40:40. The results are depicted
in figure 11. 
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Figure 11 Hydroformylation of 1-octene using SCP-2L V83C-1-P(para)-Rh at different
H2 pressure. Reaction conditions: 40 bar CO topped up with the appropriate amount of H2 to a total
pressure of 50, 60, 70, 80 bar respectively, 16h 10 min. reaction time, 35 °C, stirred at 625 rpm. Organic
solution:  Total  volume of  0.5 mL. 1-octene containing 9% (v/v) n-heptane and 1% (v/v) diphenylether,
aqueous solution: 0.5 mL 20 mM MES, 50 mM NaCl, pH=6. conversion & linear selectivity determined by
GC. SCP-2L V83C-1-P(para) : Rh = 4.9; 19.38 nanomol Rhodium; each data point represents the average
of four experiments.
The % linear selectivity is constant at about 78% indicating that both the total pressure,
as well as the increasing partial pressure of hydrogen do not influence linear selectivity.
The activity on the other hand increases from 10 to 20 bar hydrogen as well as from 30
to 40 bar. The activity drop from 20 to 30 bar hydrogen is therefore most likely due to
catalyst storage (1 day) in between the two runs resulting in a lower activity for the
stored catalyst. 
The influence of the partial CO pressure was investigated in the same way (see figure
12). One would expect a decreasing activity with increasing carbon monoxide pressure
as the standard hydroformylation activity has a negative first order in carbon monoxide
pressure. The results are depicted in figure 12. 
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Figure 12 Hydroformylation of 1-octene using SCP-2L V83C-1-P(para)-Rh at different
CO pressure. 
Reaction conditions: 40 bar H2 topped up with the appropriate amount of CO to a total pressure of 50,
60, 70, 80 bar respectively, 16h reaction time, 35 °C, stirred at 625 rpm. Organic solution: Total volume of
0.5 mL. 1-octene containing 9% (v/v) n-heptane and 1% (v/v) diphenylether, aqueous solution: 0.5 mL 20
mM MES, 50 mM NaCl, pH=6. conversion & linear selectivity determined by GC. SCP-2L V83C-1-P(para) :
Rh = 4.9; 19.38 nanomol Rhodium; each data point represents the average of four experiments.
An increase in CO (and total) pressure slightly reduces the % linear selectivity from
82% to 79%. The total pressure does not influence the % linear selectivity (see figure
13),  suggesting  a  weak inverse  interaction  between  the  CO pressure  and the  linear
selectivity. The activity drops when increasing from 10 to 20 bar of CO and again when
increasing from 30 to 40 bar CO. This time the activity increases from 20 to 30 bar,
indicating that the catalyst stored for 1 day is more active which is exactly the opposite
effect as seen before. 
These two sets of experiments clearly highlight a major issue of the Rh-enzyme: It is
almost impossible to compare different sets of experiments when the simple storage of
the catalyst for such a short time already has a significant effect on the activity of the
catalyst.
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Reusability of Rh-enzymes
The  reusability  of  Rh-enzymes  was  tested  with  SCP-2L  V83C-1-P(para)-Rh.  One
portion  of  the  Rh-enzyme batch  was  used  in  the  hydroformylation  while  the  other
portion of the batch was stored at  4 °C. After the reaction the aqueous phase from
sixteen reactions was combined, filtered, washed and reconcentrated to the same protein
concentration as the portion of the stored batch. It was then reused as catalyst in a new
round of hydroformylation experiments. The Rh-enzyme which had been stored at 4°C
in  the  meantime  was  used  as  catalyst  as  well.  LC-MS analysis  performed  on  both
batches prior to the second round of hydroformylation experiments showed the presence
of  Rh-enzyme in  the  catalyst  solution  which  was  stored while  the  catalyst  solution
which had been used in catalysis  before only contained oxides  of SCP-2L V83C-1-
P(para). The hydroformylation results were in accordance with the LC-MS results. The
reused Rh-enzyme yielded 68%-linear selectivity indicating high quantities of leached
rhodium. The Rh-enzyme which was stored yielded a linear selectivity of 77%. 
This clearly shows that the reusability of the Rh-enzymes is not only limited by the loss
of  Rh-enzyme due to  precipitation  but  also  by a  lower  selectivity,  which  might  be
attributed to oxidation of the phosphine during the workup. 
3.4 Conclusions and future work
The  aqueous  organic  hydroformylation  of  long  chain  1-alkenes  using  different  Rh-
enzymes was investigated in this chapter. The main focus was on Rh-enzymes based on
the SCP-2L scaffold.  The best  Rh-enzyme tested (SCP-2L A100C-1-P(para) showed
rate accelerations of several orders of magnitude in comparison to the corresponding
Rh/TPPTS system. In addition, a high linear selectivity was detected. The actual mode
of action for these Rh-enzymes could not be identified but some potential modes were
excluded: The leaching of either rhodium, or a Rh-P-fragment into the organic phase as
well  as  the  protein  acting  as  an  amphiphile.  The previously envisioned  role  of  the
hydrophobic  tunnel  incorporated  within  the  protein  scaffold  as  a  substrate  rich
environment  which  helps  accelerating  the  reaction  seems possible  but  could  not  be
verified.
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Future work should consider the investigation of a Rh-enzyme based on SCP-2L with a
cysteine mutation neither near or inside the tunnel, nor next to a hydrophobic pocket.
Testing  a  Rh-enzyme  of  such  a  mutant  in  the  hydroformylation  would  determine
whether the hydrophobic tunnel is indeed having the (significant) role in the reaction. It
might  also  be  worthwhile  to  investigate  the  (potential)  formation  of  micelles  under
hydroformylation conditions in the presence of Rh-enzymes by light scattering.
If further studies on SCP-2L based catalysts  are performed it  will  be worthwhile to
address the stability of the protein. Besides time consuming biological approaches it
might  be  feasible  to  address  the  mechanical  disturbance  by  stirring.  This  was
determined as the major factor causing protein precipitation. It might be worthwhile to
investigate the stability of the Rh-enzymes when shaking instead of stirring. In case they
are  more  stable  under  these  conditions  the  general  hydroformylation  setup  can  be
adjusted. In order to evaluate whether the tunnel within SCP-2L is playing any role in
the most straightforward is the use of a new mutant, in which the introduced cysteine is
not in proximity to either end of the tunnel.
132
3.5 Experimental
Protein expression, purification and modification
Protein expression and purification was performed as described in chapter 2.
Protein  modification,  synthesis  of  Rh-enzymes  and  the  analysis  of  (un)modified
proteins was performed as described in chapter 2.
ICP-MS
The  rhodium  and  phosphorous  concentrations  of  the  organic  phase  after
hydroformylation as well as the rhodium concentration in the aqueous solution before
the hydroformylation were determined by ICP-MS (see chapter 2 for more details).
GC
A CE instrument GC8000 top equipped with a AS800 autosampler was used for GC
analysis. The conversion of the 1-alkenes was determined by using calibrations of the
linear  aldehydes  (heptanal,  nonanal,  undecanal,  tridecanal,  nonadecanal)  against  the
internal standards heptane and diphenylether. The calibrations obtained were used for
both  the  linear  and  the  corresponding  branched  aldehydes.  Chirality  of  the  2-
Phenylpropionaldehyde was analysed by GC using a Supelco β-DEX 225 column.[58]
MALDI-TOF
MALDI-TOF analysis of the Rh-enzyme was performed by Dr. Catherine Botting on an
ABSciex 4800 MALDI TOF/TOF Analyser 
Calculation of the activity differences between Rh/TPPTS and Rh-enzymes
The rate constants for the aqueous biphasic conversion of 1-octene and 1-decene at
125°C, 80 bar of syn gas and a rhodium concentration of 300-400 ppm are literature
known[59] (p. 394 within the reference). The rate constant for 1-octene is 4.6*10-4 min.-1,
the one for 1-decene is 1.50*10-4 min.-1. The literature known rate constants at the given
temperature  can  be  used  to  calculate  the  (approximate)  rate  constant  at  a  different
temperature.
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The rate constant (r) for any reaction can be written as (Eq. 1)
Eq. (1):
where A is the pre-exponential factor, EA the activation energy, R the gas constant and T
the temperature. The ratio of two different rate constants r1 and r2 for the same reaction
but different temperatures (T1 and T2) can be written as (Eq. 2)
Eq. (2):
which can be rewritten as Eq. 3:
Eq. (3):
The literature known rate constants at 125°C for Rh/TPPTS are used to calculate the
rate constant at 35°C (as this was the operating temperature of the Rh-enzymes) using
Eq. (3). The activation energy of 1-dodecene for the Rh/TPPTS system was determined
as  62-73  kJ/mol.[60] The  same  activation  energy  will  be  used  for  the  subsequent
calculations regarding 1-octene and 1-decene. 
Eq.  (3)  is  used  to  calculate  the  ratio  between  rate  constants  at  T1=398.15K  and
T2=308.15K. 8.314 Jmol-1K-1 is used for the gas constant R. When an activation energy
of 62000 J/mol (lower limit) is used the rate constant at 308.15K (35°C) is a factor 237
smaller than the rate constant at 398.15K (125 °C). When an activation energy of 73000
kJ/mol (upper limit) is used the rate constant at 35 °C is by a factor of 627 smaller. 
The reaction rate of the hydroformylation is first order in the concentrations of both
rhodium and 1-alkene. It is also of a negative first order in the concentration of CO.
While the 1-alkene concentration and the CO concentration (as well as the hydrogen
concentration) are the same for the literature process and the Rh-enzymes the rhodium
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concentration is much smaller in case of the Rh-enzymes. To compare the two systems
this has to be taken into account. As already mentioned the rhodium concentration in the
Rh/TPPTS system was between 300-400 ppm. When SCP-2L A100C-1-P(para)-Rh was
used as catalyst rhodium concentrations of  ≈ 46 nanomol*mL-1 are used (see table 4).
This  corresponds  to  ≈  4.7  ppm Rh.  The  rhodium concentration  in  the  Rh/TPPTS-
literature-system is therefore by a factor of 64 to 85 higher. As mentioned the reaction
rate of the hydroformylation is 1st order in rhodium concentration, therefore the reaction
rates of the literature Rh/TPPTS system need to be reduced by a factor 64 to 85 to
account for its higher rhodium concentration.
Multiplying the factor of the higher temperature (factor 237 to factor 627) with the
factor for the higher rhodium concentration (factor 64 to factor 85) does yield the factor
by which the Rh/TPPTS system has to be reduced in order to compare it with the Rh-
enzyme. This factor is between ≈15000 to ≈53000. After multiplication of the literature
given rate constants [min.-1] by 60 the rate constant per hour [h-1] is obtained. This value
is corrected for both the higher temperature and the higher rhodium concentration by
division  through  15000 (lower  limit)  or  53000 (upper  limit)  and the  corrected  rate
constants are obtained:
rate constant (Rh/TPPTS at 35°C, 4.7 ppm Rh, 1-octene, h-1) = 5.2*10-7 to 1.8*10-6
rate constant (Rh/TPPTS at 35°C, 4.7 ppm Rh, 1-decene, h-1) = 1.7*10-7 to 6.0*10-7
When  Rh-enzymes  are  used  as  hydroformylation  catalysts  in  this  thesis  the
concentration of 1-alkene can be considered as constant as only marginal quantities are
converted. The other relevant factors stay constant as well. Therefore the values above
can be compared with the TON obtained when any Rh-enzyme was used as catalyst. As
an example the data for the hydroformylation of 1-octene and 1-decene with SCP-2L
A100C-1-P(para)-Rh  as  catalyst  is  used  (see  table  4).  The  TON  listed  in  table  4
correspond to a reaction time of 48h. After dividing these values by 48 the TOF [h-1] is
obtained. 
TOF (SCP-2L A100C-1-P(para)-Rh at 35°C, 4.7 ppm, 1-octene, h-1) = 8.5
TOF (SCP-2L A100C-1-P(para)-Rh at 35°C, 4.7 ppm, 1-octene, 48h-1 ) = 2.8
When these values for the Rh-enzyme are compared to the values calculated for the
Rh/TPPTS-system the  activity of  (this)  Rh-enzyme is  (at  least)  106 higher  than  the
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Rh/TPPTS system under similar reaction conditions.
Standard Hydroformylation setup and conditions for aqueous biphasic reactions
This setup and conditions were used unless stated otherwise.
Hydroformylation reactions were carried out in stainless steel autoclaves (up to two
simultaneously) containing up to eight glass reaction vials (volume of approximately 5
mL) each. The reaction vials were equipped with mini stirring bars as well as a septum
cap pierced with a needle in order to allow contact with the reaction gases and labelled.
The so prepared vials were placed in the autoclave which was flushed three times with
>20 bar argon before adding the chemicals. While charging the vials a positive argon
pressure was maintained by placing a tube with constant argon flow into the bottom of
the autoclave and switching off the suction of the fumehood. 0.5 mL of an aqueous
solution (20 mM MES, 50 mM NaCl, pH=6, in case of PYP based Rh-enzymes pH=7
was used) containing the Rh-enzyme was added to each vial. An aliquot was used to
determine the protein concentration by Bradford assay. A Protein-1-P:Rh ratio of about
1.5-4 was aimed for (the actual concentration and ratio was only determined once the
Rh-ICP data was known, which was in general months after the actual experiment). 0.5
mL organic solution consisting of the 1-alkene (or 1-alkene mixtures), 9% (v/v) heptane
and 1% (v/v) diphenylether as internal standard freshly filtered over silica to remove
peroxides was added. In case of competitive binding experiments stock solution of the
competitive binder in the appropriate (filtered) 1-alkene containing internal standards
were used instead (in case of pyrene decanoic acid 40 µL methanol were added as well).
Unless stated otherwise experiments were run in quadruple. An aliquot of the catalytic
solution  was  withdrawn  for  ICP-MS  analysis  to  determine  the  actual  rhodium
concentration used in the experiment. After charging the vials the suction was switched
back  on  and  the  autoclave  was  flushed  three  times  with  >20  bar  of  syn  gas  and
subsequently  charged  to  the  desired  pressure  (80  bar  of  syn  gas  in  general).  The
autoclave  was  then  placed  into  an  oil  bath  which  was  preheated  to  the  desired
temperature (35 °C in general) and preset to the desired stirring speed (625 rpm). After
the reaction time (48 h in general) the reaction was stopped by putting the autoclave on
ice and slowly releasing the pressure. The organic phase was either filtered over a small
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plug of silica before GC analysis or not filtered and analysed by ICP-MS to determine
its rhodium content.
Hydroformylation using Rh/TPPTS
2.4 mg (9.4 µmol) Rh(acac)(CO)2 and 183 mg (285 µmol, 30 eq) TPPTS * 3 Na * 4 H20
were dissolved in 18 mL distilled and degassed methanol at room temperature for 8
days. The solvent was removed and the solid redissolved in 11.0 mL degassed buffer
(20  mM MES,  50  mM NaCl,  pH =  6)  and used  as  aqueous  catalyst  solution.  261
nanomol Rh per reaction vial using the standard hydroformylation setup outlined above.
Hydroformylation using Rh(acac)(CO)2 / Phosphinoaldehydes
In  a  glove  box  sixteen  small  glass  vials  were  equipped  with  stirring  bars.  The
appropriate  amounts of Rh(acac)(CO)2 and the phosphinoaldehyde were added from
stock solutions (mixtures of freshly filtered 1-octene and internal standard (9 volume-%
heptane, 1 volume-% diphenylether)). All reaction vials were topped up with a mixture
of 1-octene containing internal standard to a total volume of 400 µL. Two autoclaves
were flushed three times with argon (>20 bar). The vials were sealed and transferred to
the autoclaves. The lid of each vial was pierced with a needle to allow contact with the
syn gas.  The autoclaves  were carefully flushed three times with syn gas  (>20 bar),
pressurised to 80 bar and put in a preheated oilbath (35 °C). The reaction was stirred at
625 rpm and stopped after 41h 15 min. by putting the autoclaves on ice and slowly
releasing the pressure.
Experimental details on table 6 (rhodium & phosphorous content in the organic
phase after hydroformylation).
The organic phase was analysed for Rhodium after standard hydroformylation settings
by ICP-MS. Different  Rh-enzymes  and different  1-alkenes  were used.  The rhodium
content in the aqueous phase before the reaction was determined by ICP-MS as well.
Protein  concentration  before  the  reaction  was  determined  by  Bradford  assay.  The
rhodium content (unit is "ppb") in the organic phase after the reaction as determined by
ICP-MS. Additionally the 1-alkene and the initial modified protein to rhodium ratios are
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given. Due to evaporation of the organic phase between submission and measurement of
the samples (matter  of  several  months)  the rhodium concentrations  listed below are
most likely significantly higher than in the initial volume especially for the shortest 1-
alkene 1-octene (due to evaporation over this  period of time). The phosphorous and
rhodium concentrations  in  the organic phase before the reaction (=blanks) were not
determined.
SCP-2L A100C-1-P(para)-Rh: SCP-2L A100C-1-P(para) : Rh = 1.5; 23.0 nanomol Rh
per vial (before the reaction).
Rh [ppb] (in the organic phase after the reaction): 1-octene: 66.6; 89.8; 1-decene: 249.9;
1-dodecene: 178.4; 1-octadecene: 150.7; 94.9.
P [ppb] (in the organic phase after the reaction): 1-octene: 89.8
SCP-2L A100C-1-P(ortho)-Rh: SCP-2L A100C-1-P(ortho) : Rh = 3.5; 26.9 nanomol Rh
per vial (before the reaction).
Rh [ppb] (in the organic phase after the reaction): 1-octene: 16.1; 1-dodecene: 14.1
P [ppb] (in the organic phase after the reaction): 1-octene: 16.1
SCP-2L A100C-1-P(meta)-Rh: SCP-2L A100C-1-P(meta) : Rh = 2.2; 37.7 nanomol Rh
per vial (before the reaction).
Rh [ppb] (in the organic phase after the reaction): 1-octene: 156.6; 1-dodecene: 315.3; 
1-octadecene: 2.7
P [ppb] (in the organic phase after the reaction): 1-octene: 156.6
SCP-2L V83C-1-P(para)-Rh: SCP-2L V83C-1-P(para) : Rh = 3.0; 46.6 nanomol Rh per
vial (before the reaction).
Rh [ppb] (in the organic phase after the reaction): 1-octene: 25.2; 42.4; 1-decene: 19.2; 
1-dodecene: 27.1; 1-octadecene: 3.9; 11.6.
P [ppb] (in the organic phase after the reaction): 1-octene: 42.4; 1-octadecene: 11.6
SCP-2L V83C-1-P(ortho)-Rh: SCP-2L V83C-1-P(ortho) : Rh = 5.8; 30.9 nanomol Rh
per vial (before the reaction).
Rh [ppb] (in the organic phase after the reaction): 1-octene: 26.1; 59.3
P [ppb] (in the organic phase after the reaction): 1-octene: 59.3
SCP-2L V83C-1-P(meta)-Rh: SCP-2L V83C-1-P(meta) : Rh = 1.8; 99.1 nanomol Rh
per vial (before the reaction).
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Rh [ppb] (in the organic phase after the reaction): 1-octene: 179.7; 201.0; 1-decene: 
440.9; 1-dodecene: 344.6; 1-octadecene: 137.8.
P [ppb] (in the organic phase after the reaction): 1-octene: 201.0
Experimental details on hydroformylations using Rh-eznymes based on Lysozyme
Lysozyme-(1)x-P(para)-Rh: Protein :  Rh = 2.0;  58.67 nanomol Rh per vial.  Stopped
after 20h reaction time. Four reactions on each of the following 1-alkenes: 1-octene, 1-
decene, 1-dodecene and 1-octadecene.
Lysozyme-(1)x-P(meta)-Rh: Protein :  Rh = 1.8; 99.12 nanomol Rh per vial.  Stopped
after  24h  and  35  min.  Due  to  the  previous  results  involving  Lysozyme  based  Rh-
enzymes hydroformylation was only tested on 1-octene (four reactions)
Lysozyme-(1)x-P(ortho)-Rh: Protein : Rh = 2.0; 76.944 nanomol Rh per vial. Due to the
previous  results  involving Lysozyme based  Rh-enzymes  hydroformylation  was  only
tested on 1-octene (four reactions). Stopped after 20h and 10 min. 
Lysozyme-(1)x-Rh: Protein : Rh = 2.0; 73.14 nanomol Rh per vial. Due to the previous
results involving Lysozyme based Rh-enzymes hydroformylation was only tested on 1-
octene (four reactions). Stopped after 20h and 10 min. 
Hydroformylation of styrene using SCP-2L A100C-1-P(para)-Rh
Standard hydroformylation conditions were used. SCP-2L A100C-1-P(para) : Rh = 2.0.
48.08 nanomol rhodium per reaction vial.  Styrene was freshly filtered over alumina.
Four experiments using neat styrene and four experiments using 0.5 mL of a mixture
containing 2.7 mL styrene and 3 µL diphenylether were used. 
Hydroformylation of styrene using SCP-2L V83C-1-P(para)-Rh
Standard hydroformylation conditions were used. SCP-2L V83C-1-P(para) : Rh = 5.9.
45.67 nanomol rhodium per reaction vial.  Styrene was freshly filtered over alumina.
Four experiments using neat styrene and three experiments using 0.5 mL of a mixture
containing 2.7 mL styrene and 3 µL diphenylether were used. 
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Hydroformylation of 1-alkene mixtures using SCP-2L V83C-1-P(para)-Rh
Two  seperate  set  of  reactions  (using  the  general  hydroformylation  setup)  were
performed in order to obtain data for this setup. Both yielded inconclusive results. The
two settings used were:
1) SCP-2L V83C-1-P(para) : Rh  ≥ 1.1. Maximum of 150 nanomol rhodium per
reaction vial, not determined by ICP-MS. The equimolar 1-alkene mixtures were
prepared  just  prior  to  the  reaction  using  stocks  of  the  freshly  filtered  (over
alumina) corresponding 1-alkene (containing internal standard).
2) SCP-2L V83C-1-P(para) : Rh  ≥ 1.2. Maximum of 145 nanomol rhodium per
reaction vial, not determined by ICP-MS. The equimolar 1-alkene mixtures were
prepared  just  prior  to  the  reaction  using  stocks  of  the  freshly  filtered  (over
alumina) corresponding 1-alkene (containing internal standard).
Hydroformylation of diluted 1-octene (in THF) using SCP-2L V83C-1-P(para)-Rh
Two seperate set of set of reactions (using the general hydroformylation setup) were
performed. Both yielded inconclusive results. The two settings used were:
1) SCP-2L V83C-1-P(para) : Rh ≥ 1.2. Maximum of 150 nanomol Rh per reaction
vial. Actual rhodium concentration not determined by ICP-MS. 
1-octene is filtered over activated alumina and the following two mixtures are
prepared  and  used  in  hydroformylation  experiments:  1)  7.2  µL  1-octene
dissolved in 1.5 mL THF. 2) 72 µL 1-octene dissolved in 1.5 mL THF. Each
mixture was tested in dublicate.
2) SCP-2L V83C-1-P(para) : Rh = 11.0. 10.94 nanomol Rh per reaction vial. 
To 1.5 mL 1-octene & internal standard 3.5 mL THF was added. Instead of 0.5
mL organic solvent the following volumes were added to the individual reaction
vial (each mixture tested in quadruple): 3 µL, 6 µL, 9 µL, 12 µL.
Recycling of Rh-enzymes
Hydroformylation of 1-octene using SCP-2L V83C-1-P(para)-Rh: Reusability 
experiment.
SCP-2L V83C-1-P(para) : Rh  ≥ 2.0. Maximum of 150 nanomol Rh per reaction vial.
140
Actual rhodium concentration not determined by ICP-MS. Standard hydroformylation
setup was performed using sixteen vials while some of the Rh-enzyme was stored in a
Schlenk at 4 °C in the meantime. After the reaction the aqueous phase of the sixteen
vials was combined, the solid removed by centrifugation and filtration,  washed, and
concentrated to a protein concentration of 8.8 mg/mL and used as new catalyst in 3
reaction vials. The Rh-enzyme which had been stored was centrifuged and filtered to
remove  precipitated  protein,  washed  and  concentrated  to  8.8  mg/mL and  used  as
catalyst  in four reaction vials.  The reused catalyst  had about half  the activity of the
stored catalyst and a % linear selectivity of about 68% was observed. The stored Rh-
enzyme resulted in a % linear selectivity of about 77%.
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Chapter  4:  Artificial  metalloenzymes  in  the  Diels-Alder
reaction
4.1 Abstract
The catalytic performance of artificial metalloenzymes was tested in the asymmetric
Diels-Alder (DA)-reaction between cyclopentadiene (Cp) and 2-azachalcone. Artificial
cobalt-, copper- and nickel-enzymes based on the SCP-2L A100C mutant modified with
either  a  phenanthroline-based (Phen)  or a  dipicolylamine-based (Picol)  moiety were
used. The copper and cobalt enzymes hardly influence the reaction in comparison to the
corresponding free metal catalysed reactions. The nickel-enzymes have an influence on
the endo/exo ratio in either way depending on the protein scaffold used. Additionally,
while most tested catalysts showed no - or hardly any - enantioselectivity 13% ee of the
endo and 29% ee of the exo product was observed when the reaction was catalysed with
the Ni-enzyme of the Phen-modified protein.
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4.2 Introduction
Diels-Alder reaction
The Diels-Alder (DA) reaction is named after the two German chemists Otto Diels and
Kurt Alder who were not the first to discover the reaction,[1,2] but realised its importance
and investigated it in great detail from the late 1920s onwards. They were awarded the
Nobel Prize in 1950 "for their discovery and development of the diene synthesis"[3] as
the DA reaction was referred to in the beginning. 
The DA reaction is a [4+2] cycloaddition between a conjugated diene and a dienophile
(usually a monoene, but an alkyne is possible as well) forming a six membered ring -
the DA-adduct - in a concerted reaction.[2] The reaction is depicted in scheme 1.
Scheme 1: Schematic representation of the DA-reaction with concerted transition 
state(s) (TS).
The versatility of the DA-reaction is indicated in the scheme above. As hetero atoms
and substituents are allowed at any of the positions (A-F) two different  regioisomers
(DA-adduct I and DA-adduct II) can be obtained. If one (or more) of the involved atoms
is a non carbon atom the reaction is considered a hetero Diels-Alder reaction and a
heterocycle is obtained. If substituents are present  up to four new stereogenic centres
can be introduced in a single Diels-Alder reaction. The DA-reaction is stereospecific,
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which means that conformations of the reacting double bonds are fully retained in the
adduct. This observation was recognised very early and described as the "cis-principle".
[4]
The DA-adduct  can form either  the "endo" or the "exo"-adduct.  As an example the
reaction between Cp and maleic anhydride is depicted in scheme 2.
Scheme 2: DA-reaction between Cp and maleic anhydride. Product distribution taken 
from[5]
The thermodynamically less stable "endo" product is the major product in most DA-
reactions. ([6,7] are  examples  for  exo-selective  DA-reaction).  The  experimental
observation  was  rationalised  with  the  frontier  molecular  orbital  (FMO)-theory.  The
FMO diagram for a normal electron demand DA reaction is depicted in figure 1. It
shows the interaction of the HOMO of a diene with the LUMO of a dienophile.
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Fig. 1: Orbital correlation diagram for a normal DA reaction with with an electron rich
diene and an electron poor dienophile.[2]
The preference of the endo-DS-adduct can be rationalised by taking secondary orbital
interactions into account (see fig. 2)
Fig. 2: Transition states (TS) of the reaction between Cp and maleic anhydride. Dashed
lines represent interactions.
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While  the  exo-TS  only  exhibits  primary  orbital  interactions  the  endo-TS  exhibits
additional secondary orbital interactions. 
Biochemical approaches to catalyse the Diels-Alder reaction
As the DA reaction is an important tool in synthetic chemistry, especially in the total
synthesis of natural compounds.[1,9–11] it was proposed that enzymes catalysing the DA
reaction (so called "Diels-Alderases") play an important role in their biosynthesis as
well[12–15]. But so far only five potential Diels-Alderases have been discovered. [16] The
biochemical approaches towards DA-catalysis will be briefly introduced.
The first RNA based Diels-Alderase was discovered in 1997 by in vitro selection of a
large library (~1014) of unique RNA sequences.[17] While one of the reactants is usually
covalently  tethered  to  RNA  (usually  via  a  polyethylene  glycol  linker[17–21])  RNA
sequences were successfully used to catalyse the reaction between untethered reactants.
[20] The  RNA sequences  tested  might  contain  unnatural  RNA to  furnish  additional
hydrophobic and dipolar interactions as well as to provide additional metal coordination
sites.[17] An increase in the reaction rate by up to four orders of magnitude[18] and up to
95% ee[20] was observed using this sort of catalysts.
The first antibody catalysed DA reaction was published in 1989.[22] In order to obtain an
antibody which is (theoretically) capable of catalysing a specific DA reaction a TS-
analogue of this reaction is needed. While most approaches use rigid TS-analogues[22–26]
it  was found that flexible ones can be successfully used, as well.[27] The synthesised
analogue is transferred into a hapten, coupled to an appropriate immunogenic protein
and used to  immunise a host  (mice in  general).  Up to 95% ee was observed using
antibodies as catalysts in a DA reaction[27] showing the potential of this approach.
DNA-based  catalysts  ("DNAzymes")  have  been  successfully  tested  in  various  DA
reactions.  The catalytically  active  Cu(II)  is  brought  into  close  proximity to  a  DNA
sequence  by  covalent  modification  of  DNA with  an  appropriate  ligand  or  by  non
covalent means.[28] Both the DNA-sequence[29] as well as the coordinating ligand[30] play
an important role in the outcome of the reaction. The DNA is not only acting as an
effective chiral scaffold yielding up to 99% ee[31] but rate accelerations of up to two
orders of magnitude were observed as well.[31] The re-usability of this type of catalysts
148
was shown for solid supported DNA and only a slight decrease in ee was observed
during ten consecutive runs indicating the stability of such DNAzymes.[32]
Copper(II) coordinating to polypeptides,[33] artificial metalloenzymes[11,34–37] or artificial
Diels-Alderase[38,39] have been successfully tested as catalysts for the DA reaction. The
metal  is  either  coordinated  to  an  appropriate  ligand  which  is  covalently  or  non-
covalently  bound  to  the  scaffold  or  directly  coordinated  to  the  amino  acids  of  the
scaffold. High ee values obtained for different substrates show the versatility of such an
approach. 
Diels-Alder reaction between Cp and 2-azachalcone 
The reaction between Cp and 2-azachalcone, which was investigated in this thesis has
been widely tested for different bio-inspired approaches based on DNAzymes[28–32,40–50],
artificial metalloenzymes[34–37,51,52] and polypeptides[33] using copper(II) as active metal
centre.  From this background this reaction can be regarded as a benchmark for bio-
inspired catalysis. Up to 99.4% ee[28,31] and endo/exo ratios ranging from 1.7 to 24[37]
have been reported  for  this  reaction.  Although copper(II)  is  more  active  than  other
transition metals it is known that nickel(II) and cobalt(II) can be used as catalysts as
well.[2] In this chapter the performance of copper(II)-bound artificial metalloenzymes
will be compared with the respective nickel(II)-, and cobalt(II)- derivatives.
The water insolubility of the substrates makes them perfect candidates to analyse the
effect  of  the  protein  scaffold  in  catalysis.  Additionally  the  results  obtained  can  be
compared  with  the  many  results  published  earlier  to  put  the  results  obtained  into
persepctive. 
The mechanism proposed for the metal catalyzed DA-reaction is shown in scheme 3.
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Scheme 3: Proposed mechanism  the  metal catalyzed DA-reaction between Cp and
trans-azachalcone.[2]
 
First  the (ligated)  metal  is  coordinating to both the nitrogen and the oxygen of  the
azachalcone,  decreasing  the  energy of  the  LUMO of  the  adjacent  double  bond and
therefore activating it for the cycloaddition. The cycloaddition takes place in the next
step when a molecule of Cp enters the cycle. In the last step the DA-adduct is released
and the (ligated) metal can start the cycle all over again. Four different products (two
endo and two exo) are formed.
150
M2+
N
O
N
O
O
N
H
H
H
H
O
N N
O
H
H
(R, R) exo (S, S)
O
N N
O
H
H
(R, R) endo (S, S) N N
M2+
N N
M2+
N N
4.3 Results and Discussion
Protein modification
For the catalysis of the DA reaction two modifications of the protein SCP-2L A100C
were used. In either modification nitrogen containing ligands were attached to the thiol
groups. The  N-Ligands used are based on the bidentate phenanthroline-like structure
(Phen)  or  the  tridentate  dipicolylamine-based  structure  (Picol).  For  both  N-ligands
tested, the synthesis of these ligands as well as the modification of the two SCP-2L
mutants was found to be straightforward.[52] The scheme for the modification of SCP-2L
A100C was introduced in chapter 2 and is depicted in scheme 4. 
Scheme. 4: Protein modification scheme and N-donor-ligands used in this chapter.
Metal coordination
The capability of the (un)modified protein to coordinate to various metals was already
discussed in chapter 2. In table 1 the metal contents of the unmodified SCP-2LA100C
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are compared with the metal contents of the  Picol and  Phen-modified derivatives. It
should be mentioned that the metal contents given in table 1 were determined after
extensive washing. The data summarized in table 1 will be used for the discussion of the
catalytic results. 
Table 1: Metal loading of SCP-2L A100C, SCP-2L A100C-Picol  and SCP-2L A100C-
Phen after the addition of of Cu, Ni and Co and after extensive washinga
a: To 0.1 µmol protein (in 20 mM MES, 50 mM NaCl, pH=6) 2-3 eq. of metal salt were added, reaction time
1 day. Buffer exchanged to 20 mM NH4OAc, pH=6 and a fifth was removed for LC-MS analysis. 4µL from
an EDTA stock solution (0.5 M, pH = 8) was added to the rest. The mixture was buffer exchanged (using
20 mM NH4OAc, pH = 6) and the flow through collected. This was repeated three times. The fractions were
combined, concentrated to dryness, topped up with water to a known total volume (1.00 mL) and the metal
content  determined  by  ICP-MS.  See  experimental  section  in  Chapter  2  for  all  details.  b:  n(metal)  /
n(Protein), corrected for the 1/5th removed for ESI-MS analysis; 50% corresponds to 0.5 mol metal per 1
mol (un)modified protein, 100% corresponds to 1 mol metal per 1 mol (un)modified protein and so on. All
details are described in the experimental section in chapter 2.
Based on the metal loading listed in table 1 it can be stated that unmodified SCP-2L
A100C has a higher complexation affinity to Cu(II) and a lower to Ni(II) and Co(II)
than  the  modified  derivatives  SCP-2L A100C-Picol and  SCP-2L  A100C-Phen.  In
addition,  it  can  be  derived  from  table  1  that  SCP-2L  A100C-Phen has  a  higher
complexation  affinity  to  the  tested  metals  salts  than  SCP-2L  A100C-Picol.  After
extensive washing the residual metal contents of SCP-2L A100C-Phen are almost four
times higher regarding Cu(II), roughly 50% higher for Ni(II) and more than nine times
higher  for  Co(II)  than  the  corresponding  metal  contents  of  SCP-2L  A100C-Picol.
Therefore it  can be expected that the metal derivatives of the SCP-2L A100C-Phen
scaffold will show much more pronounced catalytic effects than the respective SCP-2L
A100C-Picol scaffolds. 
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Protein scaffold
SCP-2L A100C
entry metal salt
1 66.3 5.8 22.9
2 6.4 7.8 11.1
3 2.5 2.9 26.8
SCP-2L A100C-Picol SCP-2L A100C-Phen
% metal loadingb % metal loadingb % metal loadingb 
Cu(OAc)
2
Ni(OAc)
2
Co(OAc)
2
Catalytic reactions
The catalytic results for the tested DA reaction are listed in table 2. 
Table  2:  Diels-Alder  reaction  between  2-azachalcone  and  Cp  in  the  presence  of
different catalystsa
a: 50 nmol of (unmodified) protein, 45 nmol of metal(II)nitrate, 0.5 µmol azachalcone and 15 µmol Cp in
0.8 mL buffer (20 mM MES, 50 mM NaCl, pH = 6). Shaken for 72h at 4 °C b: determined by HPLC, see
experimental section for details, standard deviations in brackets c: In case of ee: The first enantiomer to
elute was in excess, "-" means no ee was detected d: number of experiments e: not determined
Metal catalysed reactions (entries 1-4)
In a first set of control reactions (entries 1-3) the Diels-Alder reaction was performed in
the presence of one of the metal(II)-nitrates (Ni, Co and Cu). Also the reference reaction
without metals was performed in this context  (entries 4).  The conversion follows the
trend Cu>Ni>>Co. The Cu(II) catalysed reaction reaches almost full conversion (91%).
Ni(II)-catalysis yields 80% and Co(II) catalysis about 40% conversion. The conversion
of the uncatalysed reaction was not determined but is known to be low (≈10%) under
these conditions.[35]
The endo/exo ratio follows the trend Cu>>Co>Ni>blank. The Cu(II) catalysed reaction
gives a ratio of 13.4, the Co(II) catalysed a ratio of 8.1, the Ni(II) catalysed one a ratio
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Entry catalyst
1 Ni(II) 84 (±1) 7.4 (±0.2) - - 4
2 Cu(II) 97 (±1) 13.4 (±0.3) - - 3
3 Co(II) 42 (±2) 8.1 (±0.3) - - 3
4 Blank 6.1 (±0.1) - - 4
5 SCP-2L A100C + Ni(II) 91 (±1) 8.7 (±0.2) 4 (±1) 8 (±4) 3
6 SCP-2L A100C + Cu(II) 93 (±0) 13.3 (±0.0) - 4 (±0) 2
7 SCP-2L A100C + Co(II) 55 (±5) 7.6 (±0.1) - - 2
8 78 (±5) 8.5 (±0.6) 3 (±0) 3 (±0) 3
9 98 (±0) 14.2 (±0.4) 3 (±0) 16 (±1) 3
10 35 (±12) 9.7 (±1.2) - - 3
11 92 (±6) 5.4 (±0.1) 13 (±1) 29 (±2) 3
12 79 (±2) 13.3 (±0.5) - 6 (±1) 3
13 33 (±1) 7.0 (±0.7) - - 3
Conversion [%]b endo : exob Endo eeb,c exo eeb,c Nd
n.d.e
SCP-2L A100C-Picol + Ni(II)
SCP-2L A100C-Picol + Cu(II)
SCP-2L A100C-Picol + Co(II)
SCP-2L A100C-Phen + Ni(II)
SCP-2L A100C-Phen + Cu(II)
SCP-2L A100C-Phen + Co(II)
of 7.4 and the uncatalysed one a ratio of 6.1. As expected no enantioselectivity was
observed in these reactions.
Metal catalysis in the presence of unmodified protein (entries 5-7)
In a second set of control reactions the DA-reaction was performed in the presence of
both the unmodified protein SCP-2L A100C as well as one of the metal ions. Compared
to the previous set  of control  reactions the conversions are  similar except  for some
minor  deviations.  A slightly  lower  conversion  for  the  Cu(II)  and  a  slightly  higher
conversions for Ni(II) and Co(II) in the presence of protein compared to the metal(II)
catalysed reactions without protein was detected. The endo/exo ratios are basically the
same except for Ni(II)-catalysis  in the presence of protein which yields a higher ratio
than the free metal catalysed reaction (8.7 compared to 7.4). Interestingly a small ee was
detected for both adducts when Ni(II) was used as catalyst in the presence of the protein
(entry 5) and a small ee was detected for the exo-adduct when Cu(II) was used in the
presence of protein (entry 6).
Metal catalysis in the presence of SCP-2L A100C-  Picol   (entries 8-10)
In a next set of experiments the reaction was performed in the presence of modified
protein  SCP-2L A100C-Picol and  either  one  of  the  metal  salts  (entries  8-10).  The
differences for the actual metalloenzyme in comparison to the unmodified enzyme in
presence of the metal (entries 5-7) in respect of both the conversion and the endo/exo
ratio is in general small. The conversions for the Ni- and the Co-enzyme  are slightly
lower while the conversion of the Cu-enzyme is slightly higher. The endo/exo ratios in
the presence of Cu and Co are slightly higher while it is unchanged in the presence of
Ni when comparing it to either the free metal reactions (entries 1-3) or the reactions in
which unmodified protein was used (entries 5-7). This is in full  agreement with the
expectations  from table 1 as the affinity between SCP-2L A100C-Picol to Ni(II) and
Co(II) is lower than the affinity of unmodified protein to the same metals (see table 1).
Table 1 does show a much stronger interaction between Cu(II) and unmodified SCP-2L
A100C than  between  Cu(II)  and  SCP-2L A100C-Picol therefore  a  more  significant
difference between these two catalytic systems could be expected. As the results are also
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almost  identical  to  the ones obtained when using "free" Cu(II)  it  might  be that  the
quantity of "free" Cu(II) is still rather high when protein is present and this "free" Cu(II)
determines  the  outcome  of  the  reaction  while  the  comparably  small  quantities  of
protein-bound Cu(II) hardly influence it.
When  using  SCP-2L  A100C-Picol-Ni  (entry  8)  a  small  ee  for  both  adducts  was
detected.  The same ee  was  observed when the  unmodified  protein  was used in  the
presence of Ni(II) (entry 5). In case of SCP-2L A100C-Picol-Cu (entry 9) a small ee
could be detected for the endo-adduct and a quite significant ee was detected for the
exo-adduct. When unmodified SCP-2L A100C and Cu(II) was used as catalyst no ee
was detected for the endo adduct and only a small ee was found in the exo-adduct (entry
6).
Metal catalysis in the presence of SCP-2L A100C-  Phen   (entries 11-13)
In a next set of experiments the reaction was performed in the presence of modified
protein SCP-2L A100C-Phen and either one of the metal salts (entries 11-13). This set
of  experiments  was  expected  to  be  the  most  promising  (see  table  1)  as  the  metal
loadings are much higher for SCP-2L A100C-Phen than for SCP-2L A100C-Picol and
SCP-2L A100C (SCP-2L A100C + Cu being an exception).
The results obtained for the Cu-enzyme (entry 12) are similar to the ones obtained when
using  Cu(II)  as  catalyst,  although  the  conversion  was  lower  than  in  previous
experiments. Just like in the previous experiment where unmodified protein was present
no ee of the adduct was detected. The results obtained for the Co-enzyme (entry 13 are
similar to the other reactions with Co(II) as catalyst. In case of the Ni-enzyme (entry 11)
a slightly higher  conversion  was detected.  More interesting,  the endo/exo ratio  was
much  lower  than  in  all  previous  reactions  with  Ni(II)  as  catalyst  (entries  1,  5,  8).
Additionally the highest ee for both products was detected (13% ee for the endo) with
this Ni-enzyme as catalyst. The Ni-enzyme was the metalloenzyme in which the highest
concentrations of unligated metal were expected (according to table 1). Nevertheless the
reaction  outcome  indicates  a  high  influence  of  the  artificial  metalloenzyme  which
makes it even more significant.
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Rationalisation of the results 
Regarding the combinations of modified protein and metal, three distinct species, which
probably coexist are possible. Many intermediates of these extremes, as well as non-1:1
coordination might exist but all of these can be described as combinations of the three
systems depicted in fig. 3.
Figure 3: Potential combinations of a modified protein and a metal (II)  [depicted as
M(II)].  The  introduced  N-ligand  is  represented  by  a  "N"  in  a  box.  1:  unspecific
coordination of metal to undefined amino acids (interactions indicated by black lines).
2:  Non protein-coordinated ("free")  metal  3: coordination of  metal  to the introduced
ligand (interactions indicated by black lines).
In the first case depicted in figure 3 the metal is coordinated to amino acids rather than
to the artificially introduced ligand. In the second case no interaction between metal and
protein is present. In the third case the metal is coordinated to the introduced ligand.
Each of these species might show catalytic activity and might yield different products.
As  the  three  species  coexist  it  is  impossible  to  clearly assign  catalytic  results  to  a
distinct species. Therefore only differences in the results of comparative experiments
can be discussed.
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The catalytic results obtained make it seem likely that the outcome of the reaction is
mostly  determined  by free  metal  (figure  3,  species  2).  It  is  also  possible  that  the
difference  in  the  product  distribution  between  protein  coordinated  metal  (figure  3,
species 3) and free metal is small. SCP-2L A100C-Phen has a much higher affinity to
Co(II)  and  Ni(II)  than  SCP-2L  A100C-Picol (see  table  1)  and  results  in  lower
conversions. This might be explained by a reduced activity of the protein bound metal
in comparison to the free metal. SCP-2L A100C-Phen-Ni is the most interesting case.
Its metal loading is comparably low (see table 1) which means high concentrations of
unligated nickel will be present during reaction conditions. Nevertheless the effect on
both the selectivity as well as the enantioselectivity is much more pronounced than for
any other artificial metalloenzyme tested. This means that the protein bound nickel has
to have a high preference for the exo product and must induce a high enantioselectivity
as most of the catalysis must be determined by unligated nickel. 
4.4 Conclusions and future work
The DA-reaction catalysed by Cu(II) in the presence of the protein scaffolds SCP-2L
A100C (Phen  and  Picol modified) and SCP-2L V83C (Phen  and  Picol modified) has
been described in a previous paper.[35] Under the same experimental conditions, catalysis
with SCP-2L A100C (Phen and Picol modified) and Cu(II) yielded similar results as in
this thesis. The ee of the endo-product obtained by copper-enzymes based on the protein
mutant SCP-2L V83C was significantly higher.[35] 
In this work the Ni- and Co-derivatives of the modified proteins have been tested for the
first time. The ee induced by the combination of Ni(II) with SCP-2L A100C-Phen is
much higher than for the Cu(II) and Co(II)-derivatives. From this background it might
be worthwhile to test the Ni-derivative of the SCP-2L V83C-Phen scaffold. In order to
reduce the undesired catalytic reaction of unligated metal its concentration has to be
kept low. This can be achieved by performing catalysis at a high protein to metal ratio.
Low concentrations of unligated metal can also be obtained by the use of preformed and
washed  metalloenzymes  –  which  is  essentially  another  possibility  to  obtain  a  high
protein to metal ratio.
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4.5 Experimental
Equipment, Chemicals and suppliers
The N-ligands used for protein conjugation (Phen[53,54] and Picol[55]) were synthesised by
E.  de  Waard  and  M.  Drysdale  according  to  known  literature  procedures.
Dicyclopentadiene was cracked just before the catalysis. 2-azachalcone was synthesised
according to a literature known procedure.[56]
Protein expression, purification and modification
Protein expression, purification and modification was performed based on the procedure
described in chapter 2. 
Catalysis and analysis
Catalysis and analysis was performed based on a published procedure[35] :
50 nmol of ligand (whereas ligand refers to protein or modified protein) in buffer (20
mM MES, 50 mM NaCl, pH = 6) and 45 nmol of metal(II) nitrate (Cu or Co or Ni) in
the same buffer was mixed in a 1.5 mL Eppendorf tube and topped up with the buffer to
obtain a total volume of 794 µL. It was mixed for 1 h prior to the catalytic reactions.
Protein concentrations were determined just before addition using Bradfords reagent. 2-
azachalcone  (5  µL  from  a  100  mM  solution  in  MeCN)  and  freshly  cracked
cyclopentadiene (1 µL) were added to the reaction mixture. The obtained solution was
shaken for 72 h at 4 °C. The reaction mixtures were extracted 5 times with diethyl ether
(1 mL) and the combined organic layers were dried in vacuo. The obtained solid was
dissolved in a suitable amount of 30% IPA in hexane (HPLC grade). HPLC analysis was
performed by Dr. José Antonio Fuentes García using an OD-H column with a flow of
0.5 mL/min. of 2% IPA in hexanes (retention times: Cp: 6.7 min., exo products 12.7
min. and 14.2 min., endo products 15.8 min. and 20.4 min., azachalcone 22.9 min.). The
chromatogram was obtained by UV analysis at 212 nm and 254 nm. The spectra which
gave the highest absorption values, the sharpest peaks and the most consistent baseline
is used for analysis. The conversion was calculated using the %-area values and are
therefore approximate 
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Chapter 5: Summary, conclusion and outlook
This  thesis  describes  the  synthesis  and  application  of  artificial  metalloenzymes  for
transition metal catalysed reactions not performed by natural enzymes. The artificial
metalloenzyme are based on a concept which is depicted in figure 1.
Fig.  1  Schematic  representation  of  an  ideal  artificial  metalloenzyme  obtained  by
covalent modification.
The figure shows a protein with an active site (a hydrophobic tunnel) which is capable
to bind the desired apolar substrate (1-octene as an example). At a well defined site of
the protein a ligand with a high affinity to a transition metal is covalently introduced.
For the method used in this thesis a unique cysteine needs to be present at the desired
position  to  obtain  such  a  species.  The  introduction  of  a  unique  amino  acid  at  any
position  is  a  standard  procedure  in  molecular  biology.  Finally,  a  transition  metal  is
coordinated  to  this  ligand.  As  the  modification  is  located  near  the  active  site,  the
introduced  metal  is  in  close  proximity  to  the  substrate.  Due  to  high  substrate
concentrations within the tunnel next to the transition metal rate enhancements should
be observed. In addition,  the protein environment should induce (enantio)selectivity.
162
The  advantage  of  such  an  approach  is  that  virtually  any  protein  scaffold  and  any
transition  metal  can  be  used.  Additionally,  the  artificial  metalloenzymes  can  be
optimised  by  both  chemical-  (e.g.  choice  of  metal  and  ligand  structure)  and
biomolecular tools (e.g. optimisation of protein environment).
The main focus of the research was on the protein SCP-2L two mutants of which were
used (SCP-2L A100C and SCP-2L V83C). Both mutants have a tunnel and bear the
cysteine at opposite ends of the the tunnel. The two mutants were covalently modified
with  N- or  P-ligands to introduce suitable binding sites for transition metals. The  N-
ligands  were  based  on  1,10-phenanthroline  (Phen)-  or  di-(2-picolyl)amine)  (Picol)-
entities, whereas the P-ligands were based on triphenylphosphine derivatives (fig.2).
Fig. 2 Overview of the phosphine- and N-ligands used in the thesis.
As any modification of a natural enzyme has an impact on its tertiary structure it would
have  been  ideal  to  determine  crystal  structures  of  the  artificial  metalloenzymes  to
elucidate the protein environment next to the transition metal. This knowledge would
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make it possible to fine-tune the active site by biological or chemical means in respect
to its substrate- or metal coordination.  It would have been almost as convenient but
much more feasible to obtain crystal structures of the ligand modified proteins and use
this structure to model the artificial metalloenzymes. It is also of utmost importance to
determine the binding capabilities of artificial metalloenzymes before testing them in
catalytic reactions. An artificial metalloenzyme with a small binding capability towards
a metal is an undesired catalyst as a comparably high concentration of unligated metal
would  be  present  in  solution.  This  unligated  metal  could  outperform  the  catalytic
activity of the artificial metalloenzyme itself which would make it impossible to draw
any conclusions on the performance of the artificial metalloenzyme.
The topics of Chapter 2 are crystal structures and metal binding. The topic of chapter 3
is  the  catalytic  performance  of  phosphine  modified  enzymes  in  the  biphasic
hydroformylation of long chain 1-alkenes.  In chapter 4 the catalytic performance of
Ni(II), Cu(II) and Co(II)-enzymes of  N-ligand modified SCP-2L A100C in the Diels-
Alder reaction between cyclopentadiene and trans-azachalcone is investigated.
In Chapter 2 the crystal structure of the unmodified SCP-2L A100C is discussed. The
crystal structure shows that in comparison with its wild type the mutation has hardly
any influence on the overall structure and the electrostatic surface potential and only a
small effect on the structure of the tunnel. Unfortunately crystal structures of modified
proteins could not be obtained. 
By the addition of metal salts to the ligand modified proteins artificial metalloenzymes
were obtained. For an evaluation of their catalytic capability the interaction of the ligand
modified proteins towards different metal salts was investigated by ESI-MS and ICP-
MS. It was found that the Picol-modified SCP-2L mutants are promising scaffolds for
Pd(II)-enzymes  while  Phen-modified  SCP-2L  mutants  are  promising  scaffolds  for
Pd(II)-, Cu(II),- Co(II) and Ni(II)-enzymes.
Phosphine modified SCP-2L V83C was found to be a suitable scaffold for Rh-enzymes
regardless of the phosphine introduced. In case of phosphine modified SCP-2L A100C
the P(para) modified protein is the most promising scaffold. PYP R52G-1-P(para) was
also identified as a promising Rh-scaffold. Additionally SCP-2L A100C-1-P(para) was
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found to be a promising scaffold for Ir-enzymes. 
In Chapter 3 the previously synthesised Rh-enzymes are tested in the aqueous-organic
biphasic hydroformylation of long chain 1-alkenes (see scheme 1). 
Scheme 1: Hydroformylation of 1-alkene.
SCP-2L  A100C  and  SCP-2L  V83C  modified  with  either  of  the  three  different
phosphines were used as scaffold. The activity follows the following trends:
• In comparison with the known Rh/TPPTS catalyst system the Rh-enzymes were
found to be several orders of magnitude more active than the reference while
yielding comparable selectivities. 
• artificial metalloenzymes based on SCP-2L A100C have a higher activity than
SCP-2L V83C based ones.
• The activity of the phosphine modified proteins showed the following ranking:
P(para) > P(meta) > P(ortho)
• The activity of the substrate is decreasing with increasing chain length.
The linear selectivity is high (≈ 75% linear selectivity) for all Rh-enzymes tested.
In order to rationalise the high activities and selectivities observed the mode of action
was further  investigated.  The actual  mode of  action could not  be determined,  some
could be excluded and the initially envisioned mode of action (see fig. 1) could not be
excluded.
In Chapter 4 N-ligand modified SCP-2L A100C (see fig. 2) was used as scaffold for Ni-,
Cu-  and  Co-enzymes.  The  artificial  metalloenzymes  are  tested  in  the  Diels-Alder
reaction between cyclopentadiene and trans-azachalcone (see scheme 2). 
165
R
H2 / CO
cat. Rh-enzyme
R
RO +
O
linear (l) branched (b)(long chain)
1-alkene
Appendices
Chemicals and supplier
Acetonitrile Aldrich, HPLC grade
Aluminum oxide (neutral) Sigma-Aldrich
Ampicillin Formedium
Argon gas Boc
Benzamidine Acros, 98%
Bradford reagent Sigma-Aldrich
Calcium hydride Acros, 93 %
Carbon monoxide gas Boc
Chloramphenicol Calbiochem
Co(OAc)2 Aldrich, 99.9995%
Cobalt (II) nitrate * 6 H2O BDH, 97-101%
Copper (II) nitrate * 3 H2O Fluka, 99.0-104%
Cu(OAc)2 * H2O Fisons Scientific, >99.0 %
C0mplete EDTA free protease Roche Applied Science
   inhibitor tablets
Dicyclopentadiene Aldrich
Dithiothreitol (DTT) Formedium, 99.5%
Dimethyl formamide (DMF) Acros, >99%
Diphenylether Fluka, 99.9 %
DNase (DNase I from Sigma-Aldrich
   bovine pancreas) 
1-Decene Sigma-Aldrich, 94%
1-Dodecene Sigma-Aldrich, 94%
Ethanol Fisher Scientific, analytical grade
Fe(OAc)2 Aldrich, 95%
Glycerol Sigma-Aldrich, 99%
1-Hexene Fisher Scientific, general purpose grade
Hydrochloric acid Fisher Scientific
Hydrogen gas Boc
Hydrogen peroxide Fisher Scientific, >30% (w/v)
Imidazole Sigma-Aldrich, ≥98.5%
Iodine Fisher Scientific
Ir(acac)(CO)2 Strem, 99%
Isopropyl-1-thio-b-D- Formedium, 99.8%
   galactopyranoside (IPTG)
Kanamycin Formedium
Lysozyme Sigma-Aldrich
   (from chicken egg white) 
Magnesium BDH
3-Maleimidopropionic acid Shanghai Speed Chemicals, >97%
   hydrazide * HCl (linker, 1)
MES TCI, >98.0%
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Methanol Sigma-Aldrich, HPLC grade
Mn(Oac)2 * 4 H2O ≥99.0 %
Nickel (II) nitrate * 6 H2O Sigma-Aldrich, ≥97.0 %
Ni(OAc)2 * 4 H2O Fisons Laboratory, >98 %
Nitric acid Acros, concentrated
Nitrogen gas Boc
1-Octene Acros, ≥99%
1-Octadecene Sigma-Aldrich, >95%
Palmitic acid BDH, 98%
Potassium phosphate Fisher Scientific, analytical grade
Pt(acac)2 97%
Pd(OAc)2 Acros
Re(CO)5Br Strem, 98%
Sodium Sigma-Aldrich
Sodium chloride Fisher Scientific or Sigma-Aldrich
Styrene Acros
Syn gas Boc
Tetra hydro furane (THF) Fisher Scientific, HPLC grade
Tris(hydroxymethyl) Sigma-Aldrich, ≥99.9%
   aminomethane (Tris) 
Sodium hydroxide Fisher Scientific, analytical grade
Rh(acac)(CO)
2
 Strem, 99%
[Rh(MeCN)2COD] BF4 Aldrich
[Rh(Ph3)3CO] H Strem, 98%
Ru(acac)3 Aldrich
Toluene Sigma-Aldrich
Tris(3-sulfophenyl)phosphine J & K chemical LTD, 95%
   trisodium salt hydrate (TPPTS)
Triton X-100 Sigma-Aldrich
Zn(OAc)2 * 2 H2O Alfa Aesar, >99 %
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ESI-MS data
ESI-MS of artificial metalloenzymes
Metal(X) salts  were used as source (with X being a charge of "+1", "+2" or "+3"),
therefore it is most likely that the metal coordinating to the protein will be present as
metal(X) as well. It can be anticipated that the counterion is dissociating first in the MS
conditions  (positive  ionisation),  resulting  in  a  cationic  metallo-enzyme.  If  this
assumption is correct the detected mass of all artificial metalloenzymes is X Da lower
than the calculated mass as the program (MassLynx MaxEnt algorithm) assumes the
presence of neutral starting species when processing the raw data and calculates as if
each positive charge results from "H+".
The masses mentioned in text and figures only correspond to peak maxima. In general
each peak has a width at half height which corresponds to about  ±5 Da of this value.
Additionally the LC-MS was only calibrated on an irregular basis therefore the obtained
masses may deviate by up to 16 Da from the calculated mass. As all conclusions are
based on the mass differences between two peaks this deviation is not relevant. 
Besides the assigned peaks most spectra show additional peaks which can be assigned
to oxidised species, sodium adducts (up to four Na+ (instead of H+ were detected) and
combinations thereof. These peaks are usually not explicitly mentioned.
Reaction conditons
The reaction conditions for the following figures are specified within the experimental
section of the corresponding chapter. All reactions shown took place in 20 mM MES, 50
mM NaCl, pH=6. Except for PYP R52G, where the same buffer but at a pH of 7 was
used. 
The Picol and Phen-modified proteins were treated with 2 eq. of metal salt and left for 1
day. After 1 day the buffer was exchanged to 20 mM NH4OAc (10000 Da MWCO) and
the  solution  analysed  by ESI-MS.  Subsequently  they  were  treated  with  EDTA and
analysed by ESI-MS again
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Fig. 1 ESI-MS of SCP-2L V83C-Picol + Pd(II)
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Fig. 2 ESI-MS of SCP-2L A100C-Picol + Pd(II).
Fig. 3 ESI-MS of SCP-2L A100C-Picol + Pd(II) after EDTA-treatment.
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Fig 4 ESI-MS of A100C-Phen + Pd(II)
Fig 5 ESI-MS of SCP-2L A100C-Phen + Pd(II) after EDTA treatment.
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Fig. 6 ESI-MS of SCP-2L V83C-Phen + Pd(II)
Fig. 7 top: ESI-MS of SCP-2L A100C-Phen + Mn(II) after EDTA treatment
bottom: ESI-MS of SCP-2L A100C-Phen + Mn(II)
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Fig. 8 ESI-MS of SCP-2L V83C-Phen + Cu(II).
Fig. 9 ESI-MS of SCP-2L V83C-Phen + Ni(II).
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Fig. 10 top: ESI-MS of SCP-2L A100C-Phen + Ni(II) after EDTA treatment
bottom: ESI-MS of SCP-2L A100C-Phen + Ni(II)
Fig. 11 top: ESI-MS of SCP-2L A100C-Phen + Cu(II) after EDTA treatment
bottom: ESI-MS of SCP-2L A100C-Phen + Cu(II)
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Fig. 12 ESI-MS of SCP-2L V83C-Phen + Co(II).
Fig. 13 ESI-MS of SCP-2L A100C-1-P(para) + [Rh(MeCN)2COD]BF4
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Fig. 14 ESI-MS of SCP-2L V83C-1-P(meta) + Rh(acac)(CO)2.
Fig. 15 ESI-MS of SCP-2L V83C-1-P(ortho) + Rh(acac)(CO)2. 
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Default file
13800 13805 13810 13815 13820 13825 13830 13835 13840 13845 13850 13855 13860 13865 13870 13875 13880 13885 13890 13895 13900 13905 13910 13915 13920 13925 13930 13935 13940 13945 13950 13955 13960 13965 13970 13975 13980 13985 13990 13995 14000
mass0
100
%
LO_2013_10_24_V83C-1-P(ortho) + Rh  408 (17.484) M1 [Ev-60327,It27] (Gs,0.560,600:2595,0.10,L33,R33); Cm (283:695) TOF MS ES+ 
4.11e313827
13843
13927
13861 13894
13879
13943
13961
13976
M = 13827 Da 
M = 13843 Da M = 13927 Da 
SCP-2L V83C-1-P(ortho)
SCP-2L V83C-1-P(ortho)=O
SCP-2L V83C-1-P(ortho) + 
100
16200 16220 16240 16260 16280 16300 16320 16340 16360 16380 16400 16420 16440 16460 16480 16500 16520 16540 16560 16580 16600 16620 16640 16660 16680 16700 16720 16740 16760 16780 16800
mass0
100
%
LO_03_08_2011_PYP-1-P+Rh  566 (17.980) M1 [Ev-355330,It11] (Gs,0.680,602:2540,0.10,L33,R33); Cm (543:711) TOF MS ES+ 
1.81e416325
16307
16343
16456
16359
16439
16473
16745
16727
16763
PYP-1-P(para)
PYP-1-P(para) + 18
PYP-1-P(para)-Rh(CO)
M = 16456 Da
?
M = 16325 Da 
PYP-1-P(para)-Rh(CO) + 16
PYP-1-P(para) + 34
Fig. 16 ESI-MS of PYP R52G-1-P(para) + Rh(acac)(CO)2.
Fig. 17 ESI-MS SCP-2L A100C-1-P(para) + Ir(acac)(CO)2.
Fig.  18 ESI-MS Lysozyme-(1)x (TCEP pre treatment).  Used as feedstock in  further
reactions and modifications.
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Fig. 19 top: ESI-MS of Lysozyme-(1)x + P(ortho). 3 eq. of phosphine added and the
mixture left for 2 days. Due to low conversions another 3.8 eq. of the phosphine were
added and the mixture left for 2 days. Due to low conversions another 3.8 eq. of the
phosphine were added and the mixture left for 2 days (no significant reaction progress
could be detected anymore)
Bottom: ESI-MS of Lysozyme-(1)x feedstock.
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Fig. 20 top: ESI-MS of Lysozyme-(1)x + P(para). 5 eq. of phosphine added and the
mixture left for 1 day. Due to low conversions another 10 eq. of the phosphine were
added and the mixture left for 2 days. Due to low conversions another 10 eq. of the
phosphine were added and the mixture left for 3 days (no significant reaction progress
could be detected anymore)
Bottom: ESI-MS of Lysozyme-(1)x feedstock.
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Fig. 21 ESI-MS of SCP-2L A100C-1-P(para) + Rh(acac)(CO)2. 
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Fig. 22 ESI-MS of SCP-2L V83C-1-P(para) + Rh(acac)(CO)2. 
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Scheme 2: Diels-Alder reaction between cyclopentadiene and trans-azachalcone.
Previous investigations (chapter 2) showed a high affinity between the  Phen-modified
protein  to  Cu(II)  and  Co(II),  while  the  affinity  to  Ni(II)  was  smaller.  The  binding
capability of the  Picol-modified protein to each of these metal ions was significantly
smaller. 
The most promising catalyst was the Ni-enzyme of the Phen-modified protein though.
In spite of its (comparably) low affinity towards nickel and therefore a respectively high
concentration of unligated nickel this Ni-enzyme had the most pronounced effect on the
(enantio)selectivity  of  the  reaction.  In  comparision  to  the  unligated  metal  a  much
smaller endo/exo-product ratio as well as 13% ee for the endo-adduct and 29% ee for
the  exo-adduct  was  detected.  This  means  that  the  protein  bound  nickel  has  a  high
preference for  the exo product  and must  induce a  high enantioselectivity as a large
quantity of the catalysis must be determined by unligated nickel. This Ni-enzyme is
therefore worthwhile to be further investigated.
This thesis demonstrates the potential of new artificial metalloenzymes based on the
covalent modification. Besides the optimisation of the tested artificial metalloenzymes it
might be worthwhile to further investigate the potentially interesting catalysts identified
in this thesis. 
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